≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Lactose intolerance

DOID Endpoint Browser

E4_LACTOSEINT

lactose intolerance: Inability to fully digest and absorb lactose due to limited or no lactase activity in the small intestine. Congenital intolerance is inherited following an autosomal recessive pattern but is rare. It is more often due to a gradual decline of lactase production in adulthood following the ingestion of fewer lactose-containing foods or secondary to an intestinal mucosal brush-border injury. Prevalence is highest among Asians, Native Americans and Africans. Clinical signs include abdominal cramping, bloating, flatulence and diarrhea following the dietary intake of lactose.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E73
  • Cause of death: ICD-10 — E73

2 out of 7 registries used, show all original rules.

1038

4. Check minimum number of events

None

1038

5. Include endpoints

1328

6. Filter based on genotype QC (FinnGen only)

1234

Control definitions (FinnGen only)

Control exclude
E4_METABOLIA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E70-E90
Name in latin
Intolerantia lactosi

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1234 855 379
Unadjusted period prevalence (%) 0.26 0.30 0.17
Median age at first event (years) 43.82 42.20 47.46

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1328
Matched controls
13280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
2713A
ICD-9 Finland
Disorders of carbohydrate transport and metabolism, Intestinal disaccharidase deficiencies and disaccharide malabsorption[MALABSORPTIO LACTOSI]
+∞
322.4
296
*
E73.8
ICD-10 Finland
Other lactose intolerance
3793.3
307.7
308
*
E73.9
ICD-10 Finland
Lactose intolerance, unspecified
1783.4
307.7
595
6
E73
ICD-10 Finland
Lactose intolerance
57.4
143.4
81
15
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
7.2
136.6
225
366
E73.0
ICD-10 Finland
Congenital lactase deficiency
+∞
105.7
100
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.4
103.6
726
3497
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.4
100.0
538
2198
A06AC01
ATC
ispaghula (psylla seeds); oral
3.5
99.4
520
2086
UJF32
NOMESCO Finland
Coloscopy
3.4
92.4
478
1891
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
3.7
72.4
274
874
A02BC05
ATC
esomeprazole; systemic
2.5
55.3
618
3468
K90.0
ICD-10 Finland
Coeliac disease
6.0
53.4
98
174
C10AC01
ATC
colestyramine; oral
6.6
53.1
88
141
K59.1
ICD-10 Finland
Functional diarrhoea
4.3
52.8
146
369
A02BC01
ATC
omeprazole; systemic
2.5
52.0
441
2167
A03CA02
ATC
clidinium and psycholeptics; oral
4.8
51.6
123
276
K30
ICD-10 Finland
Functional dyspepsia
3.2
50.1
234
839
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
5.5
49.4
99
191
E73.1
ICD-10 Finland
Secondary lactase deficiency
+∞
48.2
46
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.4
46.1
433
2211
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
5.4
43.5
88
171
A02BC02
ATC
pantoprazole; systemic
2.3
42.2
933
6701
UJD02
NOMESCO Finland
Gastroscopy
4.6
41.9
105
245
N03AX16
ATC
[U] pregabalin
2.5
41.8
341
1623
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.5
39.3
316
1489
A02BA02
ATC
ranitidine; systemic
2.5
39.1
291
1323
A02BC03
ATC
lansoprazole; oral
2.3
38.7
413
2200
J01MA02
ATC
ciprofloxacin; systemic
2.1
35.1
520
3127
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
34.9
466
2695
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
4.4
34.8
90
215
M79.6
ICD-10 Finland
Pain in limb
2.0
34.4
650
4262
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.8
34.3
186
718
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
34.2
320
1601
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
13.0
34.1
33
26
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
33.7
383
2076
R06.0
ICD-10 Finland
Dyspnoea
2.2
33.3
392
2152
A03FA02
ATC
cisapride; oral, rectal
3.3
33.2
135
441
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
9.3
30.5
37
41
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
30.4
595
3897
N06AX21
ATC
duloxetine; oral
2.6
29.9
204
882
Z71.8
ICD-10 Finland
Other specified counselling
2.0
29.8
521
3278
P01AB01
ATC
metronidazole; oral, rectal
1.9
29.8
570
3699
N02AX02
ATC
tramadol; systemic, rectal
1.9
29.6
559
3609
L17
ICPC
Foot/toe symptom/complaint
2.0
29.5
448
2682
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.8
29.5
158
604
J02AC01
ATC
fluconazole; systemic
1.9
28.8
578
3798
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.9
28.5
64
136
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
9.9
27.7
32
33
R51.80
ICD-10 Finland
Headache
2.2
27.6
281
1444
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
5.1
27.4
59
121
R01AD08
ATC
fluticasone; nasal
2.0
27.4
421
2520
R03AC02
ATC
salbutamol; inhalant
1.9
26.8
787
5796
R01AD09
ATC
mometasone; nasal
1.9
26.7
655
4558
D01
ICPC
Abdominal pain/cramps general
2.3
26.6
230
1102
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
26.4
328
1815
G47.3
ICD-10 Finland
Sleep apnoea
2.1
26.3
300
1609
R42
ICD-10 Finland
Dizziness and giddiness
2.1
26.2
320
1760
E87.6
ICD-10 Finland
Hypokalaemia
7.4
26.0
38
53
D06
ICPC
Abdominal pain localized other
2.6
25.8
162
670
M54.5
ICD-10 Finland
Low back pain
1.9
25.7
526
3444
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.4
25.4
94
289
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.1
25.3
71
180
R52.9
ICD-10 Finland
Pain, unspecified
2.5
24.7
173
754
A07EC02
ATC
mesalazine; oral, rectal
3.2
24.6
100
326
R53
ICD-10 Finland
Malaise and fatigue
1.9
24.4
380
2269
D11
ICPC
Diarrhoea
2.3
24.1
216
1048
H02AB04
ATC
methylprednisolone; systemic
2.3
24.0
208
996
A02BC04
ATC
rabeprazole; oral
2.6
23.5
143
582
L03
ICPC
Low back symptom/complaint
1.9
23.4
432
2722
R06AE07
ATC
cetirizine; oral
1.8
23.2
629
4449
Z3226
NOMESCO Finland
Physiotherapist
2.1
23.0
254
1338
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
22.9
280
1533
A07DA03
ATC
loperamide; oral
4.2
22.7
61
150
U07
ICPC
Urine symptom/complaint other
2.6
22.6
137
556
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.9
22.2
383
2354
N06AB04
ATC
citalopram; systemic
2.0
22.2
288
1609
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
22.1
201
979
EB1AA, ,
SPAT
2.9
22.1
112
414
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
21.9
556
3839
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
21.8
214
1075
N05BA04
ATC
oxazepam; oral
1.9
21.8
370
2260
N03AX12
ATC
[U] gabapentin; oral
2.2
21.8
217
1097
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
21.7
428
2740
L01
ICPC
Neck symptom/complaint
2.1
21.7
256
1381
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
21.7
263
1433
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
21.5
137
570
A06AC51
ATC
ispaghula, combinations; oral
3.3
21.1
83
265
M03BX02
ATC
tizanidine; oral
1.8
21.1
804
6203
M79.7
ICD-10 Finland
Fibromyalgia
3.6
20.9
72
211
N05AH04
ATC
quetiapine; oral
2.0
20.9
273
1526
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.8
20.8
108
404
Z01.2
ICD-10 Finland
Dental examination
1.7
20.6
670
4931
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.1
20.6
227
1192
L28
ICPC
Limited function/disability (L)
2.0
20.5
242
1303
N06AX11
ATC
mirtazapine; oral
1.8
20.4
462
3070
N06AX16
ATC
venlafaxine; oral
2.1
20.2
220
1150
UJF30
NOMESCO Finland
Ileoscopy through colon
2.4
19.9
152
686
A07EA06
ATC
budesonide; oral, local oral
3.4
19.6
72
220
M25.5
ICD-10 Finland
Pain in joint
1.8
19.6
464
3117
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.5
19.5
136
589
H02AB06
ATC
prednisolone; systemic
1.7
19.5
599
4320
R02
ICPC
Shortness of breath/dyspnoea
2.2
19.4
190
951
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
19.2
448
2991
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.0
19.2
238
1302
C05AA08
ATC
fluocortolone; rectal, topical
2.2
19.2
178
873
H04.10
ICD-10 Finland
Dry eye syndrome
2.2
19.1
181
894
G44.2
ICD-10 Finland
Tension-type headache
2.1
19.1
215
1136
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.1
19.0
198
1015
WX110, ,
SPAT
2.8
19.0
101
383
A06AD11
ATC
lactulose; oral
2.2
19.0
186
932
SPAT1336
SPAT
Request for examination
3.5
18.8
66
196
J01DA01
ATC
[U] cefalexin
1.7
18.7
796
6231
J01FF01
ATC
clindamycin; systemic
1.8
18.7
349
2180
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.6
18.7
112
451
R4110
NOMESCO Finland
Physiotherapy
1.8
18.7
344
2141
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.9
18.5
92
336
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
18.5
100
382
N06AA09
ATC
amitriptyline; systemic
2.4
18.3
129
561
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
18.3
196
1016
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
18.2
755
5853
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
18.1
223
1216
J01FA10
ATC
azithromycin; systemic
1.7
17.7
800
6320
C07AB07
ATC
bisoprolol; oral
1.7
17.3
520
3696
M01AB05
ATC
diclofenac; systemic, rectal
1.7
17.2
816
6507
C01DA14
ATC
isosorbide mononitrate; oral
2.3
17.0
142
665
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
17.0
184
955
SPAT1212
SPAT
Extensive examination of musculoskeletal system
2.5
17.0
114
485
J01AA02
ATC
doxycycline; systemic
1.7
17.0
965
8053
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
17.0
347
2219
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.5
16.9
106
437
K58
ICD-10 Finland
Irritable bowel syndrome
3.5
16.9
58
170
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
16.8
535
3850
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
16.8
317
1978
M79.1
ICD-10 Finland
Myalgia
1.9
16.8
232
1314
R05
ICPC
Cough
1.7
16.7
355
2295
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.1
16.6
184
964
J01MA12
ATC
levofloxacin; systemic
1.9
16.5
220
1229
R19.4
ICD-10 Finland
Change in bowel habit
3.6
16.5
54
153
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
16.4
370
2428
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
16.4
170
868
A97
ICPC
No disease
1.8
16.2
284
1732
J01FA06
ATC
roxithromycin; oral
1.6
16.2
494
3509
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.1
16.2
178
929
C07AA05
ATC
propranolol; systemic
1.8
16.1
292
1798
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.6
15.9
95
382
A99
ICPC
Disease/condition unspecnature/site
2.2
15.9
152
752
A07EC01
ATC
sulfasalazine; oral, rectal
2.3
15.9
121
545
R03AC03
ATC
terbutaline; inhalant
2.0
15.8
190
1025
A02BA03
ATC
famotidine; systemic
3.5
15.8
54
158
R07.3
ICD-10 Finland
Other chest pain
2.2
15.7
146
714
C10AX09
ATC
ezetimibe; oral
2.1
15.7
155
777
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
15.6
619
4679
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
15.5
266
1609
AA1AD
NOMESCO Finland
CT of head and brain
1.8
15.5
315
2003
L48
ICPC
Musculoskeletal, Clarification/discussion RFE/demand
6.3
15.5
26
42
N05CF02
ATC
zolpidem; oral
1.9
15.5
229
1323
R03BA02
ATC
budesonide; inhalant
1.8
15.4
250
1487
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
15.4
188
1018
R06AX27
ATC
desloratadine; oral
1.7
15.4
419
2884
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.4
15.3
114
508
C10AA05
ATC
atorvastatin; oral
1.7
15.3
393
2663
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
15.2
294
1842
5790A
ICD-9 Finland
Intestinal malabsorption, Coeliac disease
29.0
15.2
20
7
R12
ICD-10 Finland
Heartburn
2.2
15.2
131
622
Z2221
NOMESCO Finland
Medical doctor
1.7
15.1
348
2289
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
15.1
525
3837
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
15.0
290
1817
J45
ICD-10 Finland
Asthma
2.1
14.9
151
763
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
14.9
535
3934
ZXE00
NOMESCO Finland
One hour or less
1.6
14.8
482
3460
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.0
14.8
179
966
M02AA10
ATC
ketoprofen; topical
1.9
14.8
196
1092
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.3
14.7
118
543
M01AE02
ATC
naproxen; oral, rectal
1.6
14.7
755
6030
5641A
ICD-9 Finland
Functional digestive disorders, not elsewhere classified, Irritable colon
25.3
14.7
20
8
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
14.7
446
3148
M01AH01
ATC
celecoxib; oral
1.9
14.7
215
1237
N05BA01
ATC
diazepam; systemic, rectal
2.0
14.6
169
898
A01
ICPC
Pain general/multiple sites
2.1
14.4
140
696
K50.9
ICD-10 Finland
Crohn disease, unspecified
4.7
14.3
33
72
J01FA09
ATC
clarithromycin; systemic
1.6
14.2
408
2836
H02AB07
ATC
prednisone; oral
2.0
14.1
171
922
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
14.1
387
2657
M02AA07
ATC
piroxicam; topical
1.6
14.1
411
2865
N02BE01
ATC
paracetamol; systemic, rectal
1.9
14.1
1139
10138
R10.0
ICD-10 Finland
Acute abdomen
3.2
14.1
55
175
EB1SA, ,
SPAT
2.6
14.0
86
351
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
14.0
158
832
C03CA01
ATC
furosemide; systemic
1.7
14.0
296
1899
A28
ICPC
Limited function/disability NOS
1.9
13.9
189
1061
E86
ICD-10 Finland
Volume depletion
17.8
13.8
21
12
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
13.8
685
5396
R01AD12
ATC
fluticasone furoate; nasal
1.6
13.7
438
3119
J01EA01
ATC
trimethoprim; systemic
1.7
13.7
343
2299
UKC02
NOMESCO Finland
Cystoscopy
2.0
13.7
166
896
A02BX02
ATC
sucralfate; oral
3.1
13.6
56
184
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
13.5
358
2432
A11
ICPC
Chest pain NOS
2.3
13.5
108
496
Z3231
NOMESCO Finland
Registered nurse
1.7
13.5
333
2223
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.6
13.4
79
316
L02
ICPC
Back symptom/complaint
2.0
13.3
159
853
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.2
13.3
53
171
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
13.3
126
621
Z01.7
ICD-10 Finland
Laboratory examination
1.8
13.3
226
1360
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
13.2
142
733
N06AB10
ATC
escitalopram; oral
1.7
13.2
288
1858
M54.3
ICD-10 Finland
Sciatica
2.5
13.2
82
336
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
13.2
281
1803
N17
ICPC
Vertigo/dizziness
1.9
13.1
171
945
N06AB03
ATC
fluoxetine; oral
1.9
13.1
167
917
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.8
13.0
66
244
P06
ICPC
Sleep disturbance
1.9
13.0
186
1061
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
12.9
149
789
1310
FHL
Esophagogastroscopy
19.3
12.9
19
10
A07AA02
ATC
nystatin; oral
2.5
12.9
80
328
S29
ICPC
Skin symptom/complaint other
1.7
12.9
266
1691
D82
ICPC
Teeth/gum disease
1.5
12.8
511
3819
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
12.7
193
1120
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
12.7
409
2909
M54
ICD-10 Finland
Dorsalgia
1.9
12.6
178
1009
N05CF01
ATC
zopiclone; oral
1.6
12.6
373
2599
XQ800
NOMESCO Finland
Prick test
2.1
12.5
117
573
L13
ICPC
Hip symptom/complaint
1.7
12.5
239
1485
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
12.5
287
1875
C10AA07
ATC
rosuvastatin; oral
1.6
12.5
333
2260
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
10.2
12.5
24
24
N05CD07
ATC
temazepam; oral
2.0
12.4
134
694
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
9.1
12.3
25
28
B60
ICPC
Blood and Immunity, Result test/procedure
5.2
12.2
25
49
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.9
12.2
58
207
R00.2
ICD-10 Finland
Palpitations
2.1
12.2
124
628
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
12.1
231
1435
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.1
12.0
126
645
UJF32, ,
SPAT
3.0
12.0
53
182
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
12.0
104
495
K02.1
ICD-10 Finland
Caries of dentine
1.5
11.9
775
6388
WX002
NOMESCO Finland
Sedation and analgesia
1.8
11.9
215
1314
JAH01
NOMESCO Finland
Laparoscopy
2.6
11.9
67
262
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
3.4
11.8
42
126
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
11.8
695
5605
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.7
11.8
37
102
R01AD58
ATC
fluticasone, combinations; nasal
1.6
11.8
348
2418
R05
ICD-10 Finland
Cough
1.7
11.8
283
1869
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
11.7
173
995
H03AA01
ATC
levothyroxine sodium; systemic
1.6
11.7
288
1914
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
5.6
11.7
22
40
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
11.6
289
1923
A08
ICPC
Swelling
2.4
11.6
78
332
J01DB01
ATC
cefalexin; oral
1.6
11.5
1051
9291
M50.3
ICD-10 Finland
Other cervical disc degeneration
3.9
11.5
34
90
N05BE01
ATC
buspirone; oral
3.2
11.5
46
149
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
11.4
117
593
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
11.4
168
965
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
11.4
180
1057
WX290, ,
SPAT
2.8
11.4
57
210
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
11.3
171
990
N01
ICPC
Headache
1.8
11.3
195
1176
K50.8
ICD-10 Finland
Other Crohn disease
4.0
11.2
31
78
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
11.2
129
682
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.6
11.2
66
264
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.4
11.2
75
319
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
11.2
944
8162
L08
ICPC
Shoulder symptom/complaint
1.6
11.2
282
1883
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
3.9
11.1
32
83
A01AB09
ATC
miconazole; local oral
2.1
11.1
112
565
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
11.1
242
1556
N30.0
ICD-10 Finland
Acute cystitis
1.7
11.1
235
1500
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
11.1
240
1541
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
11.0
96
457
U02
ICPC
Urinary frequency/urgency
1.8
11.0
199
1215
R52.2
ICD-10 Finland
Other chronic pain
2.7
11.0
57
214
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.0
11.0
48
164
104
Kela drug reimbursment
Thyroid insufficiency
2.3
11.0
83
373
F34.1
ICD-10 Finland
Dysthymia
2.7
10.9
58
220
R06AX22
ATC
ebastine; oral
1.7
10.9
226
1432
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.8
10.9
181
1078
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
10.9
240
1547
J31.0
ICD-10 Finland
Chronic rhinitis
2.0
10.8
125
662
R15
ICD-10 Finland
Faecal incontinence
3.1
10.8
44
144
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
4.4
10.8
27
63
AN1
HP
Coronary angiography
2.3
10.8
84
382
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.6
10.8
330
2305
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
10.8
528
4079
R06.5
ICD-10 Finland
Mouth breathing
2.1
10.7
111
565
K20
ICD-10 Finland
Oesophagitis
4.6
10.7
25
55
SFA20
NOMESCO Finland
Two-surface restoration
1.5
10.7
744
6153
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
10.7
471
3558
L15
ICPC
Knee symptom/complaint
1.6
10.7
320
2223
M54.2
ICD-10 Finland
Cervicalgia
2.0
10.7
112
573
B01AC04
ATC
clopidogrel; oral
2.0
10.7
129
694
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
10.7
132
716
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.5
10.6
68
283
H53.1
ICD-10 Finland
Subjective visual disturbances
2.2
10.6
92
437
R50.9
ICD-10 Finland
Fever, unspecified
1.7
10.6
201
1242
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
10.6
113
581
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.8
10.6
169
994
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.8
10.6
159
918
L20
ICPC
Joint symptom/complaint NOS
2.7
10.6
58
224
K59.0
ICD-10 Finland
Constipation
2.4
10.6
76
334
S21
ICPC
Skin texture symptom/complaint
1.7
10.5
194
1190
M01AX17
ATC
nimesulide; oral
1.6
10.5
254
1675
D03
ICPC
Heartburn
2.6
10.5
59
231
B03BA03
ATC
hydroxocobalamin; parenteral
2.5
10.5
66
273
N02BF02
ATC
pregabalin; oral
2.2
10.5
89
420
K08.80
ICD-10 Finland
Toothache NOS
1.9
10.5
136
750
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.0
10.4
113
586
N06AX22
ATC
agomelatine; oral
3.1
10.4
42
137
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
10.4
124
665
C07AB02
ATC
metoprolol; systemic
1.7
10.3
196
1212
K50.1
ICD-10 Finland
Crohn disease of large intestine
5.2
10.3
21
41
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.1
10.3
94
456
R03DC03
ATC
montelukast; oral
1.7
10.3
220
1405
M01AX01
ATC
nabumetone; oral
2.7
10.3
54
204
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
10.2
264
1769
R51
ICD-10 Finland
Headache
2.2
10.2
89
425
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
10.1
125
677
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
10.1
172
1030
UJD10, ,
SPAT
3.1
10.1
42
139
ZXD20
NOMESCO Finland
Day surgery
1.8
10.1
156
909
K50.0
ICD-10 Finland
Crohn disease of small intestine
3.8
10.1
30
80
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
3.2
10.1
39
124
N05AF03
ATC
chlorprothixene; systemic
3.3
10.0
38
119
G04BD07
ATC
tolterodine; oral
2.6
10.0
59
236
R11
ICD-10 Finland
Nausea and vomiting
1.9
10.0
121
651
L04AX03
ATC
methotrexate; systemic
1.9
10.0
129
710
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.9
9.9
128
704
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.8
9.9
147
846
R52.0
ICD-10 Finland
Acute pain
2.7
9.9
51
191
C10AX13
ATC
evolocumab; parenteral
16.8
9.9
15
9
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
9.9
286
1968
G04BD08
ATC
solifenacin; oral
2.3
9.8
73
326
SFA10
NOMESCO Finland
One-surface restoration
1.4
9.8
706
5839
R13
ICD-10 Finland
Dysphagia
2.2
9.8
87
418
A62
ICPC
General and Unspecified, Administrative procedure
3.2
9.8
38
121
ZXD05
NOMESCO Finland
Urgent procedure
1.5
9.8
345
2480
G03CA04
ATC
estriol; systemic, vaginal
2.2
9.8
82
385
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.8
9.8
141
804
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.1
9.8
94
466
N39.3
ICD-10 Finland
Stress incontinence
2.1
9.7
96
480
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
9.7
147
850
J45.8
ICD-10 Finland
Mixed asthma
2.9
9.7
45
159
A03DA02
ATC
pitofenone and analgesics; systemic
3.9
9.7
28
73
WX402
NOMESCO Finland
General anaesthesia
1.6
9.7
266
1807
G04BD12
ATC
mirabegron; oral
1.9
9.7
133
747
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
9.7
63
265
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.4
9.7
63
265
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
3.5
9.6
33
97
M54.6
ICD-10 Finland
Pain in thoracic spine
2.0
9.6
104
538
R60.9
ICD-10 Finland
Oedema, unspecified
2.4
9.6
68
297
N06AB06
ATC
sertraline; oral
1.8
9.6
165
992
M01AH05
ATC
etoricoxib; oral
1.4
9.6
754
6327
D19
ICPC
Teeth/gum symptom/complaint
1.5
9.6
411
3075
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
9.6
268
1828
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.9
9.6
131
735
N03AE01
ATC
clonazepam; systemic
2.3
9.5
71
317
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.3
9.5
75
343
R4120
NOMESCO Finland
Occupational therapy
2.2
9.5
79
370
ZXA10
NOMESCO Finland
Bilateral
1.7
9.5
205
1312
M01AH02
ATC
rofecoxib; oral
1.8
9.5
137
782
R63.4
ICD-10 Finland
Abnormal weight loss
2.7
9.4
51
196
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
9.4
885
7666
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
9.4
133
754
K29.1
ICD-10 Finland
Other acute gastritis
4.4
9.4
23
53
T45
ICPC
Metabolic, Observ/health educat/advice/diet
4.4
9.4
23
53
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.4
9.3
61
257
R21
ICPC
Throat symptom/complaint
1.5
9.3
320
2284
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
9.3
920
8036
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
9.3
363
2661
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.8
9.3
137
786
R60.0
ICD-10 Finland
Localized oedema
1.8
9.3
140
809
E0000UV, ,
ATC
1.4
9.3
528
4166
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
9.3
112
603
X58
ICD-10 Finland
Exposure to other specified factors
1.7
9.2
196
1249
G04CA02
ATC
tamsulosin; oral
1.7
9.2
175
1082
M05BA04
ATC
alendronic acid; oral
2.0
9.2
103
540
3015
Kela drug reimbursment
Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia
13.8
9.2
15
11
R05FB02
ATC
cough suppressants and expectorants; systemic
1.5
9.2
410
3088
T78.3
ICD-10 Finland
Angioneurotic oedema
4.0
9.1
25
63
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
9.1
382
2843
F61.0
ICD-10 Finland
Mixed personality disorders
3.6
9.0
29
82
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.5
9.0
54
219
SPAT1342
SPAT
Referral to specialised care
4.2
8.9
23
55
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.5
8.9
345
2521
A04
ICPC
Weakness/tiredness general
1.6
8.9
207
1349
D07AC13
ATC
mometasone; topical
1.5
8.9
340
2481
N06AB05
ATC
paroxetine; oral
2.2
8.8
78
374
D07AA02
ATC
hydrocortisone; topical
1.7
8.8
188
1198
Z71.9
ICD-10 Finland
Counselling, unspecified
1.9
8.8
107
577
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.9
8.8
40
140
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
8.8
272
1895
T78.4
ICD-10 Finland
Allergy, unspecified
2.2
8.8
70
322
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
8.8
101
535
R01AD05
ATC
budesonide; nasal
2.0
8.7
98
514
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
4.2
8.7
23
56
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
8.7
224
1495
R41.3
ICD-10 Finland
Other amnesia
3.1
8.7
35
114
R03BA05
ATC
fluticasone; inhalant
1.6
8.7
232
1562
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.9
8.7
112
616
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
8.7
108
587
J01AA04
ATC
lymecycline; systemic
1.7
8.7
172
1075
N03AG01
ATC
valproic acid; systemic, rectal
2.1
8.7
79
384
M01AC06
ATC
meloxicam; systemic, rectal
1.5
8.7
403
3053
M75
ICD-10 Finland
Shoulder lesions
2.3
8.6
63
279
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.8
8.6
41
147
M70.6
ICD-10 Finland
Trochanteric bursitis
1.7
8.6
164
1013
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
2.0
8.6
89
453
F32
ICD-10 Finland
Depressive episode
2.1
8.6
81
398
ZXA00
NOMESCO Finland
Right side
1.5
8.6
272
1903
D29
ICPC
Digestive symptom/complaint other
3.0
8.6
38
131
D02
ICPC
Abdominal pain epigastric
2.0
8.6
89
454
D62
ICPC
Digestive, Administrative procedure
11.7
8.6
15
13
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.6
8.6
47
182
R4110, ,
SPAT
1.7
8.5
163
1008
R07.0
ICD-10 Finland
Pain in throat
1.9
8.5
106
576
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.7
8.5
155
946
J01DA09
ATC
[U] cefadroxil
1.5
8.5
309
2226
R03BB04
ATC
tiotropium bromide; inhalant
1.9
8.5
103
555
N03AX09
ATC
lamotrigine; oral
2.2
8.5
73
347
K60.1
ICD-10 Finland
Chronic anal fissure
3.1
8.4
34
111
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.0
8.4
90
464
R32
ICD-10 Finland
Unspecified urinary incontinence
2.9
8.4
39
138
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.2
8.4
33
106
N05AA02
ATC
levomepromazine; systemic
2.5
8.4
53
220
R29
ICPC
Respiratory symptom/complaint other
2.0
8.4
93
486
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.5
8.4
51
208
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
8.4
208
1376
KH1AD
NOMESCO Finland
CT of urinary organs
2.7
8.3
45
173
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.0
8.3
84
425
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
8.3
85
432
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
8.3
361
2697
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.2
8.3
71
337
R83
ICPC
Respiratory infection other
1.5
8.3
363
2715
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.4
8.3
55
234
E66.00
ICD-10 Finland
Metabolic syndrome
2.4
8.2
58
253
M01AX05
ATC
glucosamine; oral
1.6
8.2
188
1218
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
3.4
8.2
29
87
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.6
8.2
239
1640
M01AB55
ATC
diclofenac, combinations; oral
2.1
8.2
75
365
P29
ICPC
Psychological sympt/compl other
1.8
8.2
118
673
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
8.2
138
825
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.1
8.2
74
359
ZXD35
NOMESCO Finland
Usual procedure
2.9
8.2
38
135
R20.2
ICD-10 Finland
Paraesthesia of skin
2.0
8.2
93
491
D07AD01
ATC
clobetasol; topical
1.6
8.1
190
1238
R06AE09
ATC
levocetirizine; oral
1.6
8.1
189
1230
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
8.1
583
4761
SFA30
NOMESCO Finland
Three-surface restoration
1.4
8.1
488
3865
K02.2
ICD-10 Finland
Caries of cementum
2.3
8.1
58
255
N41.1
ICD-10 Finland
Chronic prostatitis
3.3
8.1
29
88
E10
ICD-10 Finland
Type 1 diabetes mellitus
3.3
8.1
29
88
H92.0
ICD-10 Finland
Otalgia
1.9
8.1
97
521
XJH10
NOMESCO Finland
Anorectal manometry
11.8
8.1
14
12
M05BA07
ATC
risedronic acid; oral
2.8
8.1
40
147
A01AB04
ATC
amphotericin B; local oral
2.4
8.1
56
243
N02BF01
ATC
gabapentin; oral
1.8
8.1
122
706
D07AC01
ATC
betamethasone; topical
1.4
8.1
414
3187
J37.0
ICD-10 Finland
Chronic laryngitis
2.6
8.0
47
188
H3603, E103,
ICD-10 Finland
10.1
8.0
15
15
U01
ICPC
Dysuria/painful urination
1.8
8.0
111
625
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.0
8.0
35
120
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
1.6
8.0
224
1524
M48.0
ICD-10 Finland
Spinal stenosis
1.8
8.0
129
761
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
8.0
307
2235
C10AA01
ATC
simvastatin; oral
1.5
8.0
328
2420
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
8.0
353
2642
C10AA04
ATC
fluvastatin; oral
2.1
8.0
72
349
P01BA02
ATC
hydroxychloroquine; oral
1.9
8.0
101
553
A10AB04
ATC
insulin lispro; parenteral
2.8
8.0
38
137
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
7.9
87
453
SXC05
NOMESCO Finland
Other oral or dental procedure
1.9
7.9
103
568
F29
ICPC
Eye symptom/complaint other
1.7
7.9
139
840
EBA00, ,
SPAT
2.7
7.9
41
155
M01AG02
ATC
tolfenamic acid; oral, rectal
1.6
7.8
184
1200
H43.1
ICD-10 Finland
Vitreous haemorrhage
3.2
7.8
30
95
U71
ICPC
Cystitis/urinary infection other
1.9
7.8
94
505
XLA10, ,
NOMESCO Finland
2.3
7.8
58
259
D12
ICPC
Constipation
2.5
7.8
49
203
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.5
7.8
47
191
1370
FHL
Colonoscopy, whole colon
10.9
7.8
14
13
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.0
7.8
88
463
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
7.0
7.8
18
26
G04BD11
ATC
fesoterodine; oral
3.1
7.8
32
106
R06AX26
ATC
fexofenadine; oral
1.9
7.8
95
514
I25.2
ICD-10 Finland
Old myocardial infarction
2.5
7.7
48
198
N06AX05
ATC
trazodone; oral
2.9
7.7
35
123
G04CA01
ATC
alfuzosin; oral
1.9
7.7
95
516
S18
ICPC
Laceration/cut
1.4
7.7
529
4280
H03BB01
ATC
carbimazole; oral
2.5
7.6
48
199
XF402
NOMESCO Finland
ECG with work load test
1.9
7.6
92
495
U72
ICPC
Urethritis
2.8
7.6
36
129
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.9
7.6
34
118
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.3
7.6
55
243
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.1
7.6
31
102
5301A
ICD-9 Finland
Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]
8.1
7.6
16
20
7879X
ICD-9 Finland
Symptoms involving digestive system, Other symptoms involving digestive system
8.1
7.6
16
20
J20
ICD-10 Finland
Acute bronchitis
1.7
7.6
130
780
B81
ICPC
Anaemia vit B12/folate deficiency
2.6
7.6
41
158
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
7.6
143
882
WVA30, ,
SPAT
2.0
7.6
75
377
N30
ICD-10 Finland
Cystitis
1.8
7.5
115
668
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.4
7.5
355
2686
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.1
7.5
69
337
P03
ICPC
Feeling depressed
1.7
7.5
154
971
A03
ICPC
Fever
1.5
7.5
242
1698
R74
ICPC
Upper respiratory infection acute
1.4
7.5
458
3628
A10AE04
ATC
insulin glargine; parenteral
1.9
7.4
90
485
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
3.0
7.4
32
109
N02AJ13
ATC
tramadol and paracetamol; systemic
3.0
7.4
32
109
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.2
7.4
58
266
N06AX03
ATC
mianserin; oral
2.2
7.4
58
266
F45.8
ICD-10 Finland
Other somatoform disorders
1.9
7.4
98
545
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
7.3
101
568
L12
ICPC
Hand/finger symptom/complaint
1.5
7.3
221
1527
R06AX13
ATC
loratadine; oral
1.6
7.3
189
1261
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.5
7.3
44
179
A48
ICPC
General and Unspecified, Clarification/discussion RFE/demand
1.9
7.3
91
496
M05BX04
ATC
denosumab; parenteral
2.1
7.3
66
321
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
2.9
7.2
33
116
L86
ICPC
Back syndrome with radiating pain
2.0
7.2
75
384
N76.0
ICD-10 Finland
Acute vaginitis
1.8
7.2
102
579
5645A
ICD-9 Finland
Functional digestive disorders, not elsewhere classified, Functional diarrhoea
20.1
7.1
10
5
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.1
7.1
64
310
F45.0
ICD-10 Finland
Somatization disorder
8.0
7.1
15
19
R5110, ,
SPAT
1.9
7.1
91
500
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
7.1
241
1707
N06AA12
ATC
doxepin; systemic
2.2
7.1
57
264
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
7.1
113
665
XCK10
NOMESCO Finland
Photography of fundus of eye
1.9
7.1
90
494
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.7
7.0
118
704
R14
ICD-10 Finland
Flatulence and related conditions
4.2
7.0
18
43
I20.09
ICD-10 Finland
Unstable angina
2.4
7.0
46
195
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
3.0
7.0
30
102
BAA60
NOMESCO Finland
Total thyroidectomy
3.3
7.0
25
76
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
3.3
7.0
25
76
L16
ICPC
Ankle symptom/complaint
1.6
7.0
155
997
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.7
6.9
121
731
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
7.6
6.9
15
20
K29.7
ICD-10 Finland
Gastritis, unspecified
2.5
6.9
43
178
P76
ICPC
Depressive disorder
1.8
6.9
98
557
R03AK08
ATC
formoterol and beclometasone; inhalant
2.1
6.9
61
294
T90
ICPC
Diabetes non-insulin dependent
1.5
6.9
210
1454
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
6.9
117
701
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
6.9
68
342
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
6.9
154
993
A10AB05
ATC
insulin aspart; parenteral
2.0
6.9
76
398
L01BA01
ATC
methotrexate; systemic
2.4
6.8
47
204
UJF02
NOMESCO Finland
Peroral enteroscopy
11.0
6.8
12
11
F51.0
ICD-10 Finland
Nonorganic insomnia
1.5
6.8
226
1593
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.7
6.8
34
126
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.9
6.8
30
104
B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
2.9
6.8
30
104
S06.0
ICD-10 Finland
Concussion
1.7
6.8
133
829
105
Kela drug reimbursment
Adrenal cortical hypofunction
40.3
6.8
8
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.0
6.8
74
386
N20.1
ICD-10 Finland
Calculus of ureter
2.6
6.7
38
150
X15
ICPC
Vaginal symptom/complaint other
2.1
6.7
65
324
T89
ICPC
Diabetes insulin dependent
2.3
6.7
49
218
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
3.4
6.7
23
68
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.4
6.7
514
4206
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
6.7
201
1388
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
6.6
72
374
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
6.6
231
1643
M54.1
ICD-10 Finland
Radiculopathy
2.3
6.6
46
200
N02AC04
ATC
dextropropoxyphene; oral
2.5
6.6
39
157
M19.2
ICD-10 Finland
Other secondary arthrosis
4.0
6.6
18
45
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.7
6.6
136
858
294
Kela drug reimbursment
Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia
12.3
6.6
11
9
5355X
ICD-9 Finland
Gastritis and duodenitis, Unspecified gastritis and gastroduodenitis
12.3
6.6
11
9
D93
ICPC
Irritable bowel syndrome
3.3
6.6
24
74
T99
ICPC
Endocr/metab/nutrit disease other
3.4
6.6
23
69
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.0
6.6
72
376
UJF92
NOMESCO Finland
Capsular endoscopy
2.9
6.6
30
106
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.2
6.5
54
253
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.7
6.5
113
680
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.0
6.5
27
90
E66
ICD-10 Finland
Obesity
2.0
6.5
72
377
J01MA01
ATC
ofloxacin; systemic
1.9
6.5
86
478
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
6.5
223
1583
D01AE16
ATC
amorolfine; topical
1.7
6.5
124
768
K29.4
ICD-10 Finland
Chronic atrophic gastritis
3.2
6.5
25
80
D09
ICPC
Nausea
2.0
6.5
70
364
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
6.4
88
494
S01GX02
ATC
levocabastine; ophthalmic
1.9
6.4
76
407
T29
ICPC
Endocr/metab/nutr sympt/compl other
3.0
6.4
27
91
R63.1
ICD-10 Finland
Polydipsia
14.4
6.4
10
7
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
6.4
441
3543
A10AC01
ATC
insulin (human); parenteral
1.9
6.4
81
445
M54.8
ICD-10 Finland
Other dorsalgia
2.1
6.3
59
290
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
6.3
91
519
A10AA01, ,
ATC
2.9
6.3
28
97
E83.50
ICD-10 Finland
Hypercalcemia
8.2
6.3
13
16
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.4
6.3
358
2783
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
6.3
108
648
N05AX12
ATC
aripiprazole; systemic
2.1
6.3
61
304
N41.0
ICD-10 Finland
Acute prostatitis
3.6
6.3
20
56
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.3
6.3
47
211
J01CA04
ATC
amoxicillin; systemic
1.4
6.3
1046
9599
J01MA06
ATC
norfloxacin; oral
1.6
6.3
144
932
U13
ICPC
Bladder symptom/complaint other
2.6
6.3
35
137
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.2
6.3
49
224
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.3
6.3
46
205
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
6.3
88
498
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
6.3
134
853
K58.1
ICD-10 Finland
Irritable bowel syndrome with predominant diarrhoea [IBS-D]
3.9
6.3
18
47
U04
ICPC
Incontinence urine
2.0
6.3
65
333
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.6
6.3
158
1048
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
6.2
153
1008
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.2
6.2
50
232
G03FB06
ATC
medroxyprogesterone and estrogen; systemic
1.8
6.2
83
463
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.0
6.2
66
341
K80
ICPC
Cardiac arrhythmia NOS
1.8
6.2
94
545
K03.80
ICD-10 Finland
Irradiated enamel
1.9
6.2
79
434
A98
ICD-10 Finland
Other viral haemorrhagic fevers, not elsewhere classified
3.2
6.2
24
77
H29
ICPC
Ear symptom/complaint other
1.6
6.2
142
921
A11CC03
ATC
alfacalcidol; systemic
3.5
6.2
20
57
K02.0
ICD-10 Finland
Caries limited to enamel
1.4
6.2
283
2121
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
6.2
50
233
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
2.0
6.2
65
335
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
6.1
109
661
K03.28
ICD-10 Finland
Other erosion of teeth
2.5
6.1
37
151
S22
ICPC
Nail symptom/complaint
1.9
6.1
81
450
LCA06
NOMESCO Finland
Biopsy of endometrium
1.6
6.1
132
842
L95
ICPC
Osteoporosis
2.3
6.1
45
201
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.0
6.1
26
88
K58.8
ICD-10 Finland
Other and unspecified irritable bowel syndrome
7.7
6.1
13
17
R96
ICPC
Asthma
1.7
6.1
112
685
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
2.7
6.1
31
116
UJH02
NOMESCO Finland
Anoscopy
2.3
6.1
43
189
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.0
6.1
66
344
5621A
ICD-9 Finland
Diverticula of intestine, Colon[DIVERTICULOSIS COLI]
8.6
6.1
12
14
SPAT1325
SPAT
Vaccination
1.4
6.0
369
2902
N20.0
ICD-10 Finland
Calculus of kidney
3.2
6.0
23
73
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
3.2
6.0
23
73
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
3.0
6.0
26
89
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
1.8
6.0
92
535
H02AB09
ATC
hydrocortisone; systemic
2.7
6.0
31
117
WX290
NOMESCO Finland
Other blockage of nerve
1.3
6.0
603
5111
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.4
6.0
21
63
M04AA01
ATC
allopurinol; systemic
1.7
6.0
103
619
N03AF01
ATC
carbamazepine; oral, rectal
2.1
6.0
55
269
U05
ICPC
Urination problems other
2.1
6.0
55
269
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
6.1
6.0
15
25

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Internal Medicine
11 [38004456]
8.6e-01
1.3e+00
2.2e+00
6.6e+00
2.2e+00
1.5e+00
9.4e-01
cases:26.26%
controls:13.06%
cases:19.57%
controls:5.95%
cases:7.84%
controls:0.90%
cases:40.71%
controls:0.09%
cases:8.03%
controls:0.95%
cases:21.53%
controls:5.60%
cases:31.77%
controls:15.39%
318
1559
893
10379
237
710
974
11228
95
108
1116
11830
493
11
718
11927
97
113
1111
11816
254
656
926
11053
338
1605
726
8822
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
6.0e-01
2.2e+00
3.7e+00
1.0e+50
3.1e+00
1.6e+00
1.2e+00
cases:4.54%
controls:2.55%
cases:5.86%
controls:0.70%
cases:1.73%
controls:0.04%
cases:4.21%
controls:0.00%
cases:0.91%
controls:0.04%
cases:3.47%
controls:0.72%
cases:7.24%
controls:2.22%
55
305
1156
11633
71
83
1140
11855
21
5
1190
11933
51
0
1160
11938
11
5
1197
11924
41
84
1139
11625
77
231
987
10196
Pure hypercholesterolaemia
E78.01 [2000501514]
2.1e+00
1.9e+00
—
1.0e+50
3.7e+00
2.8e+00
1.6e+00
cases:3.72%
controls:0.49%
cases:2.23%
controls:0.33%
—
—
cases:5.86%
controls:0.00%
cases:1.74%
controls:0.04%
cases:4.24%
controls:0.28%
cases:3.85%
controls:0.78%
45
58
1166
11880
27
39
1184
11899
—
71
0
1140
11938
21
5
1187
11924
50
33
1130
11676
41
81
1023
10346
Other and unspecified abdominal pain
R10.4 [45568113]
1.3e+00
2.3e+00
3.3e+00
1.0e+50
2.3e+00
1.5e+00
1.3e+00
cases:11.48%
controls:3.51%
cases:11.15%
controls:1.25%
cases:4.05%
controls:0.15%
cases:3.22%
controls:0.00%
cases:1.99%
controls:0.20%
cases:5.42%
controls:1.26%
cases:13.44%
controls:4.11%
139
419
1072
11519
135
149
1076
11789
49
18
1162
11920
39
0
1172
11938
24
24
1184
11905
64
148
1116
11561
143
429
921
9998
Gastroenterology
10 [38004455]
6.3e-01
1.7e+00
3.3e+00
1.0e+50
2.7e+00
2.0e+00
1.1e+00
cases:5.20%
controls:2.85%
cases:6.44%
controls:1.21%
cases:4.05%
controls:0.15%
cases:13.13%
controls:0.00%
cases:2.65%
controls:0.18%
cases:7.46%
controls:1.11%
cases:9.12%
controls:3.14%
63
340
1148
11598
78
145
1133
11793
49
18
1162
11920
159
0
1052
11938
32
22
1176
11907
88
130
1092
11579
97
327
967
10100
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
1.1e+00
2.0e+00
3.3e+00
—
2.7e+00
1.3e+00
1.1e+00
cases:4.54%
controls:1.63%
cases:5.53%
controls:0.81%
cases:1.82%
controls:0.07%
—
—
cases:0.75%
controls:0.05%
cases:2.46%
controls:0.70%
cases:4.32%
controls:1.55%
55
195
1156
11743
67
97
1144
11841
22
8
1189
11930
—
9
6
1199
11923
29
82
1151
11627
46
162
1018
10265
Outpatient Visit
OP [9202]
4.7e-01
8.4e-01
1.2e+00
5.8e+00
1.2e+00
9.5e-01
7.6e-01
cases:65.32%
controls:54.10%
cases:58.38%
controls:37.74%
cases:21.97%
controls:7.62%
cases:51.69%
controls:0.32%
cases:22.93%
controls:8.16%
cases:58.73%
controls:35.40%
cases:76.41%
controls:60.30%
791
6459
420
5479
707
4505
504
7433
266
910
945
11028
626
38
585
11900
277
973
931
10956
693
4145
487
7564
813
6288
251
4139
Coloscopy
UJF32 [2001305029]
5.6e-01
2.1e+00
3.8e+00
1.0e+50
2.5e+00
1.8e+00
1.0e+00
cases:3.47%
controls:2.01%
cases:4.71%
controls:0.62%
cases:2.48%
controls:0.06%
cases:5.45%
controls:0.00%
cases:0.91%
controls:0.08%
cases:3.14%
controls:0.51%
cases:5.64%
controls:2.15%
42
240
1169
11698
57
74
1154
11864
30
7
1181
11931
66
0
1145
11938
11
9
1197
11920
37
60
1143
11649
60
224
1004
10203
Irritable bowel syndrome with diarrhoea
K58.0 [45596336]
1.7e+00
3.5e+00
—
—
—
3.6e+00
1.9e+00
cases:1.90%
controls:0.34%
cases:2.48%
controls:0.08%
—
—
—
—
—
—
cases:3.47%
controls:0.10%
cases:2.73%
controls:0.42%
23
41
1188
11897
30
9
1181
11929
—
—
—
41
12
1139
11697
29
44
1035
10383
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
9.4e-01
2.0e+00
3.4e+00
—
2.3e+00
1.1e+00
8.3e-01
cases:6.52%
controls:2.66%
cases:6.61%
controls:0.93%
cases:2.31%
controls:0.08%
—
—
cases:0.58%
controls:0.06%
cases:2.12%
controls:0.71%
cases:5.08%
controls:2.27%
79
318
1132
11620
80
111
1131
11827
28
9
1183
11929
—
7
7
1201
11922
25
83
1155
11626
54
237
1010
10190
ispaghula (psylla seeds); oral
A06AC01 [21600555]
1.3e+00
1.9e+00
1.6e+00
—
2.4e+00
1.9e+00
1.3e+00
cases:6.77%
controls:2.02%
cases:6.52%
controls:0.99%
cases:1.16%
controls:0.24%
—
—
cases:1.90%
controls:0.17%
cases:6.78%
controls:1.04%
cases:7.52%
controls:2.09%
82
241
1129
11697
79
118
1132
11820
14
29
1197
11909
—
23
20
1185
11909
80
122
1100
11587
80
218
984
10209
Inpatient Hospital
21 [8717]
3.9e-01
6.7e-01
9.1e-01
5.4e+00
1.5e+00
7.7e-01
5.8e-01
cases:33.53%
controls:25.49%
cases:15.19%
controls:8.43%
cases:2.64%
controls:1.08%
cases:12.88%
controls:0.07%
cases:4.30%
controls:1.01%
cases:15.68%
controls:7.94%
cases:36.84%
controls:24.62%
406
3043
805
8895
184
1006
1027
10932
32
129
1179
11809
156
8
1055
11930
52
121
1156
11808
185
930
995
10779
392
2567
672
7860
General Practice
1 [38004446]
4.8e-01
6.0e-01
1.7e+00
4.8e+00
1.2e+00
5.5e-01
6.9e-01
cases:12.39%
controls:8.01%
cases:5.70%
controls:3.22%
cases:2.15%
controls:0.40%
cases:4.62%
controls:0.04%
cases:1.49%
controls:0.46%
cases:5.93%
controls:3.52%
cases:16.35%
controls:8.97%
150
956
1061
10982
69
385
1142
11553
26
48
1185
11890
56
5
1155
11933
18
55
1190
11874
70
412
1110
11297
174
935
890
9492
Functional diarrhoea
K59.1 [45543327]
2.3e+00
3.5e+00
—
1.0e+50
—
2.4e+00
1.6e+00
cases:1.98%
controls:0.19%
cases:1.82%
controls:0.06%
—
—
cases:1.07%
controls:0.00%
—
—
cases:0.76%
controls:0.07%
cases:1.32%
controls:0.26%
24
23
1187
11915
22
7
1189
11931
—
13
0
1198
11938
—
9
8
1171
11701
14
27
1050
10400
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
1.2e+00
1.3e+00
2.3e+00
—
2.3e+00
1.3e+00
1.3e+00
cases:5.04%
controls:1.62%
cases:3.39%
controls:0.90%
cases:0.99%
controls:0.10%
—
—
cases:1.16%
controls:0.12%
cases:3.14%
controls:0.84%
cases:5.64%
controls:1.60%
61
193
1150
11745
41
108
1170
11830
12
12
1199
11926
—
14
14
1194
11915
37
98
1143
11611
60
167
1004
10260
Papillary carcinoma of the thyroid gland (thyroid gland)
C73.91 [2000501197]
2.3e+00
2.4e+00
—
—
—
2.6e+00
1.9e+00
cases:0.74%
controls:0.08%
cases:0.58%
controls:0.05%
—
—
—
—
—
—
cases:0.59%
controls:0.04%
cases:0.66%
controls:0.10%
9
9
1202
11929
7
6
1204
11932
—
—
—
7
5
1173
11704
7
10
1057
10417
mesalazine; oral, rectal
A07EC02 [21600664]
1.2e+00
1.5e+00
1.5e+00
—
1.8e+00
1.4e+00
1.8e+00
cases:1.82%
controls:0.58%
cases:2.06%
controls:0.48%
cases:0.83%
controls:0.18%
—
—
cases:1.08%
controls:0.18%
cases:2.20%
controls:0.56%
cases:3.38%
controls:0.60%
22
69
1189
11869
25
57
1186
11881
10
22
1201
11916
—
13
22
1195
11907
26
65
1154
11644
36
63
1028
10364
Coeliac disease
K90.0 [45586745]
1.6e+00
2.2e+00
2.3e+00
1.0e+50
—
3.1e+00
2.2e+00
cases:2.15%
controls:0.45%
cases:1.90%
controls:0.21%
cases:0.41%
controls:0.04%
cases:4.13%
controls:0.00%
—
—
cases:2.88%
controls:0.14%
cases:4.32%
controls:0.51%
26
54
1185
11884
23
25
1188
11913
5
5
1206
11933
50
0
1161
11938
—
34
16
1146
11693
46
53
1018
10374
Irritable bowel syndrome without diarrhoea
K58.9 [45538539]
1.8e+00
2.0e+00
—
1.0e+50
1.0e+50
3.3e+00
1.9e+00
cases:0.91%
controls:0.15%
cases:0.66%
controls:0.09%
—
—
cases:2.06%
controls:0.00%
cases:0.75%
controls:0.00%
cases:1.53%
controls:0.06%
cases:1.32%
controls:0.19%
11
18
1200
11920
8
11
1203
11927
—
25
0
1186
11938
9
0
1199
11929
18
7
1162
11702
14
20
1050
10407
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
6.9e-01
1.0e+00
1.9e+00
—
2.5e+00
1.4e+00
1.3e+00
cases:6.11%
controls:3.16%
cases:3.55%
controls:1.29%
cases:1.16%
controls:0.17%
—
—
cases:1.90%
controls:0.16%
cases:4.15%
controls:1.01%
cases:7.14%
controls:2.06%
74
377
1137
11561
43
154
1168
11784
14
20
1197
11918
—
23
19
1185
11910
49
118
1131
11591
76
215
988
10212
colestyramine; oral
C10AC01 [21601876]
1.9e+00
2.3e+00
—
—
—
2.1e+00
2.5e+00
cases:0.74%
controls:0.11%
cases:0.66%
controls:0.07%
—
—
—
—
—
—
cases:0.85%
controls:0.10%
cases:1.50%
controls:0.12%
9
13
1202
11925
8
8
1203
11930
—
—
—
10
12
1170
11697
16
13
1048
10414
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
1.2e+00
1.2e+00
1.9e+00
—
2.1e+00
1.2e+00
1.2e+00
cases:4.87%
controls:1.58%
cases:3.39%
controls:1.02%
cases:0.99%
controls:0.14%
—
—
cases:1.16%
controls:0.14%
cases:3.31%
controls:1.04%
cases:5.73%
controls:1.76%
59
189
1152
11749
41
122
1170
11816
12
17
1199
11921
—
14
17
1194
11912
39
122
1141
11587
61
184
1003
10243
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
5.4e-01
1.4e+00
2.0e+00
—
2.9e+00
1.5e+00
9.9e-01
cases:2.15%
controls:1.26%
cases:1.73%
controls:0.44%
cases:0.50%
controls:0.07%
—
—
cases:1.24%
controls:0.07%
cases:2.20%
controls:0.50%
cases:3.20%
controls:1.21%
26
150
1185
11788
21
53
1190
11885
6
8
1205
11930
—
15
8
1193
11921
26
59
1154
11650
34
126
1030
10301
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
4.2e-01
8.3e-01
1.7e+00
3.3e+00
1.2e+00
5.9e-01
6.2e-01
cases:15.52%
controls:10.75%
cases:12.80%
controls:5.99%
cases:5.28%
controls:1.01%
cases:1.16%
controls:0.04%
cases:3.73%
controls:1.12%
cases:9.92%
controls:5.75%
cases:18.52%
controls:10.92%
188
1283
1023
10655
155
715
1056
11223
64
121
1147
11817
14
5
1197
11933
45
134
1163
11795
117
673
1063
11036
197
1139
867
9288
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.5e-01
5.4e-01
1.2e+00
4.3e+00
1.1e+00
5.0e-01
3.9e-01
cases:18.58%
controls:13.86%
cases:16.76%
controls:10.47%
cases:6.11%
controls:1.88%
cases:3.72%
controls:0.05%
cases:5.96%
controls:2.11%
cases:16.19%
controls:10.53%
cases:21.43%
controls:15.63%
225
1655
986
10283
203
1250
1008
10688
74
225
1137
11713
45
6
1166
11932
72
252
1136
11677
191
1233
989
10476
228
1630
836
8797
Pain localized to other parts of lower abdomen
R10.3 [45534426]
1.2e+00
1.7e+00
—
—
3.1e+00
1.3e+00
1.2e+00
cases:6.03%
controls:1.94%
cases:3.72%
controls:0.70%
—
—
—
—
cases:1.08%
controls:0.05%
cases:2.37%
controls:0.68%
cases:7.33%
controls:2.44%
73
232
1138
11706
45
83
1166
11855
—
—
13
6
1195
11923
28
80
1152
11629
78
254
986
10173
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
3.2e-01
6.6e-01
1.4e+00
3.7e+00
1.3e+00
5.7e-01
3.2e-01
cases:21.47%
controls:16.59%
cases:20.89%
controls:11.97%
cases:8.75%
controls:2.35%
cases:4.05%
controls:0.10%
cases:7.95%
controls:2.31%
cases:18.98%
controls:11.69%
cases:25.00%
controls:19.54%
260
1981
951
9957
253
1429
958
10509
106
280
1105
11658
49
12
1162
11926
96
276
1112
11653
224
1369
956
10340
266
2037
798
8390
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
4.1e-01
6.4e-01
1.4e+00
3.5e+00
1.3e+00
6.2e-01
4.3e-01
cases:21.06%
controls:15.09%
cases:19.32%
controls:11.22%
cases:8.34%
controls:2.20%
cases:4.13%
controls:0.13%
cases:7.70%
controls:2.32%
cases:18.47%
controls:10.84%
cases:23.78%
controls:16.93%
255
1801
956
10137
234
1340
977
10598
101
263
1110
11675
50
15
1161
11923
93
277
1115
11652
218
1269
962
10440
253
1765
811
8662
loperamide; oral
A07DA03 [21600646]
1.2e+00
1.7e+00
2.0e+00
—
2.1e+00
1.6e+00
1.6e+00
cases:2.15%
controls:0.68%
cases:1.90%
controls:0.36%
cases:0.41%
controls:0.06%
—
—
cases:0.75%
controls:0.09%
cases:1.86%
controls:0.40%
cases:3.48%
controls:0.74%
26
81
1185
11857
23
43
1188
11895
5
7
1206
11931
—
9
11
1199
11918
22
47
1158
11662
37
77
1027
10350
loperamide oxide; oral
A07DA05 [21600648]
1.2e+00
1.7e+00
2.0e+00
—
2.1e+00
1.6e+00
1.6e+00
cases:2.15%
controls:0.68%
cases:1.90%
controls:0.36%
cases:0.41%
controls:0.06%
—
—
cases:0.75%
controls:0.09%
cases:1.86%
controls:0.40%
cases:3.48%
controls:0.74%
26
81
1185
11857
23
43
1188
11895
5
7
1206
11931
—
9
11
1199
11918
22
47
1158
11662
37
77
1027
10350
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.5e-01
6.3e-01
1.5e+00
3.5e+00
1.4e+00
4.6e-01
4.4e-01
cases:20.73%
controls:16.97%
cases:17.42%
controls:10.14%
cases:7.18%
controls:1.67%
cases:3.88%
controls:0.12%
cases:6.46%
controls:1.75%
cases:14.92%
controls:9.97%
cases:26.60%
controls:18.98%
251
2026
960
9912
211
1211
1000
10727
87
199
1124
11739
47
14
1164
11924
78
209
1130
11720
176
1167
1004
10542
283
1979
781
8448
Pain localized to upper abdomen
R10.1 [45568111]
1.0e+00
1.7e+00
2.4e+00
1.0e+50
1.8e+00
1.5e+00
1.1e+00
cases:3.14%
controls:1.16%
cases:2.64%
controls:0.49%
cases:0.58%
controls:0.05%
cases:0.99%
controls:0.00%
cases:0.41%
controls:0.07%
cases:1.78%
controls:0.42%
cases:3.48%
controls:1.13%
38
138
1173
11800
32
59
1179
11879
7
6
1204
11932
12
0
1199
11938
5
8
1203
11921
21
49
1159
11660
37
118
1027
10309
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
8.8e-01
1.8e+00
3.4e+00
—
1.6e+00
8.9e-01
7.3e-01
cases:7.10%
controls:3.08%
cases:6.85%
controls:1.16%
cases:2.48%
controls:0.08%
—
—
cases:0.50%
controls:0.10%
cases:2.29%
controls:0.95%
cases:5.73%
controls:2.86%
86
368
1125
11570
83
139
1128
11799
30
10
1181
11928
—
6
12
1202
11917
27
111
1153
11598
61
298
1003
10129
Bacteria [Presence] in Urine
87829-8 [36304419]
9.0e-01
9.3e-01
1.7e+00
—
1.8e+00
1.2e+00
1.1e+00
cases:6.85%
controls:2.91%
cases:3.72%
controls:1.50%
cases:0.99%
controls:0.18%
—
—
cases:1.16%
controls:0.20%
cases:4.15%
controls:1.33%
cases:7.61%
controls:2.69%
83
347
1128
11591
45
179
1166
11759
12
22
1199
11916
—
14
24
1194
11905
49
156
1131
11553
81
281
983
10146
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
9.5e-01
1.4e+00
1.9e+00
—
1.6e+00
1.1e+00
5.7e-01
cases:6.28%
controls:2.51%
cases:5.86%
controls:1.46%
cases:1.32%
controls:0.21%
—
—
cases:0.99%
controls:0.20%
cases:4.49%
controls:1.60%
cases:6.48%
controls:3.78%
76
300
1135
11638
71
174
1140
11764
16
25
1195
11913
—
12
24
1196
11905
53
187
1127
11522
69
394
995
10033
Leukocytes [#/volume] in Urine
30405-5 [3018095]
9.7e-01
1.2e+00
1.6e+00
—
1.6e+00
1.1e+00
9.2e-01
cases:9.41%
controls:3.80%
cases:6.94%
controls:2.20%
cases:1.57%
controls:0.31%
—
—
cases:1.41%
controls:0.28%
cases:6.10%
controls:2.14%
cases:10.15%
controls:4.33%
114
454
1097
11484
84
263
1127
11675
19
37
1192
11901
—
17
33
1191
11896
72
251
1108
11458
108
451
956
9976
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
8.5e-01
9.2e-01
1.6e+00
—
1.8e+00
1.1e+00
1.1e+00
cases:6.61%
controls:2.95%
cases:3.72%
controls:1.52%
cases:0.99%
controls:0.21%
—
—
cases:1.16%
controls:0.19%
cases:4.32%
controls:1.42%
cases:7.99%
controls:2.84%
80
352
1131
11586
45
181
1166
11757
12
25
1199
11913
—
14
23
1194
11906
51
166
1129
11543
85
296
979
10131
ranitidine bismuth citrate; oral
A02BA07 [21600088]
1.1e+00
1.7e+00
2.2e+00
—
1.4e+00
1.3e+00
1.2e+00
cases:4.13%
controls:1.48%
cases:2.39%
controls:0.44%
cases:0.58%
controls:0.07%
—
—
cases:0.50%
controls:0.12%
cases:1.69%
controls:0.48%
cases:5.17%
controls:1.67%
50
177
1161
11761
29
53
1182
11885
7
8
1204
11930
—
6
14
1202
11915
20
56
1160
11653
55
174
1009
10253
ranitidine; oral, parenteral
A02BA02 [21600083]
1.1e+00
1.7e+00
2.2e+00
—
1.4e+00
1.3e+00
1.2e+00
cases:4.13%
controls:1.48%
cases:2.39%
controls:0.44%
cases:0.58%
controls:0.07%
—
—
cases:0.50%
controls:0.12%
cases:1.69%
controls:0.48%
cases:5.17%
controls:1.67%
50
177
1161
11761
29
53
1182
11885
7
8
1204
11930
—
6
14
1202
11915
20
56
1160
11653
55
174
1009
10253
pH of Serum or Plasma
2753-2 [3018418]
6.0e-01
1.2e+00
1.7e+00
—
1.9e+00
1.1e+00
9.6e-01
cases:6.52%
controls:3.68%
cases:5.28%
controls:1.71%
cases:1.16%
controls:0.22%
—
—
cases:1.24%
controls:0.19%
cases:4.32%
controls:1.52%
cases:7.52%
controls:3.01%
79
439
1132
11499
64
204
1147
11734
14
26
1197
11912
—
15
23
1193
11906
51
178
1129
11531
80
314
984
10113
clidinium and psycholeptics
A03CA02 [21600204]
1.4e+00
2.5e+00
—
—
—
1.8e+00
1.5e+00
cases:2.48%
controls:0.60%
cases:2.39%
controls:0.19%
—
—
—
—
—
—
cases:1.36%
controls:0.22%
cases:3.29%
controls:0.74%
30
72
1181
11866
29
23
1182
11915
—
—
—
16
26
1164
11683
35
77
1029
10350
Physiotherapy
R4110 [2001310233]
1.1e+00
8.3e-01
1.8e+00
1.0e+50
2.6e+00
1.7e+00
1.1e+00
cases:7.35%
controls:2.56%
cases:2.06%
controls:0.91%
cases:0.58%
controls:0.10%
cases:0.91%
controls:0.00%
cases:1.08%
controls:0.08%
cases:3.22%
controls:0.63%
cases:5.73%
controls:2.03%
89
306
1122
11632
25
109
1186
11829
7
12
1204
11926
11
0
1200
11938
13
10
1195
11919
38
74
1142
11635
61
212
1003
10215
esomeprazole; oral, parenteral
A02BC05 [21600100]
8.6e-01
1.4e+00
1.4e+00
—
1.4e+00
1.2e+00
9.4e-01
cases:10.57%
controls:4.78%
cases:8.42%
controls:2.21%
cases:2.23%
controls:0.57%
—
—
cases:2.07%
controls:0.49%
cases:7.29%
controls:2.36%
cases:13.06%
controls:5.53%
128
571
1083
11367
102
264
1109
11674
27
68
1184
11870
—
25
59
1183
11870
86
276
1094
11433
139
577
925
9850
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
4.0e-01
7.0e-01
1.3e+00
3.4e+00
9.3e-01
6.6e-01
7.3e-01
cases:13.54%
controls:9.51%
cases:8.34%
controls:4.31%
cases:1.82%
controls:0.50%
cases:1.24%
controls:0.04%
cases:1.32%
controls:0.53%
cases:7.29%
controls:3.92%
cases:16.64%
controls:8.79%
164
1135
1047
10803
101
514
1110
11424
22
60
1189
11878
15
5
1196
11933
16
63
1192
11866
86
459
1094
11250
177
917
887
9510
Noninfective gastroenteritis and colitis, unspecified
K52.9 [45572215]
7.9e-01
3.2e+00
—
1.0e+50
—
1.9e+00
1.9e+00
cases:0.50%
controls:0.23%
cases:1.40%
controls:0.06%
—
—
cases:0.74%
controls:0.00%
—
—
cases:0.59%
controls:0.09%
cases:1.22%
controls:0.19%
6
27
1205
11911
17
7
1194
11931
—
9
0
1202
11938
—
7
10
1173
11699
13
20
1051
10407
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.9e-01
4.7e-01
9.8e-01
3.7e+00
1.1e+00
4.1e-01
3.1e-01
cases:20.89%
controls:17.92%
cases:18.99%
controls:12.75%
cases:5.53%
controls:2.14%
cases:3.96%
controls:0.10%
cases:6.54%
controls:2.33%
cases:17.37%
controls:12.28%
cases:26.13%
controls:20.56%
253
2139
958
9799
230
1522
981
10416
67
256
1144
11682
48
12
1163
11926
79
278
1129
11651
205
1438
975
10271
278
2144
786
8283
Other specified special examinations
Z01.8 [45581003]
2.9e-01
1.5e+00
3.5e+00
—
2.3e+00
1.2e+00
7.5e-01
cases:2.31%
controls:1.74%
cases:2.23%
controls:0.50%
cases:1.32%
controls:0.04%
—
—
cases:0.41%
controls:0.04%
cases:1.78%
controls:0.55%
cases:4.51%
controls:2.18%
28
208
1183
11730
27
60
1184
11878
16
5
1195
11933
—
5
5
1203
11924
21
64
1159
11645
48
227
1016
10200
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.0e-01
4.3e-01
9.4e-01
3.7e+00
1.1e+00
3.8e-01
3.2e-01
cases:20.89%
controls:17.81%
cases:18.33%
controls:12.72%
cases:5.28%
controls:2.14%
cases:3.96%
controls:0.10%
cases:6.62%
controls:2.26%
cases:17.12%
controls:12.32%
cases:26.13%
controls:20.42%
253
2126
958
9812
222
1518
989
10420
64
255
1147
11683
48
12
1163
11926
80
269
1128
11660
202
1443
978
10266
278
2129
786
8298
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
1.3e+00
1.7e+00
—
—
—
2.3e+00
1.6e+00
cases:1.07%
controls:0.29%
cases:0.66%
controls:0.12%
—
—
—
—
—
—
cases:0.76%
controls:0.08%
cases:1.13%
controls:0.24%
13
35
1198
11903
8
14
1203
11924
—
—
—
9
9
1171
11700
12
25
1052
10402
cisapride; oral, rectal
A03FA02 [21600485]
1.2e+00
1.9e+00
—
—
—
2.1e+00
1.7e+00
cases:1.57%
controls:0.46%
cases:1.07%
controls:0.16%
—
—
—
—
—
—
cases:1.02%
controls:0.13%
cases:1.97%
controls:0.38%
19
55
1192
11883
13
19
1198
11919
—
—
—
12
15
1168
11694
21
40
1043
10387
Ova and parasites identified in Stool by Light microscopy
10704-5 [3003327]
1.0e+00
2.3e+00
—
—
1.0e+50
2.1e+00
1.3e+00
cases:1.32%
controls:0.47%
cases:1.98%
controls:0.21%
—
—
—
—
cases:0.41%
controls:0.00%
cases:1.19%
controls:0.15%
cases:1.79%
controls:0.47%
16
56
1195
11882
24
25
1187
11913
—
—
5
0
1203
11929
14
18
1166
11691
19
49
1045
10378
Psychiatry
26 [38004469]
7.8e-01
9.3e-01
9.4e-01
—
1.6e+00
1.4e+00
1.0e+00
cases:7.76%
controls:3.72%
cases:4.62%
controls:1.87%
cases:1.98%
controls:0.79%
—
—
cases:3.39%
controls:0.70%
cases:6.95%
controls:1.89%
cases:11.47%
controls:4.37%
94
444
1117
11494
56
223
1155
11715
24
94
1187
11844
—
41
84
1167
11845
82
221
1098
11488
122
456
942
9971
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
7.0e-01
8.3e-01
1.4e+00
—
1.7e+00
1.0e+00
9.8e-01
cases:7.76%
controls:4.03%
cases:4.13%
controls:1.83%
cases:1.07%
controls:0.26%
—
—
cases:1.16%
controls:0.22%
cases:4.41%
controls:1.62%
cases:9.49%
controls:3.79%
94
481
1117
11457
50
219
1161
11719
13
31
1198
11907
—
14
26
1194
11903
52
190
1128
11519
101
395
963
10032
omeprazole; oral, parenteral
A02BC01 [21600096]
6.7e-01
1.1e+00
1.7e+00
—
1.3e+00
7.5e-01
1.1e+00
cases:5.70%
controls:3.01%
cases:3.72%
controls:1.29%
cases:1.32%
controls:0.24%
—
—
cases:1.08%
controls:0.29%
cases:2.97%
controls:1.42%
cases:8.36%
controls:2.98%
69
359
1142
11579
45
154
1166
11784
16
29
1195
11909
—
13
34
1195
11895
35
166
1145
11543
89
311
975
10116
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
6.5e-01
1.3e+00
1.4e+00
—
1.5e+00
1.1e+00
6.4e-01
cases:5.53%
controls:2.97%
cases:6.03%
controls:1.67%
cases:1.07%
controls:0.26%
—
—
cases:0.99%
controls:0.23%
cases:4.58%
controls:1.61%
cases:6.67%
controls:3.63%
67
355
1144
11583
73
199
1138
11739
13
31
1198
11907
—
12
27
1196
11902
54
188
1126
11521
71
378
993
10049
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
8.7e-01
2.3e+00
—
1.0e+50
—
1.6e+00
1.9e+00
cases:1.65%
controls:0.70%
cases:1.57%
controls:0.16%
—
—
cases:1.73%
controls:0.00%
—
—
cases:0.85%
controls:0.18%
cases:3.67%
controls:0.59%
20
83
1191
11855
19
19
1192
11919
—
21
0
1190
11938
—
10
21
1170
11688
39
61
1025
10366
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.5e-01
4.0e-01
1.2e+00
3.7e+00
9.0e-01
3.2e-01
2.3e-01
cases:21.80%
controls:19.39%
cases:20.73%
controls:14.88%
cases:8.34%
controls:2.76%
cases:4.05%
controls:0.10%
cases:7.04%
controls:2.98%
cases:18.98%
controls:14.52%
cases:27.44%
controls:23.09%
264
2315
947
9623
251
1776
960
10162
101
329
1110
11609
49
12
1162
11926
85
355
1123
11574
224
1700
956
10009
292
2408
772
8019
Medical doctor
Z2221 [2001311556]
6.9e-01
1.1e+00
2.8e+00
1.0e+50
1.8e+00
1.2e+00
7.2e-01
cases:4.54%
controls:2.32%
cases:2.06%
controls:0.72%
cases:0.83%
controls:0.05%
cases:0.41%
controls:0.00%
cases:0.50%
controls:0.08%
cases:1.95%
controls:0.57%
cases:4.42%
controls:2.20%
55
277
1156
11661
25
86
1186
11852
10
6
1201
11932
5
0
1206
11938
6
10
1202
11919
23
67
1157
11642
47
229
1017
10198
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1.4e+00
1.8e+00
—
1.0e+50
—
1.5e+00
1.7e+00
cases:3.88%
controls:0.95%
cases:2.31%
controls:0.38%
—
—
cases:0.58%
controls:0.00%
—
—
cases:1.44%
controls:0.32%
cases:3.67%
controls:0.67%
47
113
1164
11825
28
45
1183
11893
—
7
0
1204
11938
—
17
38
1163
11671
39
70
1025
10357
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
8.2e-01
7.9e-01
1.3e+00
—
1.6e+00
9.4e-01
9.6e-01
cases:7.18%
controls:3.31%
cases:3.80%
controls:1.76%
cases:0.99%
controls:0.27%
—
—
cases:1.16%
controls:0.23%
cases:4.32%
controls:1.74%
cases:8.55%
controls:3.44%
87
395
1124
11543
46
210
1165
11728
12
32
1199
11906
—
14
27
1194
11902
51
204
1129
11505
91
359
973
10068
Functional dyspepsia
K30 [45591584]
1.4e+00
2.2e+00
—
1.0e+50
—
1.5e+00
1.3e+00
cases:2.39%
controls:0.58%
cases:2.23%
controls:0.25%
—
—
cases:1.24%
controls:0.00%
—
—
cases:1.10%
controls:0.26%
cases:2.82%
controls:0.77%
29
69
1182
11869
27
30
1184
11908
—
15
0
1196
11938
—
13
30
1167
11679
30
80
1034
10347
No disease
A97 [2002000230]
4.9e-01
1.5e+00
—
—
2.0e+00
1.7e+00
1.2e+00
cases:2.31%
controls:1.42%
cases:2.31%
controls:0.51%
—
—
—
—
cases:0.50%
controls:0.07%
cases:3.22%
controls:0.62%
cases:5.45%
controls:1.68%
28
170
1183
11768
28
61
1183
11877
—
—
6
8
1202
11921
38
73
1142
11636
58
175
1006
10252
Celiac disease serology panel - Serum
94494-2 [36660697]
1.4e+00
2.2e+00
—
—
—
1.6e+00
1.2e+00
cases:3.80%
controls:1.00%
cases:3.47%
controls:0.39%
—
—
—
—
—
—
cases:1.27%
controls:0.26%
cases:2.54%
controls:0.76%
46
119
1165
11819
42
47
1169
11891
—
—
—
15
31
1165
11678
27
79
1037
10348
pantoprazole; oral, parenteral
A02BC02 [21600097]
9.3e-01
1.0e+00
1.3e+00
—
1.3e+00
8.3e-01
9.5e-01
cases:19.90%
controls:8.95%
cases:12.96%
controls:5.06%
cases:3.55%
controls:1.01%
—
—
cases:3.89%
controls:1.06%
cases:11.53%
controls:5.40%
cases:22.18%
controls:9.95%
241
1069
970
10869
157
604
1054
11334
43
120
1168
11818
—
47
127
1161
11802
136
632
1044
11077
236
1038
828
9389
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
1.2e+00
1.9e+00
—
—
—
2.2e+00
2.2e+00
cases:0.58%
controls:0.18%
cases:0.58%
controls:0.08%
—
—
—
—
—
—
cases:0.59%
controls:0.07%
cases:0.75%
controls:0.09%
7
21
1204
11917
7
10
1204
11928
—
—
—
7
8
1173
11701
8
9
1056
10418
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.5e-01
5.0e-01
1.0e+00
3.3e+00
8.9e-01
2.8e-01
2.9e-01
cases:20.89%
controls:18.50%
cases:20.40%
controls:13.44%
cases:6.19%
controls:2.38%
cases:1.57%
controls:0.06%
cases:5.79%
controls:2.46%
cases:16.53%
controls:13.02%
cases:27.44%
controls:22.04%
253
2208
958
9730
247
1605
964
10333
75
284
1136
11654
19
7
1192
11931
70
294
1138
11635
195
1525
985
10184
292
2298
772
8129
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
4.1e-01
9.6e-01
1.9e+00
—
1.3e+00
8.7e-01
7.6e-01
cases:7.76%
controls:5.28%
cases:6.03%
controls:2.40%
cases:2.64%
controls:0.40%
—
—
cases:1.57%
controls:0.42%
cases:5.17%
controls:2.24%
cases:9.87%
controls:4.86%
94
630
1117
11308
73
287
1138
11651
32
48
1179
11890
—
19
50
1189
11879
61
262
1119
11447
105
507
959
9920
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
2.1e-01
4.5e-01
1.5e+00
—
2.5e+00
1.2e+00
9.1e-01
cases:3.47%
controls:2.83%
cases:1.65%
controls:1.06%
cases:0.74%
controls:0.16%
—
—
cases:0.91%
controls:0.08%
cases:2.54%
controls:0.76%
cases:4.61%
controls:1.90%
42
338
1169
11600
20
126
1191
11812
9
19
1202
11919
—
11
9
1197
11920
30
89
1150
11620
49
198
1015
10229
Abdominal pain localized other
D06 [2002000305]
1.1e+00
1.7e+00
—
—
—
1.8e+00
1.6e+00
cases:1.57%
controls:0.53%
cases:0.91%
controls:0.17%
—
—
—
—
—
—
cases:0.76%
controls:0.13%
cases:2.16%
controls:0.46%
19
63
1192
11875
11
20
1200
11918
—
—
—
9
15
1171
11694
23
48
1041
10379
Upper gastrointestinal surgery
106 [44777669]
7.0e-01
1.1e+00
1.6e+00
—
1.1e+00
7.5e-01
8.9e-01
cases:8.84%
controls:4.57%
cases:4.62%
controls:1.66%
cases:1.49%
controls:0.30%
—
—
cases:1.08%
controls:0.36%
cases:3.64%
controls:1.75%
cases:11.37%
controls:5.01%
107
546
1104
11392
56
198
1155
11740
18
36
1193
11902
—
13
43
1195
11886
43
205
1137
11504
121
522
943
9905
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
1.3e+00
2.8e+00
—
—
1.0e+50
2.0e+00
8.6e-01
cases:1.07%
controls:0.28%
cases:1.57%
controls:0.10%
—
—
—
—
cases:0.41%
controls:0.00%
cases:0.51%
controls:0.07%
cases:0.56%
controls:0.24%
13
34
1198
11904
19
12
1192
11926
—
—
5
0
1203
11929
6
8
1174
11701
6
25
1058
10402
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
5.1e-01
9.1e-01
1.8e+00
—
1.5e+00
6.9e-01
7.1e-01
cases:8.26%
controls:5.11%
cases:6.11%
controls:2.56%
cases:1.82%
controls:0.31%
—
—
cases:1.24%
controls:0.29%
cases:4.83%
controls:2.49%
cases:11.28%
controls:5.86%
100
610
1111
11328
74
306
1137
11632
22
37
1189
11901
—
15
34
1193
11895
57
292
1123
11417
120
611
944
9816
Supplier / Service Provider
OMOP5117446 [33004]
-7.8e-01
-1.4e+00
-6.4e-01
—
2.5e+00
2.6e+00
3.1e+00
cases:12.63%
controls:24.04%
cases:2.06%
controls:7.72%
cases:0.41%
controls:0.78%
—
—
cases:0.50%
controls:0.04%
cases:3.31%
controls:0.25%
cases:10.62%
controls:0.52%
153
2870
1058
9068
25
922
1186
11016
5
93
1206
11845
—
6
5
1202
11924
39
29
1141
11680
113
54
951
10373
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
6.8e-02
3.8e-01
1.1e+00
3.3e+00
9.5e-01
2.6e-01
1.9e-01
cases:23.12%
controls:21.93%
cases:23.37%
controls:17.32%
cases:10.24%
controls:3.49%
cases:4.46%
controls:0.17%
cases:8.86%
controls:3.64%
cases:21.27%
controls:17.20%
cases:30.55%
controls:26.67%
280
2618
931
9320
283
2068
928
9870
124
417
1087
11521
54
20
1157
11918
107
434
1101
11495
251
2014
929
9695
325
2781
739
7646
Platelets [#/volume] in Blood
26515-7 [3007461]
7.0e-02
3.7e-01
1.1e+00
3.3e+00
9.6e-01
2.7e-01
1.9e-01
cases:23.12%
controls:21.90%
cases:23.37%
controls:17.34%
cases:10.24%
controls:3.50%
cases:4.38%
controls:0.17%
cases:8.94%
controls:3.61%
cases:21.27%
controls:17.14%
cases:30.55%
controls:26.58%
280
2615
931
9323
283
2070
928
9868
124
418
1087
11520
53
20
1158
11918
108
431
1100
11498
251
2007
929
9702
325
2772
739
7655
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
9.4e-01
1.9e+00
—
—
—
1.9e+00
2.2e+00
cases:0.58%
controls:0.23%
cases:0.58%
controls:0.08%
—
—
—
—
—
—
cases:0.59%
controls:0.09%
cases:0.75%
controls:0.09%
7
27
1204
11911
7
10
1204
11928
—
—
—
7
10
1173
11699
8
9
1056
10418
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
1.1e+00
1.9e+00
—
—
—
1.9e+00
2.2e+00
cases:0.58%
controls:0.18%
cases:0.58%
controls:0.08%
—
—
—
—
—
—
cases:0.59%
controls:0.09%
cases:0.75%
controls:0.09%
7
22
1204
11916
7
10
1204
11928
—
—
—
7
10
1173
11699
8
9
1056
10418
MCH [Entitic mass]
28539-5 [3035941]
6.9e-02
3.7e-01
1.2e+00
3.3e+00
9.5e-01
2.7e-01
1.9e-01
cases:23.12%
controls:21.91%
cases:23.29%
controls:17.31%
cases:10.24%
controls:3.48%
cases:4.38%
controls:0.17%
cases:8.86%
controls:3.63%
cases:21.27%
controls:17.17%
cases:30.55%
controls:26.64%
280
2616
931
9322
282
2067
929
9871
124
416
1087
11522
53
20
1158
11918
107
433
1101
11496
251
2010
929
9699
325
2778
739
7649
Leukocytes [#/volume] in Blood
26464-8 [3010813]
6.4e-02
3.7e-01
1.2e+00
3.3e+00
9.4e-01
2.7e-01
1.9e-01
cases:23.12%
controls:22.00%
cases:23.37%
controls:17.37%
cases:10.32%
controls:3.51%
cases:4.38%
controls:0.17%
cases:8.86%
controls:3.66%
cases:21.36%
controls:17.23%
cases:30.55%
controls:26.73%
280
2626
931
9312
283
2074
928
9864
125
419
1086
11519
53
20
1158
11918
107
437
1101
11492
252
2018
928
9691
325
2787
739
7640
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
6.8e-02
3.7e-01
1.1e+00
3.3e+00
9.5e-01
2.6e-01
1.9e-01
cases:23.12%
controls:21.93%
cases:23.37%
controls:17.36%
cases:10.24%
controls:3.50%
cases:4.38%
controls:0.17%
cases:8.86%
controls:3.64%
cases:21.27%
controls:17.23%
cases:30.45%
controls:26.67%
280
2618
931
9320
283
2073
928
9865
124
418
1087
11520
53
20
1158
11918
107
434
1101
11495
251
2017
929
9692
324
2781
740
7646
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
6.7e-02
3.7e-01
1.1e+00
3.3e+00
9.4e-01
2.6e-01
1.9e-01
cases:23.12%
controls:21.96%
cases:23.29%
controls:17.38%
cases:10.24%
controls:3.51%
cases:4.38%
controls:0.17%
cases:8.86%
controls:3.65%
cases:21.36%
controls:17.25%
cases:30.55%
controls:26.67%
280
2621
931
9317
282
2075
929
9863
124
419
1087
11519
53
20
1158
11918
107
436
1101
11493
252
2020
928
9689
325
2781
739
7646
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
6.8e-02
3.7e-01
1.1e+00
3.3e+00
9.4e-01
2.6e-01
1.9e-01
cases:23.12%
controls:21.93%
cases:23.37%
controls:17.36%
cases:10.16%
controls:3.50%
cases:4.38%
controls:0.17%
cases:8.77%
controls:3.62%
cases:21.19%
controls:17.23%
cases:30.55%
controls:26.68%
280
2618
931
9320
283
2072
928
9866
123
418
1088
11520
53
20
1158
11918
106
432
1102
11497
250
2017
930
9692
325
2782
739
7645
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
7.5e-01
1.9e+00
—
1.0e+50
—
2.5e+00
1.6e+00
cases:0.83%
controls:0.39%
cases:0.74%
controls:0.12%
—
—
cases:1.57%
controls:0.00%
—
—
cases:1.02%
controls:0.09%
cases:1.79%
controls:0.37%
10
47
1201
11891
9
14
1202
11924
—
19
0
1192
11938
—
12
10
1168
11699
19
39
1045
10388
Emergency Room Visit
ER [9203]
4.8e-01
9.4e-01
1.7e+00
—
1.4e+00
7.0e-01
6.0e-01
cases:31.30%
controls:22.06%
cases:16.85%
controls:7.35%
cases:4.54%
controls:0.84%
—
—
cases:3.39%
controls:0.85%
cases:14.58%
controls:7.81%
cases:36.56%
controls:23.95%
379
2634
832
9304
204
878
1007
11060
55
100
1156
11838
—
41
101
1167
11828
172
915
1008
10794
389
2497
675
7930
Inpatient Visit
IP [9201]
2.1e-01
5.7e-01
1.5e+00
—
2.1e+00
1.0e+00
6.7e-01
cases:12.72%
controls:10.53%
cases:5.78%
controls:3.35%
cases:1.98%
controls:0.44%
—
—
cases:2.48%
controls:0.31%
cases:6.86%
controls:2.65%
cases:10.43%
controls:5.62%
154
1257
1057
10681
70
400
1141
11538
24
53
1187
11885
—
30
37
1178
11892
81
310
1099
11399
111
586
953
9841
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
1.1e+00
1.9e+00
—
—
—
1.6e+00
1.3e+00
cases:1.40%
controls:0.49%
cases:0.99%
controls:0.15%
—
—
—
—
—
—
cases:1.44%
controls:0.31%
cases:2.16%
controls:0.58%
17
59
1194
11879
12
18
1199
11920
—
—
—
17
36
1163
11673
23
60
1041
10367
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
4.4e-01
8.4e-01
1.3e+00
—
1.7e+00
7.5e-01
7.8e-01
cases:8.67%
controls:5.79%
cases:6.19%
controls:2.77%
cases:1.40%
controls:0.39%
—
—
cases:1.82%
controls:0.33%
cases:5.17%
controls:2.50%
cases:9.68%
controls:4.68%
105
691
1106
11247
75
331
1136
11607
17
47
1194
11891
—
22
39
1186
11890
61
293
1119
11416
103
488
961
9939
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
6.7e-01
7.9e-01
1.3e+00
—
1.4e+00
7.6e-01
9.5e-01
cases:8.42%
controls:4.49%
cases:3.39%
controls:1.57%
cases:1.16%
controls:0.33%
—
—
cases:1.16%
controls:0.30%
cases:3.31%
controls:1.58%
cases:10.34%
controls:4.25%
102
536
1109
11402
41
187
1170
11751
14
39
1197
11899
—
14
36
1194
11893
39
185
1141
11524
110
443
954
9984
budesonide; inhalant
R03BA02 [21603285]
8.0e-01
8.7e-01
1.0e+00
—
1.3e+00
8.3e-01
9.4e-01
cases:8.34%
controls:3.92%
cases:5.20%
controls:2.25%
cases:1.32%
controls:0.49%
—
—
cases:1.57%
controls:0.42%
cases:4.92%
controls:2.20%
cases:9.96%
controls:4.15%
101
468
1110
11470
63
269
1148
11669
16
58
1195
11880
—
19
50
1189
11879
58
258
1122
11451
106
433
958
9994
Differential panel, method unspecified - Blood
69738-3 [42870588]
6.5e-01
7.8e-01
1.4e+00
—
1.1e+00
8.3e-01
9.0e-01
cases:8.34%
controls:4.52%
cases:5.28%
controls:2.49%
cases:2.06%
controls:0.49%
—
—
cases:1.41%
controls:0.48%
cases:4.92%
controls:2.19%
cases:8.46%
controls:3.62%
101
540
1110
11398
64
297
1147
11641
25
59
1186
11879
—
17
57
1191
11872
58
257
1122
11452
90
377
974
10050
prednisone
A07EA03 [21600655]
1.3e+00
1.2e+00
—
—
—
1.8e+00
1.3e+00
cases:2.97%
controls:0.85%
cases:1.07%
controls:0.33%
—
—
—
—
—
—
cases:1.69%
controls:0.27%
cases:2.82%
controls:0.75%
36
102
1175
11836
13
39
1198
11899
—
—
—
20
32
1160
11677
30
78
1034
10349
prednisone; oral
H02AB07 [21602735]
1.3e+00
1.2e+00
—
—
—
1.8e+00
1.3e+00
cases:2.97%
controls:0.85%
cases:1.07%
controls:0.33%
—
—
—
—
—
—
cases:1.69%
controls:0.27%
cases:2.82%
controls:0.75%
36
102
1175
11836
13
39
1198
11899
—
—
—
20
32
1160
11677
30
78
1034
10349
General Surgery
2 [38004447]
4.9e-01
8.5e-01
1.3e+00
—
1.3e+00
8.5e-01
7.3e-01
cases:21.30%
controls:14.24%
cases:10.73%
controls:4.87%
cases:2.64%
controls:0.71%
—
—
cases:1.99%
controls:0.54%
cases:10.08%
controls:4.59%
cases:26.13%
controls:14.50%
258
1700
953
10238
130
581
1081
11357
32
85
1179
11853
—
24
64
1184
11865
119
537
1061
11172
278
1512
786
8915
metronidazole; oral, rectal
P01AB01 [21604857]
7.7e-01
1.1e+00
1.3e+00
—
1.8e+00
9.0e-01
1.0e+00
cases:10.16%
controls:4.95%
cases:3.39%
controls:1.20%
cases:0.41%
controls:0.11%
—
—
cases:0.83%
controls:0.14%
cases:3.39%
controls:1.41%
cases:11.47%
controls:4.41%
123
591
1088
11347
41
143
1170
11795
5
13
1206
11925
—
10
17
1198
11912
40
165
1140
11544
122
460
942
9967
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.6e-01
7.4e-01
1.7e+00
—
1.2e+00
7.4e-01
7.1e-01
cases:9.17%
controls:5.97%
cases:5.86%
controls:2.90%
cases:2.64%
controls:0.49%
—
—
cases:1.99%
controls:0.63%
cases:5.51%
controls:2.71%
cases:11.65%
controls:6.07%
111
713
1100
11225
71
346
1140
11592
32
59
1179
11879
—
24
75
1184
11854
65
317
1115
11392
124
633
940
9794
Tissue transglutaminase IgG Ab [Units/volume] in Serum
32998-7 [3046870]
1.4e+00
2.4e+00
—
—
—
1.7e+00
8.4e-01
cases:1.73%
controls:0.45%
cases:3.06%
controls:0.28%
—
—
—
—
—
—
cases:1.36%
controls:0.25%
cases:1.69%
controls:0.74%
21
54
1190
11884
37
33
1174
11905
—
—
—
16
29
1164
11680
18
77
1046
10350
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
2.0e-01
3.0e-01
1.6e+00
—
2.1e+00
1.0e+00
8.1e-01
cases:4.62%
controls:3.83%
cases:1.82%
controls:1.35%
cases:0.83%
controls:0.17%
—
—
cases:0.91%
controls:0.12%
cases:2.63%
controls:0.96%
cases:5.83%
controls:2.68%
56
457
1155
11481
22
161
1189
11777
10
20
1201
11918
—
11
14
1197
11915
31
112
1149
11597
62
279
1002
10148
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
8.7e-01
—
—
—
2.1e+00
1.9e+00
1.5e+00
cases:1.07%
controls:0.45%
—
—
—
—
—
—
cases:0.50%
controls:0.06%
cases:0.93%
controls:0.15%
cases:1.79%
controls:0.41%
13
54
1198
11884
—
—
—
6
7
1202
11922
11
17
1169
11692
19
43
1045
10384
Essential (primary) hypertension
I10 [45591453]
5.7e-01
6.8e-01
1.1e+00
—
1.6e+00
8.4e-01
6.3e-01
cases:12.39%
controls:7.40%
cases:7.35%
controls:3.85%
cases:1.90%
controls:0.64%
—
—
cases:3.39%
controls:0.68%
cases:8.56%
controls:3.89%
cases:15.13%
controls:8.65%
150
884
1061
11054
89
460
1122
11478
23
76
1188
11862
—
41
81
1167
11848
101
456
1079
11253
161
902
903
9525
Orthopedic Surgery
20 [38004465]
2.6e-01
3.6e-01
1.2e+00
3.3e+00
6.0e-01
5.2e-01
5.1e-01
cases:10.65%
controls:8.41%
cases:4.87%
controls:3.45%
cases:1.32%
controls:0.42%
cases:1.07%
controls:0.04%
cases:0.91%
controls:0.50%
cases:5.76%
controls:3.49%
cases:14.19%
controls:9.04%
129
1004
1082
10934
59
412
1152
11526
16
50
1195
11888
13
5
1198
11933
11
60
1197
11869
68
409
1112
11300
151
943
913
9484
Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14361-0 [3000855]
1.4e+00
1.7e+00
—
—
—
2.4e+00
1.6e+00
cases:0.99%
controls:0.25%
cases:0.58%
controls:0.11%
—
—
—
—
—
—
cases:0.85%
controls:0.08%
cases:1.03%
controls:0.20%
12
30
1199
11908
7
13
1204
11925
—
—
—
10
9
1170
11700
11
21
1053
10406
pH of Urine
2756-5 [3015736]
4.0e-01
1.1e+00
1.4e+00
—
1.3e+00
7.6e-01
4.4e-01
cases:7.18%
controls:4.93%
cases:6.61%
controls:2.38%
cases:1.40%
controls:0.34%
—
—
cases:1.16%
controls:0.31%
cases:5.08%
controls:2.43%
cases:9.40%
controls:6.29%
87
589
1124
11349
80
284
1131
11654
17
41
1194
11897
—
14
37
1194
11892
60
285
1120
11424
100
656
964
9771
Helicobacter pylori Ag [Presence] in Stool
31843-6 [3013139]
1.2e+00
2.1e+00
—
—
—
2.0e+00
8.0e-01
cases:2.48%
controls:0.73%
cases:1.73%
controls:0.22%
—
—
—
—
—
—
cases:0.85%
controls:0.11%
cases:1.50%
controls:0.68%
30
87
1181
11851
21
26
1190
11912
—
—
—
10
13
1170
11696
16
71
1048
10356
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
9.1e-01
1.6e+00
—
—
—
1.6e+00
1.2e+00
cases:2.97%
controls:1.22%
cases:2.23%
controls:0.48%
—
—
—
—
—
—
cases:1.69%
controls:0.34%
cases:3.20%
controls:0.96%
36
146
1175
11792
27
57
1184
11881
—
—
—
20
40
1160
11669
34
100
1030
10327
Abdominal ultrasound examination
JN3AE [2001305555]
3.3e-01
1.5e+00
2.5e+00
1.0e+50
—
1.4e+00
1.4e+00
cases:1.32%
controls:0.95%
cases:0.91%
controls:0.21%
cases:0.50%
controls:0.04%
cases:0.66%
controls:0.00%
—
—
cases:0.76%
controls:0.20%
cases:2.73%
controls:0.72%
16
114
1195
11824
11
25
1200
11913
6
5
1205
11933
8
0
1203
11938
—
9
23
1171
11686
29
75
1035
10352
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
7.6e-01
9.8e-01
1.7e+00
—
1.3e+00
1.0e+00
8.0e-01
cases:9.17%
controls:4.51%
cases:5.45%
controls:2.13%
cases:1.07%
controls:0.20%
—
—
cases:0.66%
controls:0.18%
cases:5.34%
controls:2.01%
cases:9.77%
controls:4.66%
111
538
1100
11400
66
254
1145
11684
13
24
1198
11914
—
8
22
1200
11907
63
235
1117
11474
104
486
960
9941
calcium (different salts in combination); oral
A12AA20 [21600872]
7.8e-01
7.0e-01
8.6e-01
1.7e+00
9.8e-01
9.5e-01
9.6e-01
cases:10.40%
controls:5.07%
cases:8.01%
controls:4.13%
cases:2.73%
controls:1.17%
cases:0.41%
controls:0.08%
cases:2.98%
controls:1.14%
cases:10.00%
controls:4.12%
cases:13.35%
controls:5.59%
126
605
1085
11333
97
493
1114
11445
33
140
1178
11798
5
9
1206
11929
36
136
1172
11793
118
482
1062
11227
142
583
922
9844
Laboratory Visit
OMOP4822461 [32036]
4.5e-02
2.4e-01
9.4e-01
3.2e+00
8.4e-01
2.1e-01
1.0e-01
cases:25.27%
controls:24.43%
cases:26.51%
controls:22.13%
cases:15.11%
controls:6.49%
cases:7.93%
controls:0.35%
cases:13.99%
controls:6.56%
cases:25.93%
controls:22.17%
cases:32.61%
controls:30.38%
306
2917
905
9021
321
2642
890
9296
183
775
1028
11163
96
42
1115
11896
169
783
1039
11146
306
2596
874
9113
347
3168
717
7259
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
6.3e-01
9.2e-01
—
1.0e+50
1.9e+00
8.5e-01
8.4e-01
cases:5.62%
controls:3.06%
cases:2.23%
controls:0.90%
—
—
cases:0.66%
controls:0.00%
cases:0.83%
controls:0.13%
cases:2.20%
controls:0.96%
cases:6.39%
controls:2.86%
68
365
1143
11573
27
108
1184
11830
—
8
0
1203
11938
10
15
1198
11914
26
112
1154
11597
68
298
996
10129
Pharmacy visit
OMOP4822462 [581458]
1.9e-01
6.0e-01
5.8e-01
1.5e+00
8.4e-01
6.2e-01
9.4e-01
cases:81.67%
controls:78.66%
cases:78.53%
controls:66.71%
cases:44.76%
controls:31.27%
cases:6.52%
controls:1.50%
cases:50.75%
controls:30.87%
cases:80.59%
controls:68.99%
cases:95.30%
controls:88.80%
989
9391
222
2547
951
7964
260
3974
542
3733
669
8205
79
179
1132
11759
613
3683
595
8246
951
8078
229
3631
1014
9259
50
1168
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
4.1e-01
5.9e-01
1.9e+00
—
1.7e+00
9.3e-01
5.1e-01
cases:5.62%
controls:3.79%
cases:2.89%
controls:1.63%
cases:1.40%
controls:0.21%
—
—
cases:1.16%
controls:0.21%
cases:3.22%
controls:1.29%
cases:6.58%
controls:4.06%
68
453
1143
11485
35
194
1176
11744
17
25
1194
11913
—
14
25
1194
11904
38
151
1142
11558
70
423
994
10004
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
3.2e-01
7.8e-01
1.3e+00
—
1.5e+00
7.4e-01
7.1e-01
cases:8.67%
controls:6.42%
cases:6.52%
controls:3.11%
cases:1.73%
controls:0.47%
—
—
cases:1.82%
controls:0.40%
cases:5.85%
controls:2.88%
cases:10.71%
controls:5.58%
105
767
1106
11171
79
371
1132
11567
21
56
1190
11882
—
22
48
1186
11881
69
337
1111
11372
114
582
950
9845
Fatty (change of) liver, not elsewhere classified
K76.0 [45601189]
—
—
—
—
—
2.5e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.05%
cases:0.85%
controls:0.07%
—
—
—
—
—
7
6
1173
11703
9
7
1055
10420
Asthma, unspecified
J45.9 [45562456]
7.5e-01
7.5e-01
—
—
2.2e+00
1.0e+00
9.6e-01
cases:3.72%
controls:1.79%
cases:1.98%
controls:0.95%
—
—
—
—
cases:1.24%
controls:0.13%
cases:2.80%
controls:1.00%
cases:5.36%
controls:2.13%
45
214
1166
11724
24
113
1187
11825
—
—
15
16
1193
11913
33
117
1147
11592
57
222
1007
10205
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.0e-01
6.7e-01
1.6e+00
—
1.0e+00
6.6e-01
6.7e-01
cases:10.49%
controls:7.31%
cases:7.43%
controls:3.96%
cases:3.30%
controls:0.70%
—
—
cases:1.99%
controls:0.74%
cases:6.78%
controls:3.63%
cases:12.31%
controls:6.72%
127
873
1084
11065
90
473
1121
11465
40
83
1171
11855
—
24
88
1184
11841
80
425
1100
11284
131
701
933
9726
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.5e-01
7.1e-01
1.4e+00
—
9.8e-01
7.1e-01
6.9e-01
cases:9.83%
controls:6.49%
cases:6.77%
controls:3.45%
cases:2.56%
controls:0.62%
—
—
cases:1.66%
controls:0.63%
cases:6.27%
controls:3.19%
cases:10.81%
controls:5.75%
119
775
1092
11163
82
412
1129
11526
31
74
1180
11864
—
20
75
1188
11854
74
373
1106
11336
115
600
949
9827
Physiotherapist
Z3226 [2001311560]
9.4e-01
1.1e+00
—
—
—
1.7e+00
1.2e+00
cases:3.30%
controls:1.32%
cases:1.07%
controls:0.36%
—
—
—
—
—
—
cases:1.44%
controls:0.27%
cases:3.67%
controls:1.08%
40
157
1171
11781
13
43
1198
11895
—
—
—
17
32
1163
11677
39
113
1025
10314
Monocytes/Leukocytes in Blood
26485-3 [3019069]
4.4e-01
7.0e-01
1.5e+00
—
9.7e-01
7.0e-01
6.9e-01
cases:9.83%
controls:6.54%
cases:6.77%
controls:3.48%
cases:2.56%
controls:0.61%
—
—
cases:1.66%
controls:0.64%
cases:6.27%
controls:3.20%
cases:10.81%
controls:5.74%
119
781
1092
11157
82
415
1129
11523
31
73
1180
11865
—
20
76
1188
11853
74
375
1106
11334
115
599
949
9828
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.5e-01
7.0e-01
1.4e+00
—
9.7e-01
7.1e-01
6.8e-01
cases:9.83%
controls:6.51%
cases:6.77%
controls:3.48%
cases:2.56%
controls:0.62%
—
—
cases:1.66%
controls:0.64%
cases:6.27%
controls:3.18%
cases:10.81%
controls:5.77%
119
777
1092
11161
82
416
1129
11522
31
74
1180
11864
—
20
76
1188
11853
74
372
1106
11337
115
602
949
9825
Mixed asthma
J45.8 [45548118]
1.5e+00
1.8e+00
—
1.0e+50
—
—
1.6e+00
cases:0.99%
controls:0.23%
cases:0.66%
controls:0.11%
—
—
cases:0.50%
controls:0.00%
—
—
—
—
cases:1.13%
controls:0.22%
12
27
1199
11911
8
13
1203
11925
—
6
0
1205
11938
—
—
12
23
1052
10404
Person consulting for explanation of investigation findings
Z71.2 [45552100]
1.1e+00
1.6e+00
—
—
1.9e+00
1.3e+00
9.4e-01
cases:6.19%
controls:2.25%
cases:4.54%
controls:0.92%
—
—
—
—
cases:0.50%
controls:0.08%
cases:3.90%
controls:1.09%
cases:7.42%
controls:3.04%
75
269
1136
11669
55
110
1156
11828
—
—
6
9
1202
11920
46
128
1134
11581
79
317
985
10110
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.0e-01
6.8e-01
1.5e+00
—
9.6e-01
6.5e-01
6.9e-01
cases:10.16%
controls:7.04%
cases:7.27%
controls:3.83%
cases:2.97%
controls:0.67%
—
—
cases:1.82%
controls:0.70%
cases:6.53%
controls:3.50%
cases:11.94%
controls:6.36%
123
840
1088
11098
88
457
1123
11481
36
80
1175
11858
—
22
84
1186
11845
77
410
1103
11299
127
663
937
9764
Basophils [#/volume] in Blood
26444-0 [3006315]
4.0e-01
6.8e-01
1.5e+00
—
9.6e-01
6.5e-01
6.8e-01
cases:10.16%
controls:7.06%
cases:7.27%
controls:3.83%
cases:2.97%
controls:0.67%
—
—
cases:1.82%
controls:0.70%
cases:6.53%
controls:3.52%
cases:11.94%
controls:6.42%
123
843
1088
11095
88
457
1123
11481
36
80
1175
11858
—
22
84
1186
11845
77
412
1103
11297
127
669
937
9758
Stomach Pathology biopsy report
66114-0 [40768797]
8.0e-01
1.9e+00
—
1.0e+50
—
1.3e+00
9.4e-01
cases:2.97%
controls:1.36%
cases:2.15%
controls:0.34%
—
—
cases:1.16%
controls:0.00%
—
—
cases:1.27%
controls:0.37%
cases:2.63%
controls:1.05%
36
162
1175
11776
26
41
1185
11897
—
14
0
1197
11938
—
15
43
1165
11666
28
109
1036
10318
zolpidem; oral
N05CF02 [21604655]
8.2e-01
8.4e-01
7.5e-01
—
1.3e+00
8.5e-01
1.0e+00
cases:4.21%
controls:1.89%
cases:2.56%
controls:1.12%
cases:0.50%
controls:0.23%
—
—
cases:0.91%
controls:0.25%
cases:2.46%
controls:1.07%
cases:4.98%
controls:1.83%
51
226
1160
11712
31
134
1180
11804
6
28
1205
11910
—
11
30
1197
11899
29
125
1151
11584
53
191
1011
10236
Constipation, unspecified
K59.09 [2000502926]
1.2e+00
1.9e+00
—
—
—
1.7e+00
9.3e-01
cases:1.07%
controls:0.31%
cases:0.91%
controls:0.13%
—
—
—
—
—
—
cases:0.85%
controls:0.16%
cases:0.94%
controls:0.37%
13
37
1198
11901
11
16
1200
11922
—
—
—
10
19
1170
11690
10
39
1054
10388
Irritable bowel syndrome
K58 [45572218]
2.5e+00
2.3e+00
—
—
—
1.8e+00
1.4e+00
cases:0.83%
controls:0.07%
cases:0.50%
controls:0.05%
—
—
—
—
—
—
cases:0.42%
controls:0.07%
cases:0.47%
controls:0.12%
10
8
1201
11930
6
6
1205
11932
—
—
—
5
8
1175
11701
5
12
1059
10415
Emergency Medicine
93 [38004510]
4.1e-01
5.3e-01
1.4e+00
—
1.3e+00
5.5e-01
5.8e-01
cases:11.73%
controls:8.08%
cases:7.27%
controls:4.41%
cases:2.15%
controls:0.54%
—
—
cases:1.90%
controls:0.50%
cases:7.29%
controls:4.32%
cases:15.41%
controls:9.26%
142
965
1069
10973
88
527
1123
11411
26
65
1185
11873
—
23
60
1185
11869
86
506
1094
11203
164
966
900
9461
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
4.4e-01
7.1e-01
1.4e+00
—
9.3e-01
6.6e-01
6.4e-01
cases:9.83%
controls:6.53%
cases:6.77%
controls:3.44%
cases:2.48%
controls:0.63%
—
—
cases:1.66%
controls:0.66%
cases:6.19%
controls:3.31%
cases:10.53%
controls:5.86%
119
780
1092
11158
82
411
1129
11527
30
75
1181
11863
—
20
79
1188
11850
73
387
1107
11322
112
611
952
9816
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
4.1e-01
6.8e-01
1.4e+00
—
9.8e-01
6.5e-01
6.2e-01
cases:9.83%
controls:6.72%
cases:6.77%
controls:3.55%
cases:2.56%
controls:0.64%
—
—
cases:1.74%
controls:0.66%
cases:6.27%
controls:3.37%
cases:10.71%
controls:6.06%
119
802
1092
11136
82
424
1129
11514
31
76
1180
11862
—
21
79
1187
11850
74
395
1106
11314
114
632
950
9795
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
5.4e-01
9.8e-01
2.3e+00
—
-1.0e+50
1.2e+00
1.2e+00
cases:1.49%
controls:0.87%
cases:0.91%
controls:0.34%
cases:0.58%
controls:0.06%
—
—
cases:0.00%
controls:0.04%
cases:1.19%
controls:0.37%
cases:2.16%
controls:0.66%
18
104
1193
11834
11
41
1200
11897
7
7
1204
11931
—
0
5
1208
11924
14
43
1166
11666
23
69
1041
10358
Case Management Agency
251B00000X [38004193]
1.8e-01
1.9e-01
6.0e-01
3.2e+00
6.0e-01
2.4e-01
1.7e-01
cases:44.76%
controls:40.39%
cases:39.06%
controls:34.72%
cases:23.45%
controls:14.35%
cases:19.74%
controls:0.98%
cases:23.26%
controls:14.29%
cases:41.86%
controls:36.27%
cases:53.20%
controls:49.02%
542
4822
669
7116
473
4145
738
7793
284
1713
927
10225
239
117
972
11821
281
1705
927
10224
494
4247
686
7462
566
5111
498
5316
Other specified noninfective gastroenteritis and colitis
K52.88 [2000502923]
1.8e+00
2.0e+00
—
1.0e+50
—
—
2.6e+00
cases:0.41%
controls:0.07%
cases:0.50%
controls:0.07%
—
—
cases:1.07%
controls:0.00%
—
—
—
—
cases:1.32%
controls:0.10%
5
8
1206
11930
6
8
1205
11930
—
13
0
1198
11938
—
—
14
10
1050
10417
Headache
R51.80 [2000503603]
1.0e+00
1.5e+00
—
—
—
1.3e+00
7.1e-01
cases:3.63%
controls:1.32%
cases:1.57%
controls:0.34%
—
—
—
—
—
—
cases:1.44%
controls:0.38%
cases:3.20%
controls:1.59%
44
157
1167
11781
19
41
1192
11897
—
—
—
17
45
1163
11664
34
166
1030
10261
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
3.6e-01
6.5e-01
1.4e+00
—
9.3e-01
6.1e-01
6.3e-01
cases:9.99%
controls:7.21%
cases:7.18%
controls:3.90%
cases:2.89%
controls:0.70%
—
—
cases:1.82%
controls:0.73%
cases:6.53%
controls:3.66%
cases:11.75%
controls:6.63%
121
861
1090
11077
87
465
1124
11473
35
84
1176
11854
—
22
87
1186
11842
77
429
1103
11280
125
691
939
9736
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.3e+00
6.8e-01
—
—
—
1.8e+00
1.5e+00
cases:2.81%
controls:0.81%
cases:0.50%
controls:0.25%
—
—
—
—
—
—
cases:1.19%
controls:0.20%
cases:2.16%
controls:0.48%
34
97
1177
11841
6
30
1205
11908
—
—
—
14
23
1166
11686
23
50
1041
10377
FVC percent change Respiratory system
69982-7 [42868471]
1.3e+00
6.8e-01
—
—
—
1.8e+00
1.5e+00
cases:2.81%
controls:0.81%
cases:0.50%
controls:0.25%
—
—
—
—
—
—
cases:1.19%
controls:0.20%
cases:2.16%
controls:0.48%
34
97
1177
11841
6
30
1205
11908
—
—
—
14
23
1166
11686
23
50
1041
10377
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.3e+00
6.8e-01
—
—
—
1.8e+00
1.5e+00
cases:2.81%
controls:0.81%
cases:0.50%
controls:0.25%
—
—
—
—
—
—
cases:1.19%
controls:0.20%
cases:2.16%
controls:0.48%
34
97
1177
11841
6
30
1205
11908
—
—
—
14
23
1166
11686
23
50
1041
10377
FEV1 percent change
69983-5 [42868472]
1.3e+00
6.8e-01
—
—
—
1.8e+00
1.5e+00
cases:2.81%
controls:0.81%
cases:0.50%
controls:0.25%
—
—
—
—
—
—
cases:1.19%
controls:0.20%
cases:2.16%
controls:0.48%
34
97
1177
11841
6
30
1205
11908
—
—
—
14
23
1166
11686
23
50
1041
10377
FEV1 --post bronchodilation
20155-8 [3023550]
1.3e+00
6.8e-01
—
—
—
1.8e+00
1.5e+00
cases:2.81%
controls:0.81%
cases:0.50%
controls:0.25%
—
—
—
—
—
—
cases:1.19%
controls:0.20%
cases:2.16%
controls:0.48%
34
97
1177
11841
6
30
1205
11908
—
—
—
14
23
1166
11686
23
50
1041
10377
Spinal stenosis
M48.0 [45557888]
3.6e-01
8.8e-01
—
1.0e+50
2.4e+00
1.0e+00
1.0e+00
cases:1.32%
controls:0.92%
cases:0.83%
controls:0.34%
—
—
cases:0.99%
controls:0.00%
cases:0.58%
controls:0.05%
cases:1.19%
controls:0.42%
cases:2.44%
controls:0.87%
16
110
1195
11828
10
41
1201
11897
—
12
0
1199
11938
7
6
1201
11923
14
49
1166
11660
26
91
1038
10336
MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
72872-5 [43534045]
1.3e+00
3.2e+00
1.0e+50
—
—
—
3.9e-01
cases:2.73%
controls:0.75%
cases:5.95%
controls:0.25%
cases:2.89%
controls:0.00%
—
—
—
—
—
—
cases:0.75%
controls:0.51%
33
90
1178
11848
72
30
1139
11908
35
0
1176
11938
—
—
—
8
53
1056
10374
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
—
—
—
—
—
2.6e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.04%
cases:0.75%
controls:0.12%
—
—
—
—
—
7
5
1173
11704
8
12
1056
10415
Hypothyroidism, unspecified
E03.9 [45537945]
6.4e-01
7.4e-01
1.7e+00
—
2.1e+00
1.2e+00
1.3e+00
cases:2.06%
controls:1.10%
cases:1.24%
controls:0.59%
cases:0.50%
controls:0.09%
—
—
cases:0.66%
controls:0.08%
cases:2.03%
controls:0.65%
cases:4.89%
controls:1.44%
25
131
1186
11807
15
71
1196
11867
6
11
1205
11927
—
8
10
1200
11919
24
76
1156
11633
52
150
1012
10277
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
1.8e+00
—
—
—
—
2.6e+00
1.0e+00
cases:0.58%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.05%
cases:0.56%
controls:0.20%
7
11
1204
11927
—
—
—
—
8
6
1172
11703
6
21
1058
10406
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
-1.2e-01
8.1e-02
1.4e+00
—
1.7e+00
7.4e-01
5.8e-01
cases:5.45%
controls:6.11%
cases:2.23%
controls:2.06%
cases:0.99%
controls:0.24%
—
—
cases:0.99%
controls:0.18%
cases:3.05%
controls:1.49%
cases:7.33%
controls:4.25%
66
730
1145
11208
27
246
1184
11692
12
29
1199
11909
—
12
22
1196
11907
36
174
1144
11535
78
443
986
9984
Limited function/disability (L)
L28 [2002000647]
1.1e+00
2.7e-01
1.8e+00
—
2.4e+00
7.8e-01
8.5e-01
cases:3.14%
controls:1.06%
cases:0.74%
controls:0.57%
cases:0.41%
controls:0.07%
—
—
cases:0.58%
controls:0.05%
cases:1.36%
controls:0.62%
cases:3.20%
controls:1.39%
38
126
1173
11812
9
68
1202
11870
5
8
1206
11930
—
7
6
1201
11923
16
73
1164
11636
34
145
1030
10282
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
6.7e-01
6.4e-01
1.4e+00
—
1.4e+00
9.0e-01
4.7e-01
cases:3.72%
controls:1.93%
cases:2.06%
controls:1.10%
cases:0.83%
controls:0.20%
—
—
cases:0.91%
controls:0.23%
cases:2.88%
controls:1.20%
cases:4.32%
controls:2.75%
45
231
1166
11707
25
131
1186
11807
10
24
1201
11914
—
11
27
1197
11902
34
140
1146
11569
46
287
1018
10140
Rheumatism, unspecified
M79.0 [45567658]
1.4e+00
—
—
1.0e+50
—
2.4e+00
2.0e+00
cases:0.74%
controls:0.19%
—
—
—
—
cases:0.58%
controls:0.00%
—
—
cases:0.85%
controls:0.08%
cases:1.22%
controls:0.17%
9
23
1202
11915
—
—
7
0
1204
11938
—
10
9
1170
11700
13
18
1051
10409
Sleep apnoea
G47.3 [45562094]
5.6e-01
6.3e-01
8.2e-01
—
1.7e+00
9.8e-01
1.1e+00
cases:3.55%
controls:2.05%
cases:2.31%
controls:1.25%
cases:0.66%
controls:0.29%
—
—
cases:1.49%
controls:0.27%
cases:3.14%
controls:1.20%
cases:6.02%
controls:2.07%
43
245
1168
11693
28
149
1183
11789
8
35
1203
11903
—
18
32
1190
11897
37
141
1143
11568
64
216
1000
10211
Diarrhoea
D11 [2002000310]
1.1e+00
2.1e+00
—
—
—
1.3e+00
1.2e+00
cases:2.06%
controls:0.71%
cases:1.32%
controls:0.17%
—
—
—
—
—
—
cases:0.76%
controls:0.20%
cases:2.91%
controls:0.89%
25
85
1186
11853
16
20
1195
11918
—
—
—
9
24
1171
11685
31
93
1033
10334
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.2e+00
6.5e-01
—
—
—
1.6e+00
1.5e+00
cases:2.89%
controls:0.92%
cases:0.58%
controls:0.30%
—
—
—
—
—
—
cases:1.27%
controls:0.25%
cases:2.35%
controls:0.52%
35
110
1176
11828
7
36
1204
11902
—
—
—
15
29
1165
11680
25
54
1039
10373
FEV1
20150-9 [3024653]
1.2e+00
6.5e-01
—
—
—
1.6e+00
1.5e+00
cases:2.89%
controls:0.92%
cases:0.58%
controls:0.30%
—
—
—
—
—
—
cases:1.27%
controls:0.25%
cases:2.35%
controls:0.52%
35
110
1176
11828
7
36
1204
11902
—
—
—
15
29
1165
11680
25
54
1039
10373
FEV1/FVC
19926-5 [3011505]
1.2e+00
6.5e-01
—
—
—
1.6e+00
1.5e+00
cases:2.89%
controls:0.92%
cases:0.58%
controls:0.30%
—
—
—
—
—
—
cases:1.27%
controls:0.25%
cases:2.35%
controls:0.52%
35
110
1176
11828
7
36
1204
11902
—
—
—
15
29
1165
11680
25
54
1039
10373
Pulmonary Disease
29 [38004472]
6.5e-01
6.7e-01
4.5e-01
—
1.2e+00
8.3e-01
9.9e-01
cases:8.51%
controls:4.62%
cases:4.38%
controls:2.30%
cases:0.83%
controls:0.53%
—
—
cases:1.41%
controls:0.44%
cases:4.75%
controls:2.12%
cases:11.37%
controls:4.57%
103
551
1108
11387
53
274
1158
11664
10
63
1201
11875
—
17
52
1191
11877
56
248
1124
11461
121
476
943
9951
Crohn disease of small intestine
K50.0 [45596324]
1.5e+00
—
—
1.0e+50
—
2.0e+00
2.3e+00
cases:0.41%
controls:0.09%
—
—
—
—
cases:0.50%
controls:0.00%
—
—
cases:0.51%
controls:0.07%
cases:1.22%
controls:0.12%
5
11
1206
11927
—
—
6
0
1205
11938
—
6
8
1174
11701
13
13
1051
10414
Dyspnoea
R06.0 [45558449]
1.1e+00
6.4e-01
—
—
2.0e+00
8.1e-01
1.1e+00
cases:4.71%
controls:1.63%
cases:1.40%
controls:0.75%
—
—
—
—
cases:0.58%
controls:0.08%
cases:1.44%
controls:0.65%
cases:5.64%
controls:1.86%
57
194
1154
11744
17
89
1194
11849
—
—
7
9
1201
11920
17
76
1163
11633
60
194
1004
10233
tiotropium bromide; inhalant
R03BB04 [21603296]
9.6e-01
1.1e+00
1.3e+00
—
9.5e-01
1.2e+00
1.0e+00
cases:1.82%
controls:0.70%
cases:1.57%
controls:0.53%
cases:0.50%
controls:0.13%
—
—
cases:0.50%
controls:0.19%
cases:1.53%
controls:0.47%
cases:2.26%
controls:0.82%
22
84
1189
11854
19
63
1192
11875
6
16
1205
11922
—
6
23
1202
11906
18
55
1162
11654
24
85
1040
10342
Fibromyalgia
M79.7 [45553272]
7.6e-01
1.6e+00
—
1.0e+50
—
2.0e+00
2.3e+00
cases:0.41%
controls:0.19%
cases:0.50%
controls:0.10%
—
—
cases:0.91%
controls:0.00%
—
—
cases:0.68%
controls:0.09%
cases:1.60%
controls:0.16%
5
23
1206
11915
6
12
1205
11926
—
11
0
1200
11938
—
8
11
1172
11698
17
17
1047
10410
Cutaneous abscess, furuncle and carbuncle of trunk
L02.2 [45586751]
1.2e+00
2.6e+00
—
—
—
—
1.6e+00
cases:0.58%
controls:0.18%
cases:0.58%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.20%
7
21
1204
11917
7
5
1204
11933
—
—
—
—
11
21
1053
10406
Persons encountering health services in other specified circumstances
Z76.8 [45542457]
—
—
—
—
—
2.3e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.07%
cases:1.22%
controls:0.17%
—
—
—
—
—
8
8
1172
11701
13
18
1051
10409
Gastroscopy
UJD02 [2001304787]
1.0e+00
2.1e+00
—
1.0e+50
—
2.2e+00
1.0e+00
cases:0.66%
controls:0.24%
cases:0.66%
controls:0.08%
—
—
cases:1.57%
controls:0.00%
—
—
cases:0.68%
controls:0.08%
cases:0.56%
controls:0.20%
8
29
1203
11909
8
10
1203
11928
—
19
0
1192
11938
—
8
9
1172
11700
6
21
1058
10406
Abdominal pain/cramps general
D01 [2002000300]
1.3e+00
1.6e+00
2.3e+00
—
—
1.1e+00
1.4e+00
cases:2.89%
controls:0.83%
cases:0.99%
controls:0.20%
cases:0.41%
controls:0.04%
—
—
—
—
cases:0.93%
controls:0.31%
cases:3.48%
controls:0.90%
35
99
1176
11839
12
24
1199
11914
5
5
1206
11933
—
—
11
36
1169
11673
37
94
1027
10333
Other symptoms involving abdomen and pelvis, Abdominal pain
7890A [2000407034]
9.7e-01
2.4e+00
—
1.0e+50
—
2.0e+00
1.8e+00
cases:0.66%
controls:0.25%
cases:0.66%
controls:0.06%
—
—
cases:0.66%
controls:0.00%
—
—
cases:0.42%
controls:0.06%
cases:0.94%
controls:0.15%
8
30
1203
11908
8
7
1203
11931
—
8
0
1203
11938
—
5
7
1175
11702
10
16
1054
10411
Pain, unspecified
R52.9 [45544151]
1.3e+00
1.1e+00
—
—
—
1.8e+00
1.2e+00
cases:1.90%
controls:0.54%
cases:0.66%
controls:0.22%
—
—
—
—
—
—
cases:0.85%
controls:0.15%
cases:1.97%
controls:0.60%
23
64
1188
11874
8
26
1203
11912
—
—
—
10
17
1170
11692
21
63
1043
10364
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
3.2e-01
5.9e-01
1.3e+00
—
1.0e+00
6.6e-01
6.6e-01
cases:11.15%
controls:8.34%
cases:8.01%
controls:4.60%
cases:3.72%
controls:1.06%
—
—
cases:2.81%
controls:1.01%
cases:8.22%
controls:4.44%
cases:13.16%
controls:7.26%
135
996
1076
10942
97
549
1114
11389
45
126
1166
11812
—
34
121
1174
11808
97
520
1083
11189
140
757
924
9670
Pediatric Medicine
37 [38004477]
1.1e-01
5.8e-01
8.9e-01
—
1.5e+00
7.1e-01
5.1e-01
cases:8.59%
controls:7.80%
cases:6.94%
controls:4.00%
cases:2.56%
controls:1.06%
—
—
cases:4.14%
controls:0.93%
cases:6.86%
controls:3.48%
cases:8.18%
controls:5.05%
104
931
1107
11007
84
477
1127
11461
31
127
1180
11811
—
50
111
1158
11818
81
408
1099
11301
87
527
977
9900
Tension-type headache
G44.2 [45581495]
6.0e-01
1.2e+00
—
—
—
2.0e+00
1.1e+00
cases:1.98%
controls:1.10%
cases:1.07%
controls:0.34%
—
—
—
—
—
—
cases:1.36%
controls:0.19%
cases:3.01%
controls:1.05%
24
131
1187
11807
13
40
1198
11898
—
—
—
16
22
1164
11687
32
110
1032
10317
prednisolone
A07EA01 [21600653]
5.6e-01
6.9e-01
9.9e-01
—
1.3e+00
7.7e-01
8.9e-01
cases:10.24%
controls:6.14%
cases:5.45%
controls:2.81%
cases:1.07%
controls:0.40%
—
—
cases:1.49%
controls:0.41%
cases:5.68%
controls:2.70%
cases:14.29%
controls:6.43%
124
733
1087
11205
66
335
1145
11603
13
48
1198
11890
—
18
49
1190
11880
67
316
1113
11393
152
670
912
9757
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
1.5e-01
6.5e-01
1.4e+00
—
9.7e-01
5.8e-01
6.1e-01
cases:12.30%
controls:10.81%
cases:9.58%
controls:5.24%
cases:2.73%
controls:0.70%
—
—
cases:1.41%
controls:0.54%
cases:7.88%
controls:4.57%
cases:17.67%
controls:10.42%
149
1290
1062
10648
116
626
1095
11312
33
83
1178
11855
—
17
64
1191
11865
93
535
1087
11174
188
1087
876
9340
prednisolone; oral, parenteral
H02AB06 [21602734]
5.6e-01
7.0e-01
9.9e-01
—
1.3e+00
7.8e-01
8.7e-01
cases:10.16%
controls:6.08%
cases:5.45%
controls:2.79%
cases:1.07%
controls:0.40%
—
—
cases:1.49%
controls:0.41%
cases:5.68%
controls:2.69%
cases:14.00%
controls:6.41%
123
726
1088
11212
66
333
1145
11605
13
48
1198
11890
—
18
49
1190
11880
67
315
1113
11394
149
668
915
9759
Other specified counselling
Z71.8 [45581061]
1.0e+00
1.2e+00
1.1e+00
—
1.3e+00
1.2e+00
8.2e-01
cases:6.69%
controls:2.48%
cases:4.13%
controls:1.31%
cases:0.50%
controls:0.17%
—
—
cases:0.66%
controls:0.18%
cases:4.32%
controls:1.39%
cases:8.18%
controls:3.78%
81
296
1130
11642
50
156
1161
11782
6
20
1205
11918
—
8
22
1200
11907
51
163
1129
11546
87
394
977
10033
Neurology
13 [38004458]
6.0e-01
8.9e-01
9.3e-01
—
1.1e+00
8.1e-01
8.3e-01
cases:10.07%
controls:5.79%
cases:5.86%
controls:2.50%
cases:0.91%
controls:0.36%
—
—
cases:1.49%
controls:0.52%
cases:5.34%
controls:2.44%
cases:13.72%
controls:6.51%
122
691
1089
11247
71
298
1140
11640
11
43
1200
11895
—
18
62
1190
11867
63
286
1117
11423
146
679
918
9748
Pediatric Gastroenterology
OMOP4822029 [45756810]
8.1e-01
1.8e+00
—
1.0e+50
—
2.3e+00
1.3e+00
cases:0.41%
controls:0.18%
cases:0.58%
controls:0.09%
—
—
cases:0.58%
controls:0.00%
—
—
cases:0.51%
controls:0.05%
cases:0.75%
controls:0.21%
5
22
1206
11916
7
11
1204
11927
—
7
0
1204
11938
—
6
6
1174
11703
8
22
1056
10405
duloxetine; oral
N06AX21 [21604749]
9.7e-01
1.3e+00
7.9e-01
—
—
1.1e+00
8.4e-01
cases:2.39%
controls:0.92%
cases:1.65%
controls:0.47%
cases:0.50%
controls:0.23%
—
—
—
—
cases:1.53%
controls:0.54%
cases:2.63%
controls:1.15%
29
110
1182
11828
20
56
1191
11882
6
27
1205
11911
—
—
18
63
1162
11646
28
120
1036
10307
quetiapine; oral
N05AH04 [21604544]
1.0e+00
1.1e+00
9.1e-01
—
8.4e-01
1.0e+00
1.1e+00
cases:4.71%
controls:1.78%
cases:3.30%
controls:1.16%
cases:0.83%
controls:0.34%
—
—
cases:0.91%
controls:0.39%
cases:3.39%
controls:1.26%
cases:6.02%
controls:2.17%
57
213
1154
11725
40
139
1171
11799
10
40
1201
11898
—
11
47
1197
11882
40
148
1140
11561
64
226
1000
10201
Hyperlipidaemia, unspecified
E78.5 [45537986]
2.1e+00
2.1e+00
—
1.0e+50
—
—
2.0e+00
cases:0.74%
controls:0.09%
cases:0.41%
controls:0.05%
—
—
cases:0.83%
controls:0.00%
—
—
—
—
cases:1.13%
controls:0.15%
9
11
1202
11927
5
6
1206
11932
—
10
0
1201
11938
—
—
12
16
1052
10411
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
5.6e-01
7.3e-01
1.6e+00
—
2.9e+00
1.2e+00
7.1e-01
cases:2.39%
controls:1.38%
cases:1.16%
controls:0.56%
cases:0.50%
controls:0.10%
—
—
cases:0.75%
controls:0.04%
cases:1.61%
controls:0.49%
cases:2.44%
controls:1.22%
29
165
1182
11773
14
67
1197
11871
6
12
1205
11926
—
9
5
1199
11924
19
57
1161
11652
26
127
1038
10300
lansoprazole; oral
A02BC03 [21600098]
7.3e-01
1.4e+00
1.3e+00
—
9.4e-01
1.1e+00
8.6e-01
cases:5.70%
controls:2.84%
cases:4.95%
controls:1.31%
cases:0.83%
controls:0.22%
—
—
cases:0.66%
controls:0.26%
cases:3.81%
controls:1.28%
cases:7.52%
controls:3.34%
69
339
1142
11599
60
156
1151
11782
10
26
1201
11912
—
8
31
1200
11898
45
150
1135
11559
80
348
984
10079
buspirone; oral
N05BE01 [21604601]
1.1e+00
—
—
—
—
2.0e+00
2.0e+00
cases:0.50%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.51%
controls:0.07%
cases:0.94%
controls:0.12%
6
20
1205
11918
—
—
—
—
6
8
1174
11701
10
13
1054
10414
pregabalin; oral
N02BF02 [955152]
7.9e-01
9.0e-01
8.8e-01
—
9.8e-01
9.9e-01
1.3e+00
cases:4.13%
controls:1.91%
cases:2.39%
controls:0.99%
cases:0.83%
controls:0.34%
—
—
cases:0.91%
controls:0.34%
cases:2.63%
controls:0.99%
cases:7.05%
controls:1.95%
50
228
1161
11710
29
118
1182
11820
10
41
1201
11897
—
11
41
1197
11888
31
116
1149
11593
75
203
989
10224
Outpatient Hospital
22 [8756]
3.7e-01
7.0e-01
5.9e-01
—
1.5e+00
7.7e-01
6.6e-01
cases:23.70%
controls:17.65%
cases:9.41%
controls:4.93%
cases:0.99%
controls:0.55%
—
—
cases:2.24%
controls:0.49%
cases:9.41%
controls:4.59%
cases:28.38%
controls:17.01%
287
2107
924
9831
114
588
1097
11350
12
66
1199
11872
—
27
59
1181
11870
111
538
1069
11171
302
1774
762
8653
epinephrine
S01EA01 [21603673]
1.1e+00
1.3e+00
—
—
—
1.2e+00
1.6e+00
cases:1.57%
controls:0.55%
cases:0.99%
controls:0.26%
—
—
—
—
—
—
cases:1.02%
controls:0.32%
cases:2.73%
controls:0.57%
19
66
1192
11872
12
31
1199
11907
—
—
—
12
37
1168
11672
29
59
1035
10368
epinephrine; parenteral
C01CA24 [21600303]
1.1e+00
1.3e+00
—
—
—
1.2e+00
1.6e+00
cases:1.57%
controls:0.55%
cases:0.99%
controls:0.26%
—
—
—
—
—
—
cases:1.02%
controls:0.32%
cases:2.73%
controls:0.57%
19
66
1192
11872
12
31
1199
11907
—
—
—
12
37
1168
11672
29
59
1035
10368
Examination and observation for other specified reasons
Z04.8 [45552063]
6.1e-01
1.5e+00
—
—
—
1.7e+00
8.7e-01
cases:1.57%
controls:0.85%
cases:1.40%
controls:0.33%
—
—
—
—
—
—
cases:1.02%
controls:0.20%
cases:2.26%
controls:0.96%
19
102
1192
11836
17
39
1194
11899
—
—
—
12
23
1168
11686
24
100
1040
10327
Bacteria identified in Blood by Culture
600-7 [3023368]
4.6e-01
4.1e-01
1.9e+00
1.0e+50
2.1e+00
6.2e-01
5.5e-01
cases:3.88%
controls:2.49%
cases:1.49%
controls:0.99%
cases:0.74%
controls:0.12%
cases:0.58%
controls:0.00%
cases:0.91%
controls:0.11%
cases:1.78%
controls:0.97%
cases:3.95%
controls:2.31%
47
297
1164
11641
18
118
1193
11820
9
14
1202
11924
7
0
1204
11938
11
13
1197
11916
21
113
1159
11596
42
241
1022
10186
Chest pain, unspecified
R07.4 [45558450]
9.5e-01
9.2e-01
—
—
—
1.3e+00
8.5e-01
cases:4.95%
controls:1.97%
cases:1.65%
controls:0.66%
—
—
—
—
—
—
cases:2.03%
controls:0.59%
cases:4.89%
controls:2.15%
60
235
1151
11703
20
79
1191
11859
—
—
—
24
69
1156
11640
52
224
1012
10203
alprazolam; oral
N05BA12 [21604577]
7.6e-01
1.2e+00
1.4e+00
—
1.6e+00
8.6e-01
1.2e+00
cases:1.82%
controls:0.85%
cases:1.32%
controls:0.39%
cases:0.50%
controls:0.13%
—
—
cases:0.66%
controls:0.13%
cases:1.19%
controls:0.50%
cases:2.91%
controls:0.94%
22
102
1189
11836
16
47
1195
11891
6
15
1205
11923
—
8
16
1200
11913
14
59
1166
11650
31
98
1033
10329
nortriptyline; oral, parenteral
N06AA10 [21604697]
1.2e+00
—
—
—
-1.0e+50
1.7e+00
1.1e+00
cases:1.49%
controls:0.47%
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:1.02%
controls:0.19%
cases:1.69%
controls:0.57%
18
56
1193
11882
—
—
—
0
5
1208
11924
12
22
1168
11687
18
59
1046
10368
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
4.1e-01
7.6e-01
4.6e-01
—
1.3e+00
6.7e-01
8.5e-01
cases:7.35%
controls:4.99%
cases:4.38%
controls:2.09%
cases:0.66%
controls:0.42%
—
—
cases:1.16%
controls:0.33%
cases:3.73%
controls:1.94%
cases:11.18%
controls:5.13%
89
596
1122
11342
53
250
1158
11688
8
50
1203
11888
—
14
39
1194
11890
44
227
1136
11482
119
535
945
9892
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
1.3e-01
1.4e+00
—
—
—
1.4e+00
1.1e+00
cases:0.74%
controls:0.65%
cases:0.91%
controls:0.23%
—
—
—
—
—
—
cases:0.85%
controls:0.21%
cases:1.41%
controls:0.45%
9
78
1202
11860
11
27
1200
11911
—
—
—
10
25
1170
11684
15
47
1049
10380
Laboratory test
15220000 [4034850]
1.1e+00
1.2e+00
—
—
—
8.5e-01
8.5e-01
cases:3.39%
controls:1.18%
cases:1.73%
controls:0.55%
—
—
—
—
—
—
cases:1.69%
controls:0.73%
cases:4.89%
controls:2.16%
41
141
1170
11797
21
66
1190
11872
—
—
—
20
86
1160
11623
52
225
1012
10202
venlafaxine; oral
N06AX16 [21604745]
7.4e-01
1.1e+00
1.2e+00
—
1.2e+00
1.0e+00
1.0e+00
cases:2.64%
controls:1.28%
cases:1.98%
controls:0.70%
cases:0.74%
controls:0.23%
—
—
cases:0.58%
controls:0.17%
cases:2.29%
controls:0.82%
cases:4.23%
controls:1.59%
32
153
1179
11785
24
83
1187
11855
9
28
1202
11910
—
7
20
1201
11909
27
96
1153
11613
45
166
1019
10261
Normoblasts [#/volume] in Blood
715-3 [3021589]
2.9e-01
2.9e-01
1.0e+00
2.3e+00
5.5e-01
3.5e-01
5.2e-01
cases:8.59%
controls:6.58%
cases:6.03%
controls:4.59%
cases:2.56%
controls:0.95%
cases:0.50%
controls:0.05%
cases:1.82%
controls:1.06%
cases:6.36%
controls:4.55%
cases:9.77%
controls:6.02%
104
785
1107
11153
73
548
1138
11390
31
113
1180
11825
6
6
1205
11932
22
126
1186
11803
75
533
1105
11176
104
628
960
9799
Other specified urinary incontinence
N39.4 [45577525]
1.1e+00
8.8e-01
—
—
—
1.4e+00
1.3e+00
cases:1.90%
controls:0.61%
cases:0.74%
controls:0.31%
—
—
—
—
—
—
cases:1.27%
controls:0.32%
cases:2.16%
controls:0.59%
23
73
1188
11865
9
37
1202
11901
—
—
—
15
38
1165
11671
23
62
1041
10365
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
1.1e+00
1.3e+00
—
—
—
2.4e+00
1.4e+00
cases:0.58%
controls:0.18%
cases:0.41%
controls:0.11%
—
—
—
—
—
—
cases:0.85%
controls:0.08%
cases:0.94%
controls:0.23%
7
22
1204
11916
5
13
1206
11925
—
—
—
10
9
1170
11700
10
24
1054
10403
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
8.3e-01
8.4e-01
1.3e+00
—
1.3e+00
1.2e+00
9.0e-01
cases:4.71%
controls:2.11%
cases:1.82%
controls:0.80%
cases:0.58%
controls:0.15%
—
—
cases:0.41%
controls:0.12%
cases:2.71%
controls:0.79%
cases:5.55%
controls:2.33%
57
252
1154
11686
22
95
1189
11843
7
18
1204
11920
—
5
14
1203
11915
32
93
1148
11616
59
243
1005
10184
magnesium hydroxide; oral
A02AA04 [21600052]
1.1e+00
1.7e+00
—
—
—
1.8e+00
2.0e+00
cases:0.41%
controls:0.13%
cases:0.50%
controls:0.09%
—
—
—
—
—
—
cases:0.59%
controls:0.10%
cases:1.13%
controls:0.15%
5
16
1206
11922
6
11
1205
11927
—
—
—
7
12
1173
11697
12
16
1052
10411
magnesium hydroxide; oral
G04BX01 [21602658]
1.1e+00
1.7e+00
—
—
—
1.8e+00
2.0e+00
cases:0.41%
controls:0.13%
cases:0.50%
controls:0.09%
—
—
—
—
—
—
cases:0.59%
controls:0.10%
cases:1.13%
controls:0.15%
5
16
1206
11922
6
11
1205
11927
—
—
—
7
12
1173
11697
12
16
1052
10411
Besnier prurigo
L20.0 [45562534]
6.1e-01
1.6e+00
—
—
—
1.3e+00
8.9e-01
cases:1.49%
controls:0.81%
cases:1.24%
controls:0.26%
—
—
—
—
—
—
cases:1.02%
controls:0.28%
cases:2.16%
controls:0.90%
18
97
1193
11841
15
31
1196
11907
—
—
—
12
33
1168
11676
23
94
1041
10333
Pain general/multiple sites
A01 [2002000142]
1.2e+00
—
—
—
—
1.5e+00
1.0e+00
cases:1.90%
controls:0.59%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.22%
cases:1.88%
controls:0.68%
23
70
1188
11868
—
—
—
—
12
26
1168
11683
20
71
1044
10356
Headache
N01 [2002000720]
7.0e-01
1.5e+00
—
—
-1.0e+50
1.1e+00
1.1e+00
cases:1.73%
controls:0.87%
cases:1.07%
controls:0.24%
—
—
—
—
cases:0.00%
controls:0.07%
cases:1.10%
controls:0.36%
cases:4.14%
controls:1.41%
21
104
1190
11834
13
29
1198
11909
—
—
0
8
1208
11921
13
42
1167
11667
44
147
1020
10280
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
3.7e-01
7.3e-01
1.5e+00
—
1.2e+00
7.2e-01
7.2e-01
cases:5.78%
controls:4.08%
cases:3.14%
controls:1.53%
cases:1.16%
controls:0.25%
—
—
cases:0.75%
controls:0.23%
cases:2.88%
controls:1.43%
cases:7.52%
controls:3.81%
70
487
1141
11451
38
183
1173
11755
14
30
1197
11908
—
9
28
1199
11901
34
167
1146
11542
80
397
984
10030
Ulcerative colitis and Crohn's disease
208 [2001600206]
1.5e+00
—
—
—
—
—
2.2e+00
cases:0.74%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.12%
9
20
1202
11918
—
—
—
—
—
11
12
1053
10415
Scheduled procedure
ZXD10 [2001311387]
7.2e-01
9.2e-01
1.8e+00
—
2.1e+00
1.2e+00
8.3e-01
cases:7.43%
controls:3.77%
cases:2.48%
controls:1.01%
cases:0.50%
controls:0.08%
—
—
cases:0.41%
controls:0.05%
cases:2.63%
controls:0.79%
cases:6.77%
controls:3.08%
90
450
1121
11488
30
120
1181
11818
6
10
1205
11928
—
5
6
1203
11923
31
92
1149
11617
72
321
992
10106
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
7.7e-01
1.0e+00
—
—
—
9.9e-01
8.9e-01
cases:6.03%
controls:2.90%
cases:2.23%
controls:0.80%
—
—
—
—
—
—
cases:2.03%
controls:0.77%
cases:6.30%
controls:2.69%
73
346
1138
11592
27
95
1184
11843
—
—
—
24
90
1156
11619
67
280
997
10147
nitrofurantoin; oral
J01XE01 [21603058]
7.5e-01
1.0e+00
—
—
—
1.0e+00
8.7e-01
cases:3.39%
controls:1.63%
cases:1.73%
controls:0.62%
—
—
—
—
—
—
cases:1.86%
controls:0.68%
cases:4.32%
controls:1.86%
41
194
1170
11744
21
74
1190
11864
—
—
—
22
80
1158
11629
46
194
1018
10233
Other chest pain
R07.3 [45597166]
9.0e-01
1.2e+00
—
—
—
1.7e+00
1.1e+00
cases:1.49%
controls:0.61%
cases:0.58%
controls:0.18%
—
—
—
—
—
—
cases:0.85%
controls:0.16%
cases:1.60%
controls:0.53%
18
73
1193
11865
7
21
1204
11917
—
—
—
10
19
1170
11690
17
55
1047
10372
Urine symptom/complaint other
U07 [2002001142]
7.2e-01
1.8e+00
—
—
—
1.2e+00
1.9e+00
cases:0.99%
controls:0.49%
cases:0.91%
controls:0.15%
—
—
—
—
—
—
cases:0.93%
controls:0.28%
cases:2.91%
controls:0.46%
12
58
1199
11880
11
18
1200
11920
—
—
—
11
33
1169
11676
31
48
1033
10379
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
8.8e-01
1.3e+00
—
—
—
1.9e+00
1.7e+00
cases:0.66%
controls:0.28%
cases:0.58%
controls:0.15%
—
—
—
—
—
—
cases:0.68%
controls:0.10%
cases:0.75%
controls:0.13%
8
33
1203
11905
7
18
1204
11920
—
—
—
8
12
1172
11697
8
14
1056
10413
levomepromazine; oral, parenteral
N05AA02 [21604493]
9.4e-01
—
—
—
—
2.0e+00
1.6e+00
cases:0.58%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.11%
cases:1.41%
controls:0.30%
7
27
1204
11911
—
—
—
—
10
13
1170
11696
15
31
1049
10396
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.8e-01
7.3e-01
1.4e+00
—
1.4e+00
3.7e-01
3.1e-01
cases:10.65%
controls:8.29%
cases:6.94%
controls:3.45%
cases:1.90%
controls:0.47%
—
—
cases:1.24%
controls:0.30%
cases:4.49%
controls:3.13%
cases:11.56%
controls:8.75%
129
990
1082
10948
84
412
1127
11526
23
56
1188
11882
—
15
36
1193
11893
53
367
1127
11342
123
912
941
9515
Obstetrics / Gynecology
16 [38004461]
3.8e-01
5.4e-01
9.3e-01
—
8.1e-01
5.4e-01
3.4e-01
cases:20.73%
controls:15.20%
cases:9.66%
controls:5.85%
cases:2.31%
controls:0.93%
—
—
cases:2.24%
controls:1.01%
cases:9.24%
controls:5.62%
cases:19.36%
controls:14.65%
251
1815
960
10123
117
698
1094
11240
28
111
1183
11827
—
27
120
1181
11809
109
658
1071
11051
206
1528
858
8899
Choriogonadotropin [Presence] in Serum or Plasma
2118-8 [3003191]
9.1e-01
1.3e+00
—
—
—
2.0e+00
1.5e+00
cases:1.07%
controls:0.44%
cases:0.41%
controls:0.12%
—
—
—
—
—
—
cases:0.59%
controls:0.08%
cases:1.41%
controls:0.33%
13
52
1198
11886
5
14
1206
11924
—
—
—
7
9
1173
11700
15
34
1049
10393
Nausea and vomiting
R11 [45539317]
4.3e-01
1.8e+00
—
1.0e+50
—
1.7e+00
7.5e-01
cases:0.99%
controls:0.64%
cases:0.91%
controls:0.15%
—
—
cases:0.83%
controls:0.00%
—
—
cases:0.93%
controls:0.17%
cases:1.50%
controls:0.72%
12
77
1199
11861
11
18
1200
11920
—
10
0
1201
11938
—
11
20
1169
11689
16
75
1048
10352
More than three and less than five hours
ZXE20 [2001311408]
5.1e-01
—
—
—
—
2.2e+00
1.3e+00
cases:1.40%
controls:0.85%
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.08%
cases:1.69%
controls:0.46%
17
101
1194
11837
—
—
—
—
8
9
1172
11700
18
48
1046
10379
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
8.5e-01
1.5e+00
—
—
—
1.8e+00
1.7e+00
cases:0.66%
controls:0.28%
cases:0.58%
controls:0.13%
—
—
—
—
—
—
cases:0.59%
controls:0.10%
cases:0.75%
controls:0.13%
8
34
1203
11904
7
15
1204
11923
—
—
—
7
12
1173
11697
8
14
1056
10413
Obesity due to excess calories
E66.01 [2000501501]
1.2e+00
1.4e+00
—
1.0e+50
1.8e+00
5.1e-01
9.6e-01
cases:1.40%
controls:0.44%
cases:0.91%
controls:0.23%
—
—
cases:1.16%
controls:0.00%
cases:0.41%
controls:0.07%
cases:0.51%
controls:0.31%
cases:1.69%
controls:0.65%
17
53
1194
11885
11
28
1200
11910
—
14
0
1197
11938
5
8
1203
11921
6
36
1174
11673
18
68
1046
10359
ketoprofen; ointment
M02AA10 [21604046]
1.1e+00
9.5e-01
—
—
—
1.2e+00
1.1e+00
cases:3.14%
controls:1.04%
cases:1.16%
controls:0.45%
—
—
—
—
—
—
cases:1.36%
controls:0.39%
cases:3.38%
controls:1.19%
38
124
1173
11814
14
54
1197
11884
—
—
—
16
46
1164
11663
36
124
1028
10303
One hour or less
ZXE00 [2001311394]
6.9e-01
7.5e-01
1.6e+00
—
—
1.1e+00
8.8e-01
cases:7.76%
controls:4.04%
cases:2.23%
controls:1.06%
cases:0.41%
controls:0.08%
—
—
—
—
cases:2.71%
controls:0.91%
cases:7.42%
controls:3.22%
94
482
1117
11456
27
127
1184
11811
5
10
1206
11928
—
—
32
107
1148
11602
79
336
985
10091
ECG with 12 standard connections
XF400 [2001303368]
8.1e-01
7.2e-01
—
—
—
1.5e+00
1.1e+00
cases:2.64%
controls:1.20%
cases:0.99%
controls:0.49%
—
—
—
—
—
—
cases:1.02%
controls:0.23%
cases:2.54%
controls:0.84%
32
143
1179
11795
12
58
1199
11880
—
—
—
12
27
1168
11682
27
88
1037
10339
Abdominal pain epigastric
D02 [2002000301]
1.2e+00
2.2e+00
—
—
—
—
2.0e-01
cases:0.99%
controls:0.29%
cases:0.74%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.38%
12
35
1199
11903
9
10
1202
11928
—
—
—
—
5
40
1059
10387
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
3.9e-01
6.2e-01
1.3e+00
—
7.3e-01
6.2e-01
4.2e-01
cases:7.93%
controls:5.49%
cases:5.86%
controls:3.23%
cases:1.49%
controls:0.41%
—
—
cases:0.83%
controls:0.40%
cases:5.68%
controls:3.13%
cases:9.21%
controls:6.22%
96
655
1115
11283
71
386
1140
11552
18
49
1193
11889
—
10
48
1198
11881
67
367
1113
11342
98
649
966
9778
Foot/toe symptom/complaint
L17 [2002000641]
7.1e-01
9.5e-01
—
—
—
9.1e-01
7.5e-01
cases:4.71%
controls:2.36%
cases:2.15%
controls:0.84%
—
—
—
—
—
—
cases:2.37%
controls:0.97%
cases:5.83%
controls:2.84%
57
282
1154
11656
26
100
1185
11838
—
—
—
28
113
1152
11596
62
296
1002
10131
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
7.9e-01
1.3e+00
—
—
—
1.7e+00
1.7e+00
cases:0.66%
controls:0.30%
cases:0.58%
controls:0.15%
—
—
—
—
—
—
cases:0.68%
controls:0.13%
cases:0.75%
controls:0.14%
8
36
1203
11902
7
18
1204
11920
—
—
—
8
15
1172
11694
8
15
1056
10412
terbutaline; inhalant
R03AC03 [21603257]
7.5e-01
8.7e-01
—
—
—
8.5e-01
8.4e-01
cases:3.80%
controls:1.83%
cases:1.98%
controls:0.84%
—
—
—
—
—
—
cases:1.78%
controls:0.77%
cases:4.23%
controls:1.88%
46
219
1165
11719
24
100
1187
11838
—
—
—
21
90
1159
11619
45
196
1019
10231
Risk factor NOS
A23 [2002000158]
9.2e-02
8.2e-01
—
—
—
1.6e+00
1.7e+00
cases:0.74%
controls:0.68%
cases:0.50%
controls:0.22%
—
—
—
—
—
—
cases:0.76%
controls:0.16%
cases:2.82%
controls:0.52%
9
81
1202
11857
6
26
1205
11912
—
—
—
9
19
1171
11690
30
54
1034
10373
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
1.0e+00
1.1e+00
1.5e+00
—
1.1e+00
1.2e+00
7.5e-01
cases:1.73%
controls:0.63%
cases:1.24%
controls:0.43%
cases:0.50%
controls:0.11%
—
—
cases:0.58%
controls:0.18%
cases:1.53%
controls:0.48%
cases:1.60%
controls:0.76%
21
75
1190
11863
15
51
1196
11887
6
13
1205
11925
—
7
22
1201
11907
18
56
1162
11653
17
79
1047
10348
citalopram; oral, parenteral
N06AB04 [21604712]
7.4e-01
6.9e-01
8.2e-01
—
1.0e+00
1.0e+00
8.1e-01
cases:4.87%
controls:2.38%
cases:2.73%
controls:1.38%
cases:0.91%
controls:0.40%
—
—
cases:0.83%
controls:0.30%
cases:4.07%
controls:1.52%
cases:6.20%
controls:2.85%
59
284
1152
11654
33
165
1178
11773
11
48
1200
11890
—
10
36
1198
11893
48
178
1132
11531
66
297
998
10130
atorvastatin; oral
C10AA05 [21601860]
5.9e-01
6.4e-01
6.3e-01
—
9.0e-01
6.3e-01
4.8e-01
cases:6.85%
controls:3.91%
cases:6.19%
controls:3.35%
cases:1.82%
controls:0.97%
—
—
cases:2.48%
controls:1.02%
cases:6.69%
controls:3.66%
cases:7.89%
controls:5.05%
83
467
1128
11471
75
400
1136
11538
22
116
1189
11822
—
30
122
1178
11807
79
429
1101
11280
84
527
980
9900
montelukast; oral
R03DC03 [21603356]
8.1e-01
8.3e-01
2.7e-01
—
9.1e-01
7.6e-01
8.4e-01
cases:4.21%
controls:1.93%
cases:2.97%
controls:1.32%
cases:0.50%
controls:0.38%
—
—
cases:0.66%
controls:0.27%
cases:2.71%
controls:1.28%
cases:4.89%
controls:2.18%
51
230
1160
11708
36
157
1175
11781
6
45
1205
11893
—
8
32
1200
11897
32
150
1148
11559
52
227
1012
10200
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
3.6e-01
5.1e-01
6.8e-01
—
5.9e-01
5.1e-01
5.7e-01
cases:26.42%
controls:20.05%
cases:16.76%
controls:10.81%
cases:3.88%
controls:2.00%
—
—
cases:3.81%
controls:2.14%
cases:17.46%
controls:11.22%
cases:33.55%
controls:22.18%
320
2393
891
9545
203
1290
1008
10648
47
239
1164
11699
—
46
255
1162
11674
206
1314
974
10395
357
2313
707
8114
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
3.5e-01
9.3e-01
2.3e+00
1.0e+50
—
9.5e-01
6.3e-01
cases:2.15%
controls:1.52%
cases:1.40%
controls:0.56%
cases:0.66%
controls:0.07%
cases:0.91%
controls:0.00%
—
—
cases:1.10%
controls:0.43%
cases:3.10%
controls:1.68%
26
181
1185
11757
17
67
1194
11871
8
8
1203
11930
11
0
1200
11938
—
13
50
1167
11659
33
175
1031
10252
Urinary tract infection, site not specified
N39.0 [45548665]
8.0e-01
1.3e+00
—
—
—
8.2e-01
1.1e+00
cases:2.06%
controls:0.94%
cases:1.40%
controls:0.39%
—
—
—
—
—
—
cases:1.10%
controls:0.49%
cases:3.85%
controls:1.29%
25
112
1186
11826
17
47
1194
11891
—
—
—
13
57
1167
11652
41
135
1023
10292
Predominantly allergic asthma
J45.0 [45557624]
8.1e-01
1.3e+00
—
—
1.3e+00
9.2e-01
1.1e+00
cases:2.23%
controls:1.01%
cases:1.49%
controls:0.43%
—
—
—
—
cases:0.50%
controls:0.13%
cases:1.19%
controls:0.48%
cases:3.10%
controls:1.03%
27
120
1184
11818
18
51
1193
11887
—
—
6
16
1202
11913
14
56
1166
11653
33
107
1031
10320
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
7.1e-01
3.3e-01
—
—
2.5e+00
7.1e-01
7.1e-01
cases:1.90%
controls:0.95%
cases:0.74%
controls:0.54%
—
—
—
—
cases:0.50%
controls:0.04%
cases:1.02%
controls:0.50%
cases:2.63%
controls:1.31%
23
113
1188
11825
9
64
1202
11874
—
—
6
5
1202
11924
12
59
1168
11650
28
137
1036
10290
Arthritis, unspecified
M13.9 [45567463]
4.8e-01
1.2e+00
—
—
—
1.9e+00
1.3e+00
cases:0.66%
controls:0.41%
cases:0.58%
controls:0.17%
—
—
—
—
—
—
cases:0.85%
controls:0.13%
cases:1.60%
controls:0.46%
8
49
1203
11889
7
20
1204
11918
—
—
—
10
15
1170
11694
17
48
1047
10379
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
7.3e-02
4.5e-01
—
—
2.3e+00
6.9e-01
8.5e-01
cases:1.40%
controls:1.31%
cases:0.83%
controls:0.53%
—
—
—
—
cases:0.50%
controls:0.05%
cases:0.76%
controls:0.38%
cases:2.26%
controls:0.98%
17
156
1194
11782
10
63
1201
11875
—
—
6
6
1202
11923
9
45
1171
11664
24
102
1040
10325
lactulose; oral
A06AD11 [21600571]
1.0e+00
1.2e+00
1.1e+00
—
1.7e+00
9.5e-01
7.0e-01
cases:2.73%
controls:0.98%
cases:1.73%
controls:0.55%
cases:0.41%
controls:0.13%
—
—
cases:0.58%
controls:0.11%
cases:1.53%
controls:0.60%
cases:2.54%
controls:1.28%
33
117
1178
11821
21
66
1190
11872
5
16
1206
11922
—
7
13
1201
11916
18
70
1162
11639
27
133
1037
10294
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
6.6e-01
9.9e-01
—
—
1.1e+00
6.8e-01
8.0e-01
cases:7.84%
controls:4.20%
cases:3.47%
controls:1.32%
—
—
—
—
cases:0.50%
controls:0.17%
cases:2.88%
controls:1.48%
cases:9.87%
controls:4.68%
95
501
1116
11437
42
157
1169
11781
—
—
6
20
1202
11909
34
173
1146
11536
105
488
959
9939
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
6.6e-01
9.9e-01
—
—
1.1e+00
6.8e-01
8.0e-01
cases:7.84%
controls:4.20%
cases:3.47%
controls:1.32%
—
—
—
—
cases:0.50%
controls:0.17%
cases:2.88%
controls:1.48%
cases:9.87%
controls:4.68%
95
501
1116
11437
42
157
1169
11781
—
—
6
20
1202
11909
34
173
1146
11536
105
488
959
9939
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
3.8e-01
6.0e-01
2.1e+00
—
—
9.8e-01
9.9e-01
cases:1.49%
controls:1.02%
cases:0.74%
controls:0.41%
cases:0.50%
controls:0.06%
—
—
—
—
cases:0.93%
controls:0.35%
cases:2.16%
controls:0.82%
18
122
1193
11816
9
49
1202
11889
6
7
1205
11931
—
—
11
41
1169
11668
23
85
1041
10342
Emergency Room and Inpatient Visit
ERIP [262]
2.4e-01
2.9e-01
1.6e+00
—
1.5e+00
3.2e-01
3.3e-01
cases:4.05%
controls:3.20%
cases:2.15%
controls:1.62%
cases:0.99%
controls:0.20%
—
—
cases:0.75%
controls:0.17%
cases:2.29%
controls:1.67%
cases:4.79%
controls:3.48%
49
382
1162
11556
26
193
1185
11745
12
24
1199
11914
—
9
20
1199
11909
27
196
1153
11513
51
363
1013
10064
Cerebral infarction, unspecified
I63.9 [45596216]
4.0e-01
2.0e+00
-1.0e+50
1.0e+50
—
1.5e+00
1.1e+00
cases:0.66%
controls:0.44%
cases:0.74%
controls:0.10%
cases:0.00%
controls:0.04%
cases:0.58%
controls:0.00%
—
—
cases:0.68%
controls:0.15%
cases:1.60%
controls:0.55%
8
53
1203
11885
9
12
1202
11926
0
5
1211
11933
7
0
1204
11938
—
8
18
1172
11691
17
57
1047
10370
Iron deficiency anaemia, unspecified
D50.9 [45605373]
-1.6e-01
1.5e+00
—
—
—
1.6e+00
9.0e-01
cases:0.41%
controls:0.49%
cases:0.91%
controls:0.21%
—
—
—
—
—
—
cases:0.93%
controls:0.19%
cases:1.41%
controls:0.58%
5
58
1206
11880
11
25
1200
11913
—
—
—
11
22
1169
11687
15
60
1049
10367
Heartburn
R12 [45539318]
1.2e+00
1.9e+00
—
—
—
1.0e+00
1.0e+00
cases:1.57%
controls:0.48%
cases:1.07%
controls:0.17%
—
—
—
—
—
—
cases:0.68%
controls:0.24%
cases:0.94%
controls:0.35%
19
57
1192
11881
13
20
1198
11918
—
—
—
8
28
1172
11681
10
36
1054
10391
Other specified intervertebral disc degeneration
M51.3 [45591865]
2.0e-02
1.4e+00
—
—
—
1.6e+00
1.5e+00
cases:0.50%
controls:0.49%
cases:0.58%
controls:0.14%
—
—
—
—
—
—
cases:0.85%
controls:0.18%
cases:2.07%
controls:0.47%
6
58
1205
11880
7
17
1204
11921
—
—
—
10
21
1170
11688
22
49
1042
10378
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
6.6e-01
—
-1.0e+50
—
—
1.7e+00
1.3e+00
cases:0.83%
controls:0.43%
—
—
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.68%
controls:0.12%
cases:1.22%
controls:0.34%
10
51
1201
11887
—
0
5
1211
11933
—
—
8
14
1172
11695
13
35
1051
10392
tizanidine; oral
M03BX02 [21604116]
6.2e-01
7.4e-01
-3.4e-02
—
6.6e-01
1.0e+00
5.8e-01
cases:15.11%
controls:8.72%
cases:6.36%
controls:3.13%
cases:0.41%
controls:0.43%
—
—
cases:0.83%
controls:0.43%
cases:7.80%
controls:2.88%
cases:15.98%
controls:9.60%
183
1041
1028
10897
77
374
1134
11564
5
51
1206
11887
—
10
51
1198
11878
92
337
1088
11372
170
1001
894
9426
oxazepam; oral
N05BA04 [21604569]
6.7e-01
6.8e-01
3.3e-01
—
8.0e-01
7.8e-01
8.6e-01
cases:5.78%
controls:3.05%
cases:3.39%
controls:1.74%
cases:0.74%
controls:0.54%
—
—
cases:1.08%
controls:0.49%
cases:3.64%
controls:1.71%
cases:7.71%
controls:3.42%
70
364
1141
11574
41
208
1170
11730
9
64
1202
11874
—
13
58
1195
11871
43
200
1137
11509
82
357
982
10070
Contusion of other parts of wrist and hand
S60.2 [45602941]
1.2e+00
-1.0e+50
—
—
—
1.8e+00
9.4e-01
cases:1.07%
controls:0.32%
cases:0.00%
controls:0.07%
—
—
—
—
—
—
cases:0.59%
controls:0.10%
cases:0.66%
controls:0.26%
13
38
1198
11900
0
8
1211
11930
—
—
—
7
12
1173
11697
7
27
1057
10400
Issue of repeat prescription
Z76.0 [45542456]
6.7e-01
1.0e+00
—
—
1.8e+00
9.9e-01
9.8e-01
cases:2.23%
controls:1.16%
cases:2.23%
controls:0.83%
—
—
—
—
cases:0.41%
controls:0.07%
cases:2.80%
controls:1.06%
cases:6.20%
controls:2.42%
27
138
1184
11800
27
99
1184
11839
—
—
5
8
1203
11921
33
124
1147
11585
66
252
998
10175
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
3.4e-01
9.2e-01
1.6e+00
—
1.6e+00
1.1e+00
9.6e-01
cases:1.98%
controls:1.42%
cases:1.65%
controls:0.66%
cases:0.50%
controls:0.10%
—
—
cases:0.58%
controls:0.12%
cases:1.61%
controls:0.56%
cases:2.82%
controls:1.10%
24
170
1187
11768
20
79
1191
11859
6
12
1205
11926
—
7
14
1201
11915
19
65
1161
11644
30
115
1034
10312
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
2.7e-01
6.7e-01
1.2e+00
—
6.9e-01
4.1e-01
4.3e-01
cases:19.24%
controls:15.35%
cases:15.77%
controls:8.78%
cases:3.63%
controls:1.17%
—
—
cases:2.07%
controls:1.05%
cases:12.54%
controls:8.68%
cases:24.15%
controls:17.21%
233
1832
978
10106
191
1048
1020
10890
44
140
1167
11798
—
25
125
1183
11804
148
1016
1032
10693
257
1795
807
8632
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
5.0e-01
5.1e-01
5.9e-01
—
6.9e-01
5.5e-01
6.7e-01
cases:9.17%
controls:5.77%
cases:9.58%
controls:5.96%
cases:3.22%
controls:1.81%
—
—
cases:3.23%
controls:1.64%
cases:10.17%
controls:6.11%
cases:12.88%
controls:7.01%
111
689
1100
11249
116
711
1095
11227
39
216
1172
11722
—
39
196
1169
11733
120
716
1060
10993
137
731
927
9696
Pain in limb
M79.6 [45587063]
7.6e-01
8.1e-01
—
1.0e+50
1.1e+00
6.3e-01
7.3e-01
cases:7.68%
controls:3.75%
cases:3.14%
controls:1.42%
—
—
cases:0.50%
controls:0.00%
cases:0.50%
controls:0.17%
cases:3.05%
controls:1.65%
cases:9.02%
controls:4.56%
93
448
1118
11490
38
170
1173
11768
—
6
0
1205
11938
6
20
1202
11909
36
193
1144
11516
96
475
968
9952
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
2.9e-01
6.7e-01
1.2e+00
—
9.3e-01
5.3e-01
5.2e-01
cases:12.96%
controls:10.07%
cases:8.34%
controls:4.45%
cases:1.90%
controls:0.58%
—
—
cases:1.32%
controls:0.53%
cases:6.78%
controls:4.12%
cases:14.85%
controls:9.36%
157
1202
1054
10736
101
531
1110
11407
23
69
1188
11869
—
16
63
1192
11866
80
482
1100
11227
158
976
906
9451
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
8.7e-01
1.7e+00
—
—
—
1.1e+00
1.2e+00
cases:1.49%
controls:0.63%
cases:1.32%
controls:0.25%
—
—
—
—
—
—
cases:0.76%
controls:0.26%
cases:1.88%
controls:0.55%
18
75
1193
11863
16
30
1195
11908
—
—
—
9
31
1171
11678
20
57
1044
10370
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.7e-01
7.2e-01
2.0e+00
—
1.2e+00
8.0e-01
8.6e-01
cases:1.57%
controls:1.32%
cases:1.32%
controls:0.64%
cases:0.58%
controls:0.08%
—
—
cases:0.41%
controls:0.13%
cases:1.36%
controls:0.61%
cases:2.91%
controls:1.26%
19
158
1192
11780
16
77
1195
11861
7
9
1204
11929
—
5
15
1203
11914
16
72
1164
11637
31
131
1033
10296
fluticasone furoate; nasal
R01AD12 [21605053]
6.4e-01
7.1e-01
6.3e-01
-1.0e+50
9.1e-01
7.6e-01
7.8e-01
cases:12.22%
controls:6.87%
cases:6.28%
controls:3.17%
cases:0.99%
controls:0.53%
cases:0.00%
controls:0.06%
cases:1.08%
controls:0.44%
cases:5.59%
controls:2.71%
cases:13.44%
controls:6.64%
148
820
1063
11118
76
379
1135
11559
12
63
1199
11875
0
7
1211
11931
13
52
1195
11877
66
317
1114
11392
143
692
921
9735
fluticasone; nasal
R01AD08 [21605050]
6.4e-01
7.1e-01
6.3e-01
-1.0e+50
9.1e-01
7.6e-01
7.8e-01
cases:12.22%
controls:6.87%
cases:6.28%
controls:3.17%
cases:0.99%
controls:0.53%
cases:0.00%
controls:0.06%
cases:1.08%
controls:0.44%
cases:5.59%
controls:2.71%
cases:13.44%
controls:6.64%
148
820
1063
11118
76
379
1135
11559
12
63
1199
11875
0
7
1211
11931
13
52
1195
11877
66
317
1114
11392
143
692
921
9735
Moderate depressive episode
F32.1 [45552478]
6.6e-01
—
-1.0e+50
—
—
1.7e+00
1.2e+00
cases:0.66%
controls:0.34%
—
—
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.76%
controls:0.15%
cases:1.13%
controls:0.34%
8
41
1203
11897
—
0
5
1211
11933
—
—
9
17
1171
11692
12
35
1052
10392
Ear symptom/complaint other
H29 [2002000484]
1.0e+00
1.8e+00
—
—
—
5.3e-01
8.4e-01
cases:1.98%
controls:0.70%
cases:0.83%
controls:0.13%
—
—
—
—
—
—
cases:0.51%
controls:0.30%
cases:1.79%
controls:0.78%
24
84
1187
11854
10
16
1201
11922
—
—
—
6
35
1174
11674
19
81
1045
10346
Other obesity
E66.8 [45533036]
1.3e+00
1.5e+00
—
1.0e+50
—
1.0e+00
1.1e+00
cases:0.91%
controls:0.24%
cases:0.74%
controls:0.16%
—
—
cases:0.50%
controls:0.00%
—
—
cases:0.51%
controls:0.19%
cases:1.03%
controls:0.35%
11
29
1200
11909
9
19
1202
11919
—
6
0
1205
11938
—
6
22
1174
11687
11
37
1053
10390
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
6.7e-01
1.1e+00
—
—
—
1.1e+00
7.5e-01
cases:2.64%
controls:1.37%
cases:1.24%
controls:0.42%
—
—
—
—
—
—
cases:1.10%
controls:0.37%
cases:2.26%
controls:1.07%
32
164
1179
11774
15
50
1196
11888
—
—
—
13
43
1167
11666
24
112
1040
10315
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
4.8e-01
1.0e+00
—
—
—
1.1e+00
7.5e-01
cases:2.31%
controls:1.45%
cases:1.32%
controls:0.47%
—
—
—
—
—
—
cases:1.36%
controls:0.48%
cases:3.20%
controls:1.53%
28
173
1183
11765
16
56
1195
11882
—
—
—
16
56
1164
11653
34
160
1030
10267
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
-1.2e-02
5.6e-01
2.4e+00
—
8.1e-01
4.6e-01
4.8e-01
cases:3.14%
controls:3.17%
cases:2.31%
controls:1.33%
cases:1.32%
controls:0.13%
—
—
cases:0.41%
controls:0.18%
cases:1.78%
controls:1.13%
cases:5.73%
controls:3.63%
38
379
1173
11559
28
159
1183
11779
16
15
1195
11923
—
5
22
1203
11907
21
132
1159
11577
61
378
1003
10049
potassium chloride; oral
A12BA01 [21600877]
4.0e-01
5.2e-01
—
—
1.7e+00
1.1e+00
6.6e-01
cases:1.16%
controls:0.78%
cases:0.91%
controls:0.54%
—
—
—
—
cases:0.66%
controls:0.12%
cases:1.61%
controls:0.54%
cases:2.07%
controls:1.08%
14
93
1197
11845
11
65
1200
11873
—
—
8
14
1200
11915
19
63
1161
11646
22
113
1042
10314
Vertigo/dizziness
N17 [2002000728]
5.8e-01
1.9e+00
—
—
—
7.2e-01
8.9e-01
cases:1.24%
controls:0.70%
cases:1.16%
controls:0.17%
—
—
—
—
—
—
cases:0.59%
controls:0.29%
cases:1.88%
controls:0.78%
15
83
1196
11855
14
20
1197
11918
—
—
—
7
34
1173
11675
20
81
1044
10346
ezetimibe; oral
C10AX09 [21601896]
7.6e-01
1.0e+00
1.4e+00
—
7.4e-01
9.5e-01
8.5e-01
cases:1.90%
controls:0.90%
cases:2.23%
controls:0.80%
cases:0.74%
controls:0.19%
—
—
cases:0.58%
controls:0.28%
cases:2.29%
controls:0.90%
cases:2.54%
controls:1.10%
23
107
1188
11831
27
96
1184
11842
9
23
1202
11915
—
7
33
1201
11896
27
105
1153
11604
27
115
1037
10312
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
3.6e-01
3.5e-01
1.5e+00
—
—
7.0e-01
6.4e-01
cases:4.29%
controls:3.04%
cases:2.06%
controls:1.47%
cases:0.74%
controls:0.17%
—
—
—
—
cases:2.54%
controls:1.28%
cases:5.26%
controls:2.85%
52
363
1159
11575
25
175
1186
11763
9
20
1202
11918
—
—
30
150
1150
11559
56
297
1008
10130
mometasone; nasal
R01AD09 [21605051]
7.5e-01
6.2e-01
8.8e-01
—
1.2e+00
7.2e-01
7.3e-01
cases:11.64%
controls:5.86%
cases:3.88%
controls:2.13%
cases:0.74%
controls:0.31%
—
—
cases:0.91%
controls:0.27%
cases:4.83%
controls:2.40%
cases:13.53%
controls:6.98%
141
700
1070
11238
47
254
1164
11684
9
37
1202
11901
—
11
32
1197
11897
57
281
1123
11428
144
728
920
9699
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
6.8e-01
1.2e+00
—
—
—
6.6e-01
9.5e-01
cases:6.03%
controls:3.16%
cases:3.22%
controls:1.01%
—
—
—
—
—
—
cases:2.20%
controls:1.15%
cases:9.02%
controls:3.69%
73
377
1138
11561
39
120
1172
11818
—
—
—
26
135
1154
11574
96
385
968
10042
amoxicillin; oral, parenteral
J01CA04 [21602823]
5.2e-01
4.2e-01
2.1e-01
—
9.6e-01
4.8e-01
4.2e-01
cases:29.56%
controls:19.97%
cases:9.08%
controls:6.17%
cases:0.83%
controls:0.67%
—
—
cases:1.41%
controls:0.54%
cases:9.15%
controls:5.84%
cases:27.54%
controls:19.95%
358
2384
853
9554
110
736
1101
11202
10
80
1201
11858
—
17
65
1191
11864
108
684
1072
11025
293
2080
771
8347
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
8.3e-01
5.9e-01
—
—
1.4e+00
9.7e-01
1.0e+00
cases:4.21%
controls:1.88%
cases:1.73%
controls:0.97%
—
—
—
—
cases:0.66%
controls:0.17%
cases:2.29%
controls:0.88%
cases:3.95%
controls:1.50%
51
225
1160
11713
21
116
1190
11822
—
—
8
20
1200
11909
27
103
1153
11606
42
156
1022
10271
fluconazole; oral, parenteral
J02AC01 [21603080]
5.7e-01
7.7e-01
2.1e-01
—
1.2e+00
7.2e-01
7.1e-01
cases:9.83%
controls:5.78%
cases:4.71%
controls:2.23%
cases:0.41%
controls:0.34%
—
—
cases:0.66%
controls:0.21%
cases:4.24%
controls:2.10%
cases:12.22%
controls:6.38%
119
690
1092
11248
57
266
1154
11672
5
40
1206
11898
—
8
25
1200
11904
50
246
1130
11463
130
665
934
9762
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
1.5e+00
1.1e+00
—
1.0e+50
—
1.4e+00
1.3e+00
cases:1.07%
controls:0.25%
cases:0.58%
controls:0.20%
—
—
cases:0.41%
controls:0.00%
—
—
cases:0.59%
controls:0.15%
cases:1.03%
controls:0.28%
13
30
1198
11908
7
24
1204
11914
—
5
0
1206
11938
—
7
17
1173
11692
11
29
1053
10398
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
8.0e-01
5.0e-01
6.0e-01
—
5.3e-01
9.2e-01
1.1e+00
cases:1.90%
controls:0.86%
cases:0.99%
controls:0.60%
cases:0.41%
controls:0.23%
—
—
cases:0.41%
controls:0.24%
cases:1.61%
controls:0.65%
cases:3.29%
controls:1.17%
23
103
1188
11835
12
72
1199
11866
5
27
1206
11911
—
5
29
1203
11900
19
76
1161
11633
35
122
1029
10305
Acute vaginitis
N76.0 [45543891]
1.0e+00
7.6e-01
—
—
—
1.8e+00
8.1e-01
cases:1.24%
controls:0.46%
cases:0.41%
controls:0.19%
—
—
—
—
—
—
cases:0.85%
controls:0.15%
cases:1.03%
controls:0.46%
15
55
1196
11883
5
23
1206
11915
—
—
—
10
17
1170
11692
11
48
1053
10379
Lichen simplex chronicus and prurigo
L28 [45755471]
2.8e+00
—
—
—
—
—
—
cases:0.66%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
8
5
1203
11933
—
—
—
—
—
—
azathioprine; oral, parenteral
L04AX01 [21603927]
2.4e-01
5.3e-01
—
—
—
1.3e+00
1.5e+00
cases:0.41%
controls:0.33%
cases:0.50%
controls:0.29%
—
—
—
—
—
—
cases:1.02%
controls:0.29%
cases:1.69%
controls:0.38%
5
39
1206
11899
6
35
1205
11903
—
—
—
12
34
1168
11675
18
40
1046
10387
Malaise and fatigue
R53 [45553741]
6.8e-01
8.0e-01
—
1.0e+50
—
1.1e+00
9.6e-01
cases:3.30%
controls:1.71%
cases:1.65%
controls:0.75%
—
—
cases:0.50%
controls:0.00%
—
—
cases:2.37%
controls:0.79%
cases:5.08%
controls:2.01%
40
204
1171
11734
20
89
1191
11849
—
6
0
1205
11938
—
28
92
1152
11617
54
210
1010
10217
Anxiety disorder, unspecified
F41.9 [45542849]
8.1e-01
8.4e-01
—
1.0e+50
1.9e+00
7.9e-01
6.6e-01
cases:1.82%
controls:0.81%
cases:0.91%
controls:0.39%
—
—
cases:0.58%
controls:0.00%
cases:0.75%
controls:0.11%
cases:1.10%
controls:0.50%
cases:2.26%
controls:1.18%
22
97
1189
11841
11
47
1200
11891
—
7
0
1204
11938
9
13
1199
11916
13
59
1167
11650
24
123
1040
10304
Exposure to unspecified factor
X59 [45756412]
7.3e-01
-1.4e-02
—
—
2.0e+00
7.9e-01
4.5e-01
cases:2.64%
controls:1.29%
cases:0.50%
controls:0.50%
—
—
—
—
cases:0.50%
controls:0.07%
cases:0.93%
controls:0.43%
cases:2.35%
controls:1.51%
32
154
1179
11784
6
60
1205
11878
—
—
6
8
1202
11921
11
50
1169
11659
25
157
1039
10270
hypromellose
S01KA02 [21605115]
7.8e-01
1.1e+00
—
—
-1.0e+50
7.3e-01
8.2e-01
cases:2.89%
controls:1.34%
cases:1.65%
controls:0.54%
—
—
—
—
cases:0.00%
controls:0.09%
cases:1.27%
controls:0.61%
cases:3.01%
controls:1.34%
35
160
1176
11778
20
65
1191
11873
—
—
0
11
1208
11918
15
72
1165
11637
32
140
1032
10287
cetirizine; oral
R06AE07 [21603497]
5.5e-01
7.0e-01
2.5e-03
—
8.1e-01
6.3e-01
8.3e-01
cases:12.14%
controls:7.35%
cases:6.19%
controls:3.17%
cases:0.50%
controls:0.49%
—
—
cases:0.83%
controls:0.37%
cases:6.02%
controls:3.31%
cases:16.45%
controls:7.91%
147
878
1064
11060
75
378
1136
11560
6
59
1205
11879
—
10
44
1198
11885
71
387
1109
11322
175
825
889
9602
Hypersensitivity skin testing
268377001 [4147813]
-1.4e-02
1.5e+00
—
—
—
—
1.2e+00
cases:0.74%
controls:0.75%
cases:0.83%
controls:0.19%
—
—
—
—
—
—
—
—
cases:2.44%
controls:0.72%
9
90
1202
11848
10
23
1201
11915
—
—
—
—
26
75
1038
10352
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
1.2e-01
6.7e-01
1.9e+00
—
—
6.3e-01
7.6e-01
cases:1.57%
controls:1.40%
cases:1.40%
controls:0.72%
cases:0.58%
controls:0.08%
—
—
—
—
cases:1.27%
controls:0.68%
cases:2.91%
controls:1.38%
19
167
1192
11771
17
86
1194
11852
7
10
1204
11928
—
—
15
80
1165
11629
31
144
1033
10283
General anaesthesia
WX402 [2001310806]
4.6e-01
4.1e-01
—
—
—
1.4e+00
1.3e+00
cases:2.48%
controls:1.58%
cases:0.91%
controls:0.60%
—
—
—
—
—
—
cases:2.03%
controls:0.50%
cases:3.67%
controls:1.06%
30
189
1181
11749
11
72
1200
11866
—
—
—
24
58
1156
11651
39
111
1025
10316
Pneumonia, unspecified
J18.9 [45601123]
9.5e-01
2.7e-01
—
—
—
9.8e-01
7.5e-01
cases:3.39%
controls:1.33%
cases:0.91%
controls:0.70%
—
—
—
—
—
—
cases:1.69%
controls:0.64%
cases:4.51%
controls:2.19%
41
159
1170
11779
11
83
1200
11855
—
—
—
20
75
1160
11634
48
228
1016
10199
Migraine without aura [common migraine]
G43.0 [45600784]
6.0e-01
5.7e-01
—
1.0e+50
—
1.6e+00
1.1e+00
cases:0.99%
controls:0.54%
cases:0.41%
controls:0.23%
—
—
cases:0.58%
controls:0.00%
—
—
cases:1.19%
controls:0.24%
cases:2.35%
controls:0.82%
12
65
1199
11873
5
28
1206
11910
—
7
0
1204
11938
—
14
28
1166
11681
25
85
1039
10342
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
7.1e-01
—
—
1.0e+50
—
1.4e+00
1.3e+00
cases:0.58%
controls:0.28%
—
—
—
—
cases:0.50%
controls:0.00%
—
—
cases:1.02%
controls:0.26%
cases:1.41%
controls:0.39%
7
34
1204
11904
—
—
6
0
1205
11938
—
12
30
1168
11679
15
41
1049
10386
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
7.4e-01
7.7e-01
6.8e-01
—
1.2e+00
1.0e+00
9.0e-01
cases:3.80%
controls:1.84%
cases:1.82%
controls:0.85%
cases:0.50%
controls:0.25%
—
—
cases:0.75%
controls:0.23%
cases:2.54%
controls:0.92%
cases:4.61%
controls:1.93%
46
220
1165
11718
22
101
1189
11837
6
30
1205
11908
—
9
27
1199
11902
30
108
1150
11601
49
201
1015
10226
More than one and less than three hours
ZXE10 [2001311401]
6.2e-01
8.0e-01
2.0e+00
—
—
1.2e+00
8.8e-01
cases:6.11%
controls:3.38%
cases:1.65%
controls:0.75%
cases:0.41%
controls:0.06%
—
—
—
—
cases:1.95%
controls:0.61%
cases:6.11%
controls:2.62%
74
404
1137
11534
20
89
1191
11849
5
7
1206
11931
—
—
23
72
1157
11637
65
273
999
10154
Helicobacter pylori Ab [Units/volume] in Serum
7900-4 [3017895]
8.8e-01
2.7e+00
—
—
—
—
4.0e-01
cases:0.91%
controls:0.38%
cases:1.07%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.32%
11
45
1200
11893
13
9
1198
11929
—
—
—
—
5
33
1059
10394
hydroxocobalamin
V03AB33 [21605256]
7.9e-01
8.8e-01
—
—
—
1.2e+00
1.4e+00
cases:1.32%
controls:0.60%
cases:1.40%
controls:0.59%
—
—
—
—
—
—
cases:1.86%
controls:0.55%
cases:2.73%
controls:0.68%
16
72
1195
11866
17
70
1194
11868
—
—
—
22
64
1158
11645
29
71
1035
10356
hydroxocobalamin; parenteral
B03BA03 [21601123]
7.9e-01
8.8e-01
—
—
—
1.2e+00
1.4e+00
cases:1.32%
controls:0.60%
cases:1.40%
controls:0.59%
—
—
—
—
—
—
cases:1.86%
controls:0.55%
cases:2.73%
controls:0.68%
16
72
1195
11866
17
70
1194
11868
—
—
—
22
64
1158
11645
29
71
1035
10356
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
5.8e-01
1.2e+00
-1.0e+50
—
—
1.6e+00
1.0e+00
cases:1.57%
controls:0.89%
cases:0.74%
controls:0.23%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.93%
controls:0.19%
cases:1.79%
controls:0.64%
19
106
1192
11832
9
27
1202
11911
0
5
1211
11933
—
—
11
22
1169
11687
19
67
1045
10360
Anaemia, unspecified
D64.9 [45600610]
-7.0e-02
1.1e+00
—
1.0e+50
—
1.6e+00
9.9e-01
cases:0.58%
controls:0.62%
cases:0.50%
controls:0.17%
—
—
cases:0.41%
controls:0.00%
—
—
cases:1.19%
controls:0.23%
cases:1.41%
controls:0.53%
7
74
1204
11864
6
20
1205
11918
—
5
0
1206
11938
—
14
27
1166
11682
15
55
1049
10372
Diverticular disease of intestine, part unspecified, without perforation or abscess
K57.9 [45543325]
—
—
—
1.0e+50
—
2.6e+00
1.9e+00
—
—
—
—
—
—
cases:0.50%
controls:0.00%
—
—
cases:0.59%
controls:0.04%
cases:0.56%
controls:0.09%
—
—
—
6
0
1205
11938
—
7
5
1173
11704
6
9
1058
10418

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
408
1637
3.15
74.72
2.6
2.6
96.34
111.67
ug/g
0.49
329
1286
578
2986
2.66
63.99
1.6
1.4
1.14
1.83
u/ml
1.10
128
815
501
2583
2.51
53.63
1.8
1.5
2.12
2.28
g/l
1.29
273
1607
124
291
4.60
49.21
1.4
1.4
288.81
304.21
ug/g
0.30
63
171
265
1046
2.92
47.76
1.3
1.2
—
—
—
0
0
613
3692
2.23
43.56
6.8
6.5
—
—
—
0
0
701
4493
2.19
42.16
7.8
5.8
1.22
1.22
mmol/l
0.02
654
4130
687
4432
2.14
39.87
5.1
4.6
36.65
36.29
g/l
0.98
642
4143
752
5064
2.12
38.47
3.1
2.4
77.37
76.31
nmol/l
0.45
702
4631
749
5080
2.09
37.05
8.6
6.1
1.22
1.22
mmol/l
0.10
664
4377
304
1445
2.43
36.84
1.3
1.2
—
—
—
0
0
786
5442
2.09
36.58
5.9
6.1
10.56
11.15
umol/l
0.84
750
5174
836
5943
2.10
35.96
7.9
6.6
0.18
0.19
e9/l
0.11
700
5238
1047
8161
2.34
35.05
9.5
7.4
76.54
78.34
u/l
0.88
1004
7727
174
640
2.98
35.04
1.2
1.1
—
1.00
—
0
7
812
5770
2.05
34.20
7.6
6.3
0.04
0.04
e9/l
0.17
665
5018
810
5763
2.04
33.84
7.6
6.3
0.57
0.56
e9/l
0.40
667
5014
674
4508
2.01
33.38
2.5
1.9
98.48
97.70
pmol/l
0.17
383
2377
256
1184
2.44
32.60
1.5
1.4
—
—
—
0
0
763
5359
2.00
32.52
7.5
6.3
56.09
56.33
%
0.23
728
5137
756
5304
1.99
32.19
7.7
6.5
8.55
8.64
%
0.40
713
4991
755
5307
1.98
31.83
7.6
6.4
2.73
2.85
%
0.89
713
4986
754
5299
1.98
31.79
7.7
6.5
0.66
0.69
%
0.68
710
4971
768
5451
1.97
31.23
7.6
6.4
29.26
29.03
%
0.23
732
5192
815
5904
1.98
31.21
7.7
6.3
1.95
1.96
e9/l
0.14
690
5270
432
2539
2.04
30.09
4.5
4.0
91.38
92.25
%
0.29
424
2474
473
2917
1.97
28.40
4.1
3.5
7.40
7.40
ph
0.08
299
2097
857
6427
1.94
28.32
10.7
9.2
4.13
3.95
e9/l
1.04
721
5634
938
7303
1.97
27.08
6.2
4.3
2903.24
2632.08
e6/l
0.05
17
90
552
3650
1.88
26.35
3.2
3.3
2.36
2.36
mmol/l
0.15
495
3347
298
1594
2.12
26.26
3.5
2.8
1.94
3.22
e6/l
1.61
112
771
585
3971
1.85
25.44
5.0
3.6
53.39
103.47
e6/l
1.20
368
2722
237
1195
2.20
24.11
5.2
5.3
1.04
1.06
mmol/l
0.49
218
1102
502
3301
1.84
23.78
2.9
2.3
54.59
62.34
u/l
2.31
468
3053
278
1504
2.07
23.51
3.7
3.7
0.82
0.83
mmol/l
0.29
263
1423
449
2861
1.86
23.47
2.8
2.2
2.66
2.81
mg/l
0.69
389
2460
312
1769
2.00
23.13
3.4
2.7
0.69
1.10
e6/l
2.07
125
947
259
1375
2.10
22.99
3.0
2.3
23.10
22.98
%
0.04
237
1284
663
4774
1.78
22.89
4.1
3.2
6.17
6.23
ph
0.62
304
2702
294
1649
2.01
22.40
3.0
2.2
14.33
13.61
umol/l
0.67
272
1546
274
1514
2.02
21.71
3.0
2.2
2.43
2.37
g/l
1.11
248
1400
203
1002
2.21
21.62
2.6
2.4
35.98
86.29
u/l
0.52
171
842
497
3337
1.78
21.43
3.8
3.0
27.06
84.36
e6/l
1.88
349
2555
444
2886
1.81
21.34
3.9
3.0
0.21
0.38
e6/l
2.37
291
2118
762
5800
1.74
20.86
3.8
3.0
102.51
95.26
ug/l
0.27
719
5465
407
2592
1.82
20.84
4.5
4.0
—
—
—
0
0
442
2898
1.79
20.46
1.8
1.6
20.32
20.43
nmol/l
0.06
384
2447
228
1205
2.08
20.29
2.4
2.9
5.65
6.82
umol/l
0.99
189
1051
168
788
2.30
20.18
1.3
1.2
—
—
—
0
0
1060
8936
1.92
20.00
5.9
4.3
14.81
14.61
pmol/l
2.09
1019
8276
284
1638
1.93
19.69
1.6
1.4
453.97
513.93
titre
0.39
63
323
778
6012
1.71
19.63
4.5
3.6
0.00
1.17
estimate
0.50
136
1287
782
6069
1.70
19.25
4.6
3.6
0.06
0.25
estimate
0.35
131
1240
770
5954
1.70
19.19
4.5
3.6
0.00
0.00
estimate
0.50
135
1268
438
2913
1.75
19.02
2.4
2.0
152.42
227.83
u/l
1.30
415
2766
148
675
2.34
18.93
3.7
3.3
4.53
4.60
pmol/l
0.41
123
608
274
1581
1.92
18.90
1.9
1.7
1137.34
1179.41
nmol/l
0.34
212
1196
378
2432
1.77
18.30
1.9
1.8
1.61
1.14
mg/l
0.73
282
1830
779
6085
1.68
18.29
6.3
4.5
6.54
6.44
mmol/l
0.61
744
5667
1174
10354
2.15
18.08
7.5
5.2
1.75
1.86
mu/l
2.96
1129
9692
396
2597
1.75
17.86
3.1
3.1
1583.63
1017.84
ng/l
0.98
335
2148
473
3279
1.69
17.31
3.5
2.8
—
—
—
0
0
86
320
2.80
16.75
1.2
1.2
—
—
—
0
0
512
3658
1.65
16.49
3.5
3.2
29.79
30.82
u/l
0.33
485
3463
315
2004
1.75
15.49
3.0
2.7
2.43
2.44
mmol/l
0.65
273
1805
377
2525
1.69
15.36
2.7
2.5
325.43
326.06
umol/l
0.04
335
2240
576
4296
1.60
15.24
15.0
11.4
1.21
1.19
inr
0.43
458
3581
283
1767
1.76
14.79
4.2
3.2
112.64
523.75
ng/l
3.63
196
1193
186
1021
1.96
14.63
2.4
2.1
373.19
370.83
nmol/l
0.05
170
952
481
3476
1.60
14.28
2.7
2.2
—
—
—
0
0
1213
11025
2.16
14.22
21.3
13.0
21.30
22.33
mg/l
0.54
1057
8864
501
3661
1.59
14.17
4.5
3.1
26.96
58.11
ng/l
0.84
301
2299
160
851
2.00
13.75
13.0
8.7
95.47
95.66
%
0.13
151
825
174
953
1.95
13.74
12.4
8.3
0.78
0.93
mmol/l
0.18
143
774
185
1039
1.91
13.55
2.6
3.0
1.68
1.73
%
0.38
158
947
150
787
2.02
13.38
13.6
9.0
120.75
121.11
g/l
0.08
143
769
98
440
2.33
12.95
1.6
1.6
16.49
8.36
u/ml
0.78
16
113
171
954
1.91
12.75
2.8
2.4
0.23
0.21
g/l
2.16
158
901
123
611
2.12
12.70
1.4
1.3
—
—
—
0
0
907
7689
1.57
12.58
4.0
3.1
42.12
41.10
u/l
0.18
870
7307
330
2240
1.63
12.37
1.5
1.3
28.91
30.71
iu/ml
0.08
76
643
171
967
1.88
12.22
12.4
8.2
5.03
5.13
kpa
0.78
163
926
171
968
1.88
12.18
12.4
8.2
12.11
12.80
kpa
1.04
163
927
69
271
2.63
12.14
2.6
2.8
3.81
2.86
index
0.32
31
136
202
1211
1.79
11.94
11.1
6.7
104.48
104.72
mmol/l
0.32
202
1211
170
967
1.87
11.92
12.8
8.2
7.43
7.42
ph
1.12
74
529
133
707
1.98
11.41
3.8
3.4
86.12
79.73
ng/l
0.34
113
619
1201
11026
1.93
11.38
23.3
14.3
3.93
3.94
mmol/l
0.63
1180
10757
1199
11002
1.92
11.37
23.1
14.2
139.57
139.69
mmol/l
1.00
1180
10753
126
660
2.00
11.26
4.3
4.0
7.42
7.41
ph
0.49
103
553
73
308
2.45
11.09
1.4
1.3
—
—
—
0
0
567
4436
1.49
10.90
2.4
2.0
—
—
—
0
0
126
677
1.95
10.47
4.3
3.9
5.13
5.16
kpa
0.16
120
657
240
1570
1.65
10.23
1.7
1.6
—
—
—
0
0
444
3344
1.49
10.12
5.7
5.9
—
—
—
0
0
440
3321
1.49
9.88
4.1
3.2
7.76
7.76
mmol/l
0.01
395
2839
144
824
1.84
9.87
14.5
8.7
—
—
—
0
0
208
1330
1.67
9.66
1.6
1.4
—
—
—
0
0
70
315
2.29
9.24
1.2
1.1
3.16
7.45
eliau/ml
0.79
13
49
297
2096
1.54
9.08
1.5
1.3
12.35
11.66
u/ml
0.03
96
833
43
155
2.83
8.97
2.1
1.9
5.45
4.97
mmol/24h
0.30
36
141
148
879
1.77
8.96
2.9
3.0
10.32
10.42
g/l
0.12
135
817
213
1408
1.61
8.62
2.1
2.2
29.85
29.26
s
0.71
203
1364
95
496
1.99
8.59
1.6
1.9
4.21
7.85
iu/ml
0.78
14
108
55
230
2.45
8.57
2.7
2.2
133.18
130.61
g/l
0.38
44
188
618
5073
1.41
8.47
11.3
10.3
0.00
0.00
e9/l
1.13
462
4162
95
502
1.96
8.30
1.8
1.6
0.30
0.29
mg/l
0.07
41
217
273
1928
1.52
8.24
3.2
2.6
516.81
535.53
mosm/kgh2o
0.66
235
1693
167
1052
1.67
8.16
1.4
1.5
—
—
—
0
0
94
498
1.96
8.16
2.6
2.3
—
—
—
0
0
72
346
2.14
8.13
1.2
1.2
8.78
2.45
u/ml
—
6
28
313
2280
1.49
8.13
2.8
2.4
5.97
7.17
e6/l
0.72
278
2076
119
683
1.82
8.08
2.2
1.8
1.33
1.41
g/l
0.18
110
633
72
348
2.13
8.02
1.2
1.2
21.16
7.99
u/ml
—
10
51
65
302
2.21
7.99
1.3
1.2
—
901.67
—
0
12
1092
9984
1.53
7.89
6.9
5.2
38.95
37.92
mmol/mol
3.14
1052
9377
48
197
2.49
7.80
1.2
1.0
—
—
—
0
0
143
877
1.71
7.72
1.4
1.3
181.01
210.69
u/ml
0.24
132
818
32
107
3.04
7.65
1.7
1.4
0.19
0.17
nmol/l
0.32
25
79
106
600
1.83
7.53
2.2
2.0
—
—
—
0
0
65
311
2.15
7.45
1.3
1.2
115.71
101.18
titre
—
7
34
378
2908
1.42
7.25
4.9
3.9
9.54
6.14
mg/mmol
0.82
240
1772
372
2857
1.42
7.19
4.2
3.3
51.77
35.67
mg/l
0.71
248
1791
73
372
2.02
7.10
2.0
2.0
1.40
1.46
g/l
0.19
66
333
89
487
1.89
7.04
4.6
4.1
—
—
—
0
0
1228
11613
1.76
6.95
14.7
10.6
26.05
25.27
u/l
0.65
1207
11306
64
315
2.08
6.84
1.6
1.6
9.57
10.46
g/l
1.01
55
284
536
4404
1.36
6.83
2.0
1.8
1.42
1.33
mmol/l
1.48
468
3771
44
185
2.43
6.83
1.2
1.1
4.10
1.81
eliau/ml
1.06
26
88
207
1441
1.52
6.60
2.6
2.0
—
—
—
0
0
610
5134
1.35
6.57
3.1
2.7
—
—
estimate
—
0
0
68
348
2.01
6.55
1.5
1.7
0.24
0.23
g/l
0.18
59
334
151
980
1.61
6.55
5.2
3.4
7.37
7.34
ph
2.29
113
693
70
363
1.98
6.50
1.5
1.7
1.15
1.19
g/l
0.57
62
348
36
142
2.58
6.40
1.4
1.3
—
—
—
0
0
148
962
1.61
6.38
3.8
4.2
7.39
7.38
ph
0.73
81
551
70
366
1.96
6.36
1.4
1.3
—
—
—
0
0
41
177
2.36
6.04
2.3
3.1
27.88
35.12
umol/l
1.57
34
161
185
1283
1.51
5.99
2.1
1.6
—
—
—
0
0
71
385
1.89
5.81
1.8
2.7
20.30
20.68
s
0.43
63
350
67
360
1.91
5.65
3.2
3.9
335.72
437.59
mg/l
0.25
25
164
32
127
2.56
5.64
1.5
1.6
58.43
25.07
ng/l
0.65
32
127
118
749
1.63
5.61
2.2
2.4
66.16
66.89
g/l
0.50
109
689
1226
11677
1.65
5.60
25.3
15.9
73.63
72.33
umol/l
0.84
1213
11537
44
204
2.20
5.52
1.2
1.0
—
—
—
0
0
1107
10333
1.43
5.47
5.6
4.4
5.90
5.75
mmol/l
3.12
1048
9527
122
786
1.61
5.47
2.7
3.0
74.37
68.75
e9/l
0.77
81
583
141
945
1.55
5.34
3.8
4.1
1.39
1.70
mmol/l
0.56
128
810
95
579
1.69
5.29
1.1
1.1
—
—
—
0
0
304
2362
1.37
5.28
1.8
1.7
—
—
—
0
0
277
2127
1.38
5.16
1.9
1.7
36752568.90
33019305.92
pmol/l
0.03
234
1802
121
799
1.57
4.90
2.5
2.5
21.58
22.11
au/ml
0.03
14
93
27
106
2.58
4.90
2.0
1.4
—
—
nmol/l
—
0
0
136
924
1.53
4.85
2.5
2.5
6.09
6.15
ph
0.31
89
610
352
2834
1.33
4.79
2.2
2.1
—
—
—
0
0
18
57
3.19
4.77
2.6
2.2
1.79
1.81
umol/l
0.03
18
50
38
177
2.18
4.75
1.2
1.3
3.45
3.65
u/ml
0.08
20
75
25
96
2.63
4.74
1.5
2.3
76.90
75.87
mmol/l
0.03
20
77
46
232
2.02
4.69
2.6
2.7
1.24
1.76
ratio
1.46
19
132
1132
10676
1.41
4.66
5.3
4.4
4.63
4.73
mmol/l
2.51
1086
10059
1143
10801
1.42
4.62
6.1
4.9
2.73
2.79
mmol/l
1.62
1093
10118
16
48
3.36
4.61
1.1
3.8
0.27
0.20
e9/l
—
8
29
111
730
1.57
4.59
1.4
1.3
30.76
34.53
au/ml
—
5
57
117
785
1.54
4.43
2.6
2.2
12.43
12.65
nmol/l
0.10
104
723
54
295
1.87
4.39
2.5
2.5
—
—
—
0
0
47
248
1.93
4.25
1.7
1.8
195.00
209.33
pmol/l
0.35
41
239
1123
10621
1.37
4.16
5.2
4.3
1.46
1.50
mmol/l
2.89
1072
9937
44
229
1.95
4.14
2.6
3.9
60.47
63.32
%
0.38
39
224
124
856
1.49
4.12
3.0
3.7
4.76
4.62
kpa
0.27
119
830
31
142
2.21
4.07
1.1
1.2
—
—
—
0
0
155
1121
1.43
4.06
1.5
1.4
—
—
—
0
0
88
567
1.59
3.99
1.7
1.6
326.04
298.94
mu/l
0.20
80
509
190
1435
1.38
3.88
4.0
3.0
3.97
4.78
e9/l
1.63
157
1264
54
309
1.78
3.82
2.3
1.9
3.92
4.57
iu/l
0.25
26
117
75
471
1.63
3.79
1.2
1.3
—
—
—
0
0
75
472
1.62
3.76
1.4
1.2
0.29
1.23
u/ml
—
7
34
188
1425
1.37
3.76
1.3
1.3
—
—
—
0
0
133
958
1.43
3.58
1.4
1.2
126.94
138.24
u/ml
0.14
44
379
14
46
3.07
3.53
1.1
1.2
129.32
146.09
nmol/l
0.57
14
46
23
99
2.35
3.51
1.1
2.8
41.93
41.49
%
0.05
23
99
58
349
1.69
3.47
1.1
1.2
—
—
—
0
0
25
113
2.24
3.43
1.4
2.8
1351.00
1273.34
e6/l
0.17
20
99
37
195
1.92
3.41
1.2
1.7
0.70
0.81
g/l
0.32
30
160
1195
11494
1.40
3.31
17.9
11.6
—
—
—
0
0
97
669
1.49
3.28
2.1
2.2
3.75
6.95
ug/l
3.49
80
590
320
2662
1.27
3.26
4.4
3.6
1.02
1.02
kg/l
0.44
203
1717
21
90
2.35
3.25
1.4
1.1
—
—
—
0
0
20
84
2.40
3.23
1.5
1.5
6.46
5.60
ug/l
0.34
20
73
50
295
1.72
3.23
3.0
2.3
—
—
—
0
0
22
97
2.29
3.20
2.7
2.4
16.64
12.07
index
0.79
14
59
391
3341
1.24
3.14
4.7
3.7
0.00
0.00
estimate
1.34
129
1210
31
162
1.94
2.96
2.1
2.4
122.45
92.31
ug/min
0.15
25
93
30
155
1.96
2.96
1.1
1.1
—
—
—
0
0
104
747
1.43
2.88
1.4
1.4
25.20
23.43
iu/l
0.22
75
632
10
27
3.72
2.88
1.8
1.3
94.70
86.11
nmol/24h
—
10
27
1061
10083
1.26
2.87
4.5
3.7
1.30
1.23
mmol/l
2.91
1000
9355
17
71
2.41
2.80
1.8
2.4
—
—
—
0
0
53
332
1.62
2.78
6.5
8.4
—
—
—
0
0
5
6
8.36
2.75
1.2
2.2
4.10
4.07
mmol/l
—
5
6
36
204
1.79
2.71
1.2
1.2
—
—
—
0
0
1253
12208
1.47
2.68
31.6
20.0
259.26
256.39
e9/l
0.81
1230
11982
33
183
1.82
2.67
3.8
3.6
—
—
—
0
0
97
700
1.42
2.64
2.7
2.2
4095.74
6392.33
u/l
0.45
32
286
1253
12212
1.46
2.63
31.5
19.9
90.74
90.51
fl
1.01
1245
12087
1253
12214
1.46
2.61
31.4
19.9
30.19
30.15
pg
0.32
1245
12087
1253
12214
1.46
2.61
32.8
20.3
39.95
40.64
%
1.08
1245
12081
92
1260
0.71
2.60
1.4
1.3
—
—
—
0
0
1253
12215
1.46
2.60
31.6
20.0
4.46
4.50
e12/l
2.59
1227
11957
1253
12217
1.45
2.57
31.7
20.0
6.70
6.64
e9/l
0.53
1226
11953
18
81
2.24
2.54
1.2
1.1
—
—
—
0
0
318
2713
1.23
2.54
5.6
4.6
—
—
—
0
0
19
88
2.18
2.51
1.4
3.1
185.36
230.32
e6/l
0.77
14
76
1253
12224
1.44
2.49
31.8
20.1
133.42
134.95
g/l
3.84
1245
12097
41
251
1.65
2.39
1.1
1.1
5.83
14.40
au/ml
—
8
68
8
22
3.65
2.36
2.5
2.2
—
—
—
0
0
30
169
1.79
2.34
1.2
1.2
4003.26
186.36
iu/ml
—
8
40
34
199
1.73
2.33
1.4
2.0
1.13
0.81
nmol/l
0.83
26
167
22
112
1.98
2.31
1.7
2.2
—
—
—
0
0
27
148
1.84
2.29
1.4
1.5
6.93
7.28
mmol/l
0.32
27
132
11
40
2.76
2.27
1.5
1.1
—
—
—
0
0
77
549
1.43
2.27
3.2
3.3
124.86
129.73
g/l
0.97
72
532
33
194
1.72
2.24
1.2
1.1
—
—
—
0
0
18
86
2.11
2.23
1.3
1.1
95.61
118.85
pmol/l
1.55
18
86
18
86
2.11
2.23
1.4
3.1
469.85
505.11
e6/l
0.14
13
71
87
637
1.39
2.21
2.7
1.8
—
—
—
0
0
75
535
1.43
2.21
1.3
1.3
232.42
236.26
miu/ml
0.03
38
263
70
494
1.44
2.19
4.8
5.6
—
—
—
0
0
23
122
1.90
2.17
2.4
3.1
20.65
21.76
nmol/l
0.21
23
115
73
521
1.42
2.15
2.4
1.9
—
—
—
0
0
71
505
1.43
2.14
6.6
7.7
24.71
24.47
mmol/l
0.21
65
482
17
81
2.11
2.13
1.2
1.0
—
—
—
0
0
18
88
2.06
2.12
1.6
1.6
14.06
11.47
umol/l
0.42
18
79
40
253
1.60
2.08
2.3
1.6
8100.04
9181.31
e6/l
0.11
24
183
246
2086
1.22
2.07
5.1
5.0
1.52
2.77
ug/l
1.94
229
1883
5
10
5.01
2.07
1.0
1.1
—
—
—
0
0
5
10
5.01
2.07
2.8
2.2
—
—
—
0
0
22
117
1.90
2.07
3.3
2.3
0.76
0.88
%
—
10
78
118
917
1.31
2.06
3.8
4.4
3.88
23.56
ug/l
1.50
93
742
10
38
2.64
2.00
1.0
1.3
4.30
0.72
u/ml
—
10
38
119
931
1.31
1.99
5.5
4.4
0.15
0.10
%
0.14
41
224
19
98
1.95
1.95
4.2
4.3
24.24
74.85
u/ml
—
9
28
6
16
3.76
1.93
1.3
1.2
—
—
—
0
0
48
325
1.49
1.88
2.8
3.3
21.98
833.59
u/ml
1.46
40
275
122
968
1.29
1.85
5.4
4.3
0.43
0.95
%
2.18
44
261
90
686
1.33
1.82
2.6
1.8
—
—
—
0
0
409
4534
0.86
1.81
3.1
2.7
—
—
—
0
0
17
87
1.97
1.80
1.2
1.1
—
—
—
0
0
46
312
1.49
1.80
1.0
1.1
4.75
5.24
u/ml
0.06
26
193
11
47
2.35
1.78
1.5
1.1
159.70
98.04
nmol/l
—
5
35
50
347
1.46
1.75
2.5
2.0
3.56
2.38
ug/l
0.23
45
302
133
1075
1.26
1.75
2.0
1.9
0.20
0.02
estimate
0.66
25
235
90
692
1.32
1.73
2.7
1.8
—
—
—
0
0
89
684
1.32
1.72
2.7
1.8
—
—
—
0
0
13
61
2.14
1.72
3.1
2.3
25.69
28.02
umol/l
0.41
13
53
501
4579
1.15
1.71
4.6
3.5
0.00
0.06
estimate
1.68
107
1067
29
179
1.63
1.70
2.0
1.6
—
—
—
0
0
15
75
2.01
1.70
2.2
2.6
1.71
2.00
u/field
—
7
41
39
259
1.52
1.69
1.4
1.7
5.44
31.27
e6/l
0.60
32
198
88
678
1.32
1.68
2.1
3.2
23.82
81.83
u/ml
2.36
82
650
58
418
1.41
1.68
1.2
1.4
—
15.27
—
0
10
37
245
1.52
1.64
1.5
1.7
—
—
—
0
0
11
49
2.26
1.63
1.1
4.0
11697.27
64.47
mg/l
0.47
11
36
39
262
1.50
1.62
1.5
1.7
1217.61
812.28
e6/l
0.21
33
209
17
91
1.88
1.61
1.2
1.1
—
—
—
0
0
118
952
1.26
1.59
5.6
4.7
0.03
0.17
%
1.55
38
211
80
615
1.32
1.56
2.3
3.0
157.76
171.51
ng/l
0.15
73
562
40
273
1.48
1.55
1.3
1.3
238.42
235.75
u/ml
0.03
26
158
372
3349
1.15
1.55
4.0
2.9
0.00
0.09
estimate
0.96
108
1025
13
64
2.04
1.54
2.3
2.8
622.69
869.11
u/ml
0.50
13
64
20
115
1.75
1.53
3.5
2.2
32.10
31.50
pg
0.31
20
115
73
556
1.33
1.52
2.0
1.9
0.06
1.36
estimate
0.47
17
184
5
15
3.34
1.52
1.2
1.3
5.72
5.91
mmol/l
—
5
15
115
931
1.26
1.52
5.4
4.2
0.44
0.65
%
0.68
41
248
59
438
1.36
1.46
1.4
1.5
8.34
8.73
u/l
0.09
40
338
16
87
1.85
1.46
2.2
2.2
1.29
0.98
g/24h
0.31
11
45
5
16
3.13
1.44
1.8
2.1
—
—
—
0
0
34
230
1.49
1.40
3.4
3.4
29.63
25.59
mg/l
0.17
18
154
51
375
1.37
1.36
1.2
1.2
—
—
—
0
0
19
113
1.69
1.32
1.2
1.2
—
—
—
0
0
17
98
1.74
1.31
1.1
1.2
35.74
30.80
mg/l
0.20
17
75
148
1254
1.20
1.30
3.5
3.0
0.69
0.73
ug/l
0.21
95
747
42
303
1.40
1.26
1.0
1.1
0.48
1.42
u/ml
1.09
21
155
65
503
1.31
1.26
1.1
1.1
—
—
—
0
0
17
100
1.71
1.23
1.1
1.3
0.70
2.67
u/ml
—
10
51
17
100
1.71
1.23
1.1
1.1
0.27
2.32
u/ml
—
9
42
5
19
2.64
1.21
1.6
1.5
—
—
—
0
0
64
497
1.30
1.21
1.4
1.3
—
—
—
0
0
13
71
1.84
1.19
1.2
1.2
—
—
—
0
0
989
9569
1.13
1.19
26.3
16.6
332.00
332.40
g/l
0.72
983
9505
85
688
1.25
1.17
2.8
1.8
—
—
—
0
0
17
102
1.68
1.16
1.1
1.1
—
—
—
0
0
7
30
2.34
1.12
1.3
1.4
—
—
—
0
0
8
40
2.01
1.12
1.1
1.9
30.25
27.70
%
—
8
40
19
119
1.61
1.12
1.1
1.1
20.31
17.06
u/ml
—
7
56
21
135
1.56
1.11
2.6
2.2
—
—
—
0
0
16
96
1.67
1.10
1.6
1.3
2961.57
53364.79
e6/l
—
7
61
12
66
1.83
1.09
2.7
1.8
—
—
—
0
0
19
120
1.59
1.09
1.7
2.2
—
—
—
0
0
5
22
2.28
1.03
1.0
1.4
4.78
5.08
nmol/l
—
5
22
47
359
1.32
1.03
1.1
1.2
1.86
3.21
u/ml
0.36
25
205
5
23
2.18
0.98
1.8
1.3
12.00
16.57
g/l
—
5
17
7
37
1.90
0.94
1.4
1.6
—
—
—
0
0
60
481
1.26
0.94
3.1
1.9
—
—
—
0
0
16
101
1.59
0.93
1.1
1.1
0.15
1.69
u/ml
—
5
34
6
27
2.23
0.93
1.7
1.8
—
—
—
0
0
24
167
1.45
0.92
3.5
3.4
—
—
—
0
0
101
858
1.19
0.91
1.4
1.4
—
—
—
0
0
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
15
94
1.60
0.90
1.1
1.1
218.00
210.24
mg/l
0.06
15
82
38
491
0.77
0.86
1.1
1.1
0.65
0.63
ratio
—
6
53
93
790
1.19
0.85
2.2
2.1
0.11
0.37
e6/l
2.57
83
752
40
513
0.77
0.85
1.2
1.1
1.46
1.55
g/l
1.57
40
513
6
31
1.94
0.84
1.3
1.5
136.08
139.73
mmol/24h
—
6
31
8
45
1.78
0.84
3.6
3.2
—
—
—
0
0
94
1095
0.85
0.82
1.6
1.7
3.51
3.46
mmol/l
0.16
67
754
6
32
1.88
0.82
1.8
1.4
—
—
—
0
0
13
81
1.61
0.81
1.5
1.4
0.80
1.17
promille
0.60
13
63
24
172
1.40
0.81
2.9
4.3
1.95
2.38
mmol/l
0.53
17
114
93
796
1.18
0.80
4.7
3.3
1.22
1.23
mmol/l
0.37
76
669
6
33
1.82
0.79
1.0
1.1
27.50
28.06
s
—
6
33
6
33
1.82
0.79
2.0
1.4
—
—
—
0
0
0
27
0.00
0.77
0.0
1.3
—
13.29
—
0
11
40
316
1.27
0.74
1.1
1.1
2.18
1.72
u/ml
0.14
23
176
7
41
1.71
0.70
1.7
1.3
—
—
—
0
0
18
127
1.42
0.68
2.8
2.3
—
—
—
0
0
130
1450
0.89
0.65
1.8
1.9
3.55
3.43
ratio
0.51
100
1105
11
70
1.58
0.65
1.6
1.5
4.05
3.06
mg/l
0.38
11
65
30
233
1.29
0.65
1.4
1.5
141.75
143.70
au/ml
—
8
61
30
233
1.29
0.65
1.6
2.6
3.33
6.38
umol/l
2.18
22
174
43
524
0.81
0.64
1.2
1.2
0.85
0.88
g/l
0.37
43
524
33
412
0.80
0.61
1.4
1.5
—
—
—
0
0
38
307
1.24
0.61
1.4
1.3
—
—
—
0
0
8
51
1.57
0.60
3.6
2.9
—
—
—
0
0
17
122
1.40
0.60
1.8
1.8
—
—
—
0
0
30
236
1.28
0.60
1.0
1.1
0.96
6.46
u/ml
—
10
113
32
255
1.26
0.58
1.3
1.5
—
—
—
0
0
13
89
1.47
0.58
1.1
1.0
—
—
—
0
0
6
36
1.67
0.56
1.5
2.4
13.28
15.61
umol/l
—
6
36
34
418
0.81
0.56
1.4
1.6
—
—
—
0
0
14
99
1.42
0.54
1.0
1.2
—
—
—
0
0
32
258
1.25
0.54
1.6
1.5
0.53
0.38
nmol/l
0.34
24
211
7
45
1.56
0.49
6.6
1.6
—
—
—
0
0
105
949
1.12
0.48
5.4
3.6
—
—
—
0
0
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
12
85
1.42
0.47
4.6
2.2
1.19
1.19
mmol/l
0.05
12
85
28
227
1.24
0.47
1.0
1.1
0.10
0.30
u/ml
—
7
82
5
82
0.61
0.46
2.4
1.3
6.30
6.89
mmol/l
—
5
74
85
945
0.89
0.44
1.5
1.6
1008.46
1000.33
mu/l
0.03
76
811
28
229
1.23
0.44
1.8
1.8
—
—
—
0
0
32
266
1.21
0.43
1.2
1.1
—
—
—
0
0
32
266
1.21
0.43
1.2
1.1
—
—
—
0
0
5
31
1.62
0.43
4.2
2.7
—
—
—
0
0
11
151
0.73
0.43
1.4
1.3
—
—
—
0
0
31
258
1.21
0.42
1.1
1.1
5.23
4.41
u/ml
0.06
14
137
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
3.0
—
434.13
—
0
15
0
15
0.00
0.41
0.0
1.2
—
47.14
—
0
7
0
15
0.00
0.41
0.0
1.1
—
0.16
—
0
7
0
16
0.00
0.41
0.0
5.2
—
7.33
—
0
16
5
34
1.47
0.40
6.0
6.1
4.00
7.76
%
—
5
34
5
34
1.47
0.40
3.0
3.0
15.40
44.79
%
—
5
34
10
71
1.41
0.39
1.8
1.7
—
—
—
0
0
17
215
0.79
0.39
8.5
4.6
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
0.02
—
0
19
0
19
0.00
0.39
0.0
1.3
—
67.63
—
0
19
16
124
1.29
0.38
5.4
2.6
—
—
—
0
0
11
80
1.38
0.38
1.1
1.4
—
—
—
0
0
12
89
1.35
0.38
4.6
2.2
4.10
3.98
mmol/l
0.42
12
89
12
89
1.35
0.38
4.6
2.2
107.67
105.63
mmol/l
1.02
12
89
18
145
1.24
0.33
1.6
1.6
—
—
—
0
0
13
100
1.30
0.33
1.2
1.1
—
—
—
0
0
11
83
1.33
0.32
2.5
1.5
46.67
36.00
%
—
6
51
14
110
1.28
0.31
1.9
1.6
90.35
90.40
%
0.01
14
110
7
55
1.27
0.30
1.7
2.3
167.86
133.40
nmol/l
—
7
50
8
64
1.25
0.27
1.0
1.0
—
—
—
0
0
11
86
1.28
0.26
1.1
1.2
—
—
—
0
0
182
1738
1.05
0.26
1.6
1.6
—
—
—
0
0
6
85
0.70
0.24
2.5
1.7
—
—
—
0
0
18
152
1.19
0.23
1.2
1.5
—
—
—
0
0
18
152
1.19
0.23
1.2
1.5
—
—
—
0
0
18
152
1.19
0.23
1.2
1.5
—
—
—
0
0
18
152
1.19
0.23
1.2
1.5
—
—
—
0
0
5
40
1.25
0.22
5.2
3.5
—
—
—
0
0
5
40
1.25
0.22
1.6
3.6
15.56
15.59
%
—
5
40
0
10
0.00
0.21
0.0
1.2
—
140.40
—
0
5
0
10
0.00
0.21
0.0
1.0
—
0.06
—
0
10
0
12
0.00
0.21
0.0
3.5
—
44.57
—
0
7
0
13
0.00
0.21
0.0
1.6
—
4.71
—
0
7
31
278
1.12
0.20
2.3
3.5
54.65
57.00
%
0.38
31
278
6
48
1.25
0.20
1.7
1.9
—
42.29
—
0
7
186
1794
1.04
0.19
1.9
1.8
—
—
—
0
0
6
51
1.18
0.19
1.0
1.9
0.00
0.00
estimate
—
6
51
14
118
1.19
0.19
1.4
1.1
—
—
—
0
0
6
53
1.13
0.18
1.3
1.7
77.17
111.53
ng/l
—
6
53
13
110
1.18
0.17
1.2
1.2
—
—
—
0
0
5
70
0.71
0.16
1.6
1.6
0.60
0.48
e9/l
—
5
70
6
76
0.79
0.15
1.2
1.4
—
—
—
0
0
6
80
0.75
0.15
1.3
1.2
—
—
—
0
0
22
197
1.12
0.15
1.3
1.2
—
—
—
0
0
130
1342
0.97
0.12
1.7
1.8
—
—
—
0
0
11
95
1.16
0.11
1.5
2.1
64.50
34.22
mg/l
—
6
64
5
44
1.14
0.10
2.8
1.5
1.26
1.27
nmol/l
—
5
33
11
97
1.14
0.09
1.2
1.5
—
—
—
0
0
6
71
0.84
0.07
1.3
1.3
63.33
76.65
umol/l
—
6
71
14
129
1.09
0.05
3.3
2.1
—
—
—
0
0
68
691
0.98
0.02
1.9
1.7
—
—
—
0
0
353
3516
1.01
0.02
1.6
1.6
—
—
—
0
0
13
132
0.98
0.00
1.3
1.7
8.65
7.66
mmol/l
0.75
13
127
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
-0.00
1.0
1.1
505.02
169.82
iu/ml
—
5
56
5
49
1.02
-0.00
2.8
2.9
6.60
8.28
mmol/l
—
5
49
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
0.52
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
70
1.00
-0.00
3.0
1.4
—
—
—
0
0
6
63
0.95
-0.00
1.0
1.3
159.00
178.29
pmol/l
—
6
63
0
5
0.00
-0.00
0.0
1.0
—
1.01
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
7.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
66.13
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
8
81
0.99
-0.00
2.5
1.5
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_LACTOSEINT – Lactose intolerance

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).